Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same

ABSTRACT

The present invention provides a substantially purified nucleic acid molecule encoding a Brassica oleracea APETALA1 (AP1) gene product, Brassica oleracea var. botrytis AP1 gene product or a Zea mays AP1 gene product. The invention also provides a substantially purified Brassica oleracea AP1 gene product, a substantially purified Brassica oleracea var. botrytis AP1 gene product or a substantially purified Zea mays AP1 gene product in addition to an antibody that specifically binds such an AP1 gene product. In addtion, the invention provides an expression vector containing a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a heterologous regulatory element. Kits for converting shoot meristem to floral meristem in an angiosperm and kits for promoting early reproductive development in a seed plant also are provided.

This work was supported by grant DCB-9018749 awarded by the NationalScience Foundation and by grant USDA 93-37304 awarded by the UnitedStates Department of Agriculture. The United States Government hascertain rights in this invention.

BACKGROUND OF THE INVENTION

1. Field of the Invention

This invention relates generally to the field of plant geneticengineering and more specifically to genes involved in the regulation ofplant reproductive development.

2. Background of the Invention

A flower is the reproductive structure of a flowering plant. Followingfertilization, the ovary of the flower becomes a fruit and bears seeds.As a practical consequence, production of fruit and seed-derived cropssuch as grapes, beans, corn, wheat, rice and hops is dependent uponflowering.

Early in the life cycle of a flowering plant, vegetative growth occurs,and roots, stems and leaves are formed. During the later period ofreproductive growth, flowers as well as new shoots or branches develop.However, the factors responsible for the transition from vegetative toreproductive growth, and the onset of flowering, are poorly understood.

A variety of external signals, such as length of daylight andtemperature, affect the time of flowering. The time of flowering also issubject to genetic controls that prevent young plants from floweringprematurely. Thus, the pattern of genes expressed in a plant is animportant determinant of the time of flowering.

Given these external signals and genetic controls, a relatively fixedperiod of vegetative growth precedes flowering in a particular plantspecies. The length of time required for a crop to mature to floweringlimits the geographic location in which it can be grown and can be animportant determinant of yield. In addition, since the time of floweringdetermines when a plant is reproductively mature, the pace of a plantbreeding program also depends upon the length of time required for aplant to flower.

Traditionally, plant breeding involves generating hybrids of existingplants, which are examined for improved yield or quality. Theimprovement of existing plant crops through plant breeding is central toincreasing the amount of food grown in the world since the amount ofland suitable for agriculture is limited. For example, the developmentof new strains of wheat, corn and rice through plant breeding hasincreased the yield of these crops grown in underdeveloped countriessuch as Mexico, India and Pakistan. Unfortunately, plant breeding isinherently a slow process since plants must be reproductively maturebefore selective breeding can proceed.

For some plant species, the length of time needed to mature to floweringis so long that selective breeding, which requires several rounds ofbackcrossing progeny plants with their parents, is impractical. Forexample, perennial trees such as walnut, hickory, oak, maple and cherrydo not flower for several years after planting. As a result, breeding ofsuch plant species for insect or disease-resistance or to produceimproved wood or fruit, for example, would require decades, even if onlya few rounds of selection were performed.

Methods of promoting early reproductive development can make breeding oflong generation seed plants such as trees practical for the first time.Methods of promoting early reproductive development also would be usefulfor shortening growth periods, thereby broadening the geographic rangein which a crop such as rice, corn or coffee can be grown.Unfortunately, methods for promoting early reproductive development in aseed plant have not yet been described. Thus, there is a need formethods that promote early reproductive development. The presentinvention satisfies this need and provides related advantages as well.

SUMMARY OF THE INVENTION

The present invention provides a substantially purified nucleic acidmolecule encoding a Brassica oleracea APETALA1 (AP1) gene product, aBrassica oleracea var. botrytis AP1 gene product and a Zea mays AP1 geneproduct. Methods of producing an AP1 gene product by expressing anucleic acid molecule encoding a Brassica oleracea AP1 gene product, aBrassica oleracea var. botrytis AP1 gene product or a Zea mays AP1 geneproduct also are provided.

The invention further provides a substantially purified Brassicaoleracea AP1 gene product, a substantially purified Brassica oleraceavar. botrytis AP1 gene product and a substantially purified Zea mays AP1gene product. In addition, the invention provides an antibody, such as amonoclonal antibody, that specifically binds an AP1 gene product of theinvention.

The invention also provides an expression vector, such as a plantexpression vector, which contains a nucleic acid molecule encoding afloral meristem identity gene product such as AP1, CAL or LFY operablylinked to a heterologous regulatory element. In addition, the presentinvention provides a kit for converting shoot meristem to floralmeristem, which contains a plant expression vector having a nucleic acidmolecule encoding a floral meristem identity gene product operablylinked to a heterologous regulatory element in an angiosperm. Theinvention additionally provides a kit for promoting early reproductivedevelopment in a seed plant, which contains a plant expression vectorhaving a nucleic acid molecule encoding a floral meristem identity geneproduct operably linked to a heterologous regulatory element.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates a western-blot analysis of tissues from wild type andmutant Arabidopsis plants with anti-AP1 antisera.

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides a non-naturally occurring seed plantcontaining a first ectopically expressible nucleic acid moleculeencoding a first floral meristem identity gene product, provided thatthe nucleic acid molecule is not ectopically expressed due to a mutationin an endogenous TERMINAL FLOWER gene. For example, the inventionprovides a transgenic seed plant containing a first ectopicallyexpressible floral meristem identity gene product such as APETALA1(AP1), CAULIFLOWER (CAL) or LEAFY (LFY). A transgenic seed plant can be,for example, an angiosperm such as a cereal plant, leguminous plant,oilseed plant, hardwood tree, fruit-bearing plant or ornamental floweror a gymnosperm such as a coniferous tree.

A flower, like a leaf or shoot, is derived from the shoot apicalmeristem, which is a collection of undifferentiated cells set asideduring embryogenesis. The production of vegetative structures, such asleaves or shoots, and of reproductive structures, such as flowers, istemporally segregated, such that a leaf or shoot arises early in a plantlife cycle, while a flower develops later. The transition fromvegetative to reproductive development is the consequence of a processtermed floral induction (Yanofsky, Ann. Rev. Plant Physiol, Plant Mol.Biol. 46:167-188 (1995), which is incorporated herein by reference).

Once induced, shoot apical meristem either persists and produces floralmeristem, which gives rise to flowers, and lateral meristem, which givesrise to branches, or is itself converted to floral meristem. Floralmeristem differentiates into a single flower having a fixed number offloral organs in a whorled arrangement. Dicots, for example, containfour whorls (concentric rings), in which sepals (first whorl) and petals(second whorl) surround stamens (third whorl) and carpels (fourthwhorl).

Although shoot meristem and floral meristem both consist of meristemictissue, shoot meristem is distinguishable from the more specializedfloral meristem. Shoot meristem generally is indeterminate and givesrise to an unspecified number of floral and lateral meristems. Incontrast, floral meristem is determinate and gives rise to the fixednumber of floral organs that comprise a flower.

By convention herein, a wild-type gene sequence is represented in uppercase italic letters (for example, APETALA1), and a wild-type geneproduct is represented in upper case non-italic letters (APETALA1).Further, a mutant gene allele is represented in lower case italicletters (ap1), and a mutant gene product is represented in lower casenon-italic letters (ap1).

Genetic studies have identified a number of genes involved in regulatingflower development. These genes can be classified into different groupsdepending on their function. Flowering time genes, for example, areinvolved in floral induction and regulate the transition from vegetativeto reproductive growth. In comparison, the floral meristem identitygenes, which are the subject matter of the present invention asdisclosed herein, encode proteins that promote the conversion of shootmeristem to floral meristem in an angiosperm. In addition, floral organidentity genes encode proteins that determine whether sepals, petals,stamens or carpels are formed during floral development (Yanofsky,supra, 1995; Weigel, Ann. Rev. Genetics 29:19-39 (1995), which isincorporated herein by reference). Some of the floral meristem identitygene products also have a role in specifying floral organ identity.

Floral meristem identity genes have been identified by characterizinggenetic mutations that prevent or alter floral meristem formation. Amongfloral meristem identity gene mutations in Arabidopsis thaliana, thosein the gene LEAFY (LFY) generally have the strongest effect on floralmeristem identity. Mutations in LFY completely transform the basal-mostflowers into secondary shoots and have variable effects on later-arising(apical) flowers. In comparison, mutations in the floral meristemidentity gene APETALA1 (AP1) result in replacement of a few basalflowers by inflorescence shoots that are not subtended by leaves. Anapical flower produced in an ap1 mutant has an indeterminate structure,in which a flower arises within a flower. These mutant phenotypesindicate that both AP1 and LFY contribute to establishing the identityof the floral meristem although neither gene is absolutely required. Thephenotype of lfy ap1 double mutants, in which structures withflower-like characteristics are very rare, indicates that LFY and AP1encode partially redundant activities.

In addition to the LFY and AP1 genes, a third locus that greatlyenhances the ap1 mutant phenotype has been identified in Arabidopsis.This locus, designated CAULIFLOWER (CAL), derives its name from theresulting "cauliflower" phenotype, which is strikingly similar to thecommon garden variety of cauliflower (Kempin et al., Science 267:522-525(1995), which is incorporated herein by reference). In an ap1 cal doublemutant, floral meristem behaves as shoot meristem in that there is amassive proliferation of meristems in the position that normally wouldbe occupied by a single flower. However, an Arabidopsis mutant lackingonly CAL, such as cal-1, has a normal phenotype, indicating that AP1 cansubstitute for the loss of CAL in these plants. In addition, becausefloral meristem that forms in an ap1 mutant behaves as shoot meristem inan ap1 cal double mutant, CAL can largely substitute for AP1 inspecifying floral meristem. These genetic data indicate that CAL and AP1encode activities that are partially redundant in converting shootmeristem to floral meristem.

Other genetic loci play at least minor roles in specifying floralmeristem identity. For example, although a mutation in APETALA2 (AP2)alone does not result in altered inflorescence characteristics, ap2 ap1double mutants have indeterminate flowers (flowers with shoot-likecharacteristics; Bowman et al., Development 119:721-743 (1993), which isincorporated herein by reference). Also, mutations in the CLAVATA1(CLV1) gene result in an enlarged meristem and lead to a variety ofphenotypes (Clark et al., Development 119:397-418 (1993)). In a clv1 ap1double mutant, formation of flowers is initiated, but the center of eachflower often develops as an indeterminate inflorescence. Thus, mutationsin CLAVATA1 result in the loss of floral meristem identity in the centerof wild-type flowers. Genetic evidence also indicates that the geneproduct of UNUSUAL FLORAL ORGANS (UFO) plays a role in determining theidentity of floral meristem. Additional floral meristem identity genesassociated with altered floral meristem formation remain to be isolated.

Mutations in another locus, designated TERMINAL FLOWER (TFL), producephenotypes that generally are reversed as compared to mutations in thefloral meristem identity genes. For example, tfl mutants flower early,and the indeterminate apical and lateral meristems develop asdeterminate floral meristems (Alvarez et al., Plant J. 2:103-116(1992)). These characteristics indicate that the TFL promotesmaintenance of shoot meristem. TFL also acts directly or indirectly tonegatively regulate AP1 and LFY expression in shoot meristem since theseAP1 and LFY are ectopically expressed in the shoot meristem of tflmutants (Gustafson-Brown et al., Cell 76:131-143 (1994); Weigel et al.,Cell 69:843-859 (1992)). It is recognized that a plant having a mutationin TFL can have a phenotype similar to a non-naturally occurring seedplant of the invention. Such tfl mutants, however, which have a mutationin an endogenous TERMINAL FLOWER gene, are explicitly excluded from thescope of the present invention.

The results of such genetic studies indicate that several floralmeristem identity gene products, including AP1, CAL and LFY, actredundantly to convert shoot meristem to floral meristem in anangiosperm. As disclosed herein, ectopic expression of a single floralmeristem identity gene product such as AP1, CAL or LFY is sufficient toconvert shoot meristem to floral meristem in an angiosperm. Thus, thepresent invention provides a non-naturally occurring seed plant such asan angiosperm or gymnosperm that contains a first ectopicallyexpressible nucleic acid molecule encoding a first floral meristemidentity gene product, provided that such ectopic expression is not dueto a mutation in an endogenous TERMINAL FLOWER gene.

As disclosed herein, an ectopically expressible nucleic acid moleculeencoding a floral meristem identity gene product can be, for example, atransgene encoding a floral meristem identity gene product under controlof a heterologous gene regulatory element. In addition, such anectopically expressible nucleic acid molecule can be an endogenousfloral meristem identity gene coding sequence that is placed undercontrol of a heterologous gene regulatory element. The ectopicallyexpressible nucleic acid molecule also can be, for example, anendogenous floral meristem identity gene having a modified generegulatory element such that the endogenous floral meristem identitygene is no longer subject to negative regulation by TFL.

The term "ectopically expressible" is used herein to refer to a nucleicacid molecule encoding a floral meristem identity gene product that canbe expressed in a tissue other than a tissue in which it normally isexpressed or at a time other than the time at which it normally isexpressed, provided that the floral meristem identity gene product isnot expressed from its native, naturally occurring promoter. Ectopicexpression of a floral meristem identity gene product is a result of theexpression of the gene coding region from a heterologous promoter orfrom a modified variant of its own promoter, such that expression of thefloral meristem identity gene product is no longer in the tissue inwhich it normally is expressed or at the time at which it normally isexpressed. An exogenous nucleic acid molecule encoding an AP1 geneproduct under control of its native, wild type promoter, for example,does not constitute an ectopically expressible nucleic acid moleculeencoding a floral meristem identity gene product. However, a nucleicacid molecule encoding an AP1 gene product under control of aconstitutive promoter, which results in expression of AP1 in a tissuesuch as shoot meristem where it is not normally expressed, is anectopically expressible nucleic acid molecule as defined herein.

Actual ectopic expression of a floral meristem identity gene isdependent on various factors and can be constitutive or inducibleexpression. For example, AP1, which normally is expressed in floralmeristem, is ectopically expressible in the shoot meristem of anangiosperm. As disclosed herein, when a floral meristem identity geneproduct such as AP1, CAL or LFY is ectopically expressed in shootmeristem in an angiosperm, the shoot meristem is converted to floralmeristem and early reproductive development can occur (see Examples I,III and IV).

An ectopically expressible nucleic acid molecule encoding a floralmeristem identity gene product can be expressed prior to the time indevelopment at which the corresponding endogenous gene normally isexpressed. For example, an Arabidopsis plant grown under continuouslight conditions expresses AP1 just prior to day 18, when normalreproductive development (flowering) begins. However, as disclosedherein, AP1 can be ectopically expressed in shoot meristem prior to day18, resulting in early conversion of shoot meristem to floral meristemand early reproductive development. As disclosed in Example ID, atransgenic Arabidopsis plant that ectopically expresses AP1 in shootmeristem under control of a constitutive promoter can flower at day 10,which is earlier than the time of reproductive development for anon-transgenic plant grown under the same conditions (day 18). It isrecognized that in some transgenic seed plants containing, for example,an exogenous nucleic acid molecule encoding AP1 under control of aconstitutive promoter, neither the exogenous nor endogenous AP1 will beexpressed. Such transgenic plants in which AP1 gene expression iscosuppressed, although not characterized by early reproductivedevelopment, also can be valuable as disclosed below.

As used herein, the term "floral meristem identity gene product" means agene product that promotes conversion of shoot meristem to floralmeristem in an angiosperm. As disclosed herein in Examples I, II andIII, expression of a floral meristem identity gene product such as AP1,CAL or LFY in shoot meristem can convert shoot meristem to floralmeristem in an angiosperm. Furthermore, ectopic expression of a floralmeristem identity gene product also can promote early reproductivedevelopment (see Example ID).

A floral meristem identity gene product is distinguishable from a lateflowering gene product or an early flowering gene product. The use of alate flowering gene product or an early flowering gene product is notencompassed within the scope of the present invention. In addition,reference is made herein to an "inactive" floral meristem identity geneproduct, as exemplified by the product of the Brassica oleracea var.botrytis CAL gene (BobCAL) (see below). Expression of an inactive floralmeristem identity gene product in an angiosperm does not result in theconversion of shoot meristem to floral meristem in the angiosperm. Aninactive floral meristem identity gene product such as BobCAL isexcluded from the meaning of the term "floral meristem identity geneproduct" as defined herein.

A floral meristem identity gene product can be, for example, an AP1 geneproduct having the amino acid sequence of SEQ ID NO: 2, which is a 256amino acid gene product encoded by the Arabidopsis thaliana AP1 cDNA.The Arabidopsis AP1 cDNA encodes a highly conserved MADS domain, whichcan function as a DNA-binding domain, and a K domain, which hasstructural similarity to the coiled-coil domain of keratins and can beinvolved in protein-protein interactions.

As used herein, the term "APETALA1," "AP1" or "AP1 gene product" means afloral meristem identity gene product that is characterized, in part, byhaving an amino acid sequence that has at least about 70 percent aminoacid identity with the amino acid sequence of SEQ ID NO: 2 in the regionfrom amino acid 1 to amino acid 163 or with the amino acid sequence ofSEQ ID NO: 8 in the region from amino acid 1 to amino acid 163. Likeother floral meristem identity gene products, AP1 promotes conversion ofshoot meristem to floral meristem in an angiosperm. An AP1 gene productuseful in the invention can be, for example, Arabidopsis AP1 having theamino acid sequence of SEQ ID NO: 2; Brassica oleracea AP1 having theamino acid sequence of SEQ ID NO: 4; Brassica oleracea var. botrytis AP1having the amino acid sequence of SEQ ID NO: 6 or Zea mays AP1 havingthe amino acid sequence of SEQ ID NO: 8.

In wild-type Arabidopsis, AP1 RNA is expressed in flowers but is notdetectable in roots, stems or leaves (Mandel et al., Nature 360:273-277(1992), which is incorporated herein by reference). The earliestdetectable expression of AP1 RNA is in young floral meristem at the timeit initially forms on the flanks of shoot meristem. Expression of AP1increases as the floral meristem increases in size; no AP1 expression isdetectable in shoot meristem. In later stages of development, AP1expression ceases in cells that will give rise to reproductive organs ofa flower (stamens and carpels), but is maintained in cells that willgive rise to non-reproductive organs (sepals and petals; Mandel, supra,1992). Thus, in nature, AP1 expression is restricted to floral meristemand to certain regions of the flowers that develop from this meristemictissue.

CAULIFLOWER (CAL) is another example of a floral meristem identity geneproduct. As used herein, the term "CAULIFLOWER," "CAL" or "CAL geneproduct" means a floral meristem identity gene product that ischaracterized, in part, by having an amino acid sequence that has atleast about 70 percent amino acid identity with the amino acid sequenceof SEQ ID NO: 10 in the region from amino acid 1 to amino acid 160 orwith the amino acid sequence of SEQ ID NO: 12 in the region from aminoacid 1 to amino acid 160.

A CAL gene product is exemplified by the Arabidopsis CAL gene product,which has the amino acid sequence of SEQ ID NO: 10, or the Brassicaoleracea CAL gene product, which has the amino acid sequence of SEQ IDNO: 12. As disclosed herein, CAL, like AP1, contains a MADS domain and aK domain. The MADS domains of CAL and AP1 differ in only five of 56amino acid residues, where four of the five differences representconservative amino acid replacements. Over the entire sequence, theArabidopsis CAL and Arabidopsis AP1 sequences (SEQ ID NOS: 10 and 2) are76% identical and are 88% similar if conservative amino acidsubstitutions are allowed.

Similar to the expression pattern of AP1, CAL RNA is expressed in youngfloral meristem in Arabidopsis. However, in contrast to AP1 expression,which is high throughout sepal and petal development, CAL expression islow in these organs. Thus, in nature, CAL is expressed in floralmeristem and, to a lesser extent, in the organs of developed flowers.

The skilled artisan will recognize that, due to the high sequenceconservation between AP1 and CAL, a novel ortholog can be categorized asboth a CAL and an AP1, as defined herein. However, if desired, an AP1ortholog can be distinguished from a CAL ortholog by demonstrating agreater similarity to Arabidopsis AP1 than to any other MADS box gene,such as CAL, as set forth in Purugganan et al. (Genetics 140:345-356(1995), which is incorporated herein by reference). Furthermore, AP1 canbe distinguished from CAL by its ability to complement, or restore awild-type phenotype, when introduced into a strong ap1 mutant. Forexample, introduction of Arabidopsis AP1 (AGL7) complements thephenotype of the strong ap1-1 mutant; however, introduction of CAL(AGL10) into a cal-1 ap1-1 mutant plant yields the ap1-1 single mutantphenotype, demonstrating that CAL cannot complement the ap1-1 mutation(see, for example, Mandel et al., supra, 1992; Kempin et al., supra,1995). Thus, AP1 can be distinguished from CAL, if desired, by theability of a nucleic acid molecule encoding AP1 to complement a strongap1 mutant such as ap1-1 or ap1-15.

LEAFY (LFY) is yet another example of a floral meristem identity geneproduct. As used herein, the term "LEAFY" or "LFY" or "LFY gene product"means a floral meristem identity gene product that is characterized, inpart, by having an amino acid sequence that has at least about 70percent amino acid identity with the amino acid sequence of SEQ ID NO:16. In nature, LFY is expressed in floral meristem as well as duringvegetative development. As disclosed herein, ectopic expression in shootmeristem of a floral meristem identity gene product, which normally isexpressed in floral meristem, can convert shoot meristem to floralmeristem in an angiosperm. Under appropriate conditions, ectopicexpression in shoot meristem of a floral meristem identity gene productsuch as AP1, CAL, LFY, or a combination thereof, can promote earlyreproductive development.

Flower development in Arabidopsis is recognized in the art as a modelfor flower development in angiosperms in general. Gene orthologscorresponding to the Arabidopsis genes involved in the early steps offlower formation have been identified in distantly related angiospermspecies, and these gene orthologs show remarkably similar patterns ofRNA expression. Mutations in gene orthologs also result in phenotypesthat correspond to the phenotype produced by a similar mutation inArabidopsis. For example, orthologs of the Arabidopsis floral meristemidentity genes AP1 and LFY and the Arabidopsis organ identity genesAGAMOUS, APETALA3 and PISTILLATA have been isolated from monocots suchas maize and, where characterized, reveal the anticipated RNA expressionpatterns and related mutant phenotypes (Schmidt et al., Plant Cell5:729-737 (1993); and Veit et al., Plant Cell 5:1205-1215 (1993), eachof which is incorporated herein by reference). Furthermore, a geneortholog can be functionally interchangeable in that it can functionacross distantly related species boundaries (Mandel et al., Cell71:133-143 (1992), which is incorporated herein by reference). Takentogether, these data suggest that the underlying mechanisms controllingthe initiation and proper development of flowers are conserved acrossdistantly related dicot and monocot boundaries.

Floral meristem identity genes in particular are conserved amongdistantly related angiosperm and gymnosperm species. For example, a geneortholog of Arabidopsis AP1 has been isolated from Antirrhinum majus(snapdragon; Huijser et al., EMBO J. 11:1239-1249 (1992), which isincorporated herein by reference). As disclosed herein, an ortholog ofArabidopsis AP1 also has been isolated from Brassica oleracea var.botrytis (cauliflower) and Zea Mays (maize; see Example VA).Furthermore, AP1 orthlogs also can be isolated from gymnosperms.Similarly, gene orthologs of Arabidopsis LFY have been isolated fromangiosperms such as Antirrhinum majus, tobacco and poplar tree and fromgymnosperms such as Douglas fir (Coen et al., Cell, 63:1311-1322 (1990);Kelly et al., Plant Cell 7:225-234 (1995); and Rottmann et al., CellBiochem. Suppl. 17B: 23 (1993); Strauss et al., Molec. Breed 1:5-26(1995), each of which is incorporated herein by reference). Theconservation of floral meristem identity gene products in non-floweringplants such as coniferous trees indicates that floral meristem identitygenes can promote the reproductive development of gymnosperms as well asangiosperms.

The characterization of ap1 and lfy mutants also indicates that floralmeristem identity gene products such as AP1 and LFY function similarlyin distantly related plant species. For example, a mutation in theAntirrhinum AP1 ortholog results in a phenotype similar to theArabidopsis ap1 indeterminate flower within a flower phenotype (Huijseret al., supra, 1992). In addition, a mutation in the Antirrhinum LFYortholog results in a phenotype similar to the Arabidopsis lfy mutantphenotype (Coen et al., supra, 1995)

A floral meristem identity gene product also can function across speciesboundaries. For example, introduction of a nucleic acid moleculeencoding Arabidopsis LFY into a heterologous seed plant such as tobaccoor aspen results in early reproductive development (Weigel and Nilsson,Nature 377:495-500 (1995), which is incorporated herein by reference).As disclosed herein, a nucleic acid molecule encoding an Arabidopsis AP1gene product (SEQ ID NO: 1) or an Arabidopsis CAL gene product (SEQ IDNO: 9) can be introduced into a heterologous seed plant such as corn,wheat, rice or pine and, upon ectopic expression, can promote earlyreproductive development in the transgenic seed plant. Furthermore, asdisclosed herein, the conserved nature of the AP1, CAL and LFY codingsequences among diverse seed plant species allows a nucleic acidmolecule encoding a floral meristem identity gene product isolated fromessentially any seed plant to be introduced into essentially any otherseed plant, wherein, upon appropriate expression of the introducednucleic acid molecule in the seed plant, the floral meristem identitygene product promotes early reproductive development in the seed plant.

If desired, a novel AP1, CAL or LFY coding sequence can be isolated froma seed plant using a nucleotide sequence as a probe and methods wellknown in the art of molecular biology (Sambrook et al. (eds.), MolecularCloning: A Laboratory Manual (Second Edition), Plainview, N.Y.: ColdSpring Harbor Laboratory Press (1989), which is incorporated herein byreference). As exemplified herein and discussed in detail below (seeExample VA), an AP1 ortholog from Zea Mays (maize; SEQ ID NO: 7) wasisolated using the Arabidopsis AP1 cDNA (SEQ ID NO: 1) as a probe.

In one embodiment, the invention provides a non-naturally occurring seedplant that contains a first ectopically expressible nucleic acidmolecule encoding a floral meristem identity gene product, provided thatthe first nucleic acid molecule is not ectopically expressed due to amutation in an endogenous TERMINAL FLOWER gene, and that ischaracterized by early reproductive development. As used herein, theterm "characterized by early reproductive development," when used inreference to a non-naturally occurring seed plant of the invention,means a non-naturally occurring seed plant that forms reproductivestructures earlier than the time when reproductive structures form on acorresponding naturally occurring seed plant that is grown under thesame conditions and that does not ectopically express a floral meristemidentity gene product. For example, the reproductive structure of anangiosperm is a flower, and the reproductive structure of a coniferousplant is a cone. For a particular naturally occurring seed plant,reproductive development occurs at a well-defined time that depends, inpart, on genetic factors as well as on environmental conditions, such asday length and temperature. Thus, given a defined set of environmentalcondition and lacking ectopic expression of a floral meristem identitygene product, a naturally occurring seed plant will undergo reproductivedevelopment at a relatively fixed time.

It is recognized that various transgenic plants that are characterizedby early reproductive development have been described previously. Suchtransgenic plants, as discussed herein, are distinguishable from anon-naturally occurring seed plant of the invention or are explicitlyexcluded from the present invention. The product of a "late-floweringgene" can promote early reproductive development. However, a lateflowering gene product is not a floral meristem identity gene productsince it does not specify the conversion of shoot meristem to floralmeristem in an angiosperm. Therefore, a transgenic plant expressing alate-flowering gene product is distinguishable from a non-naturallyoccurring seed plant of the invention. For example, a transgenic plantexpressing the late-flowering gene, CONSTANS (CO), flowers earlier thanthe corresponding wild type plant, but does not contain an ectopicallyexpressible nucleic acid molecule encoding a floral meristem identitygene product (Putterill et al., Cell 80:847-857 (1995)). Thus, theearly-flowering transgenic plant described by Putterill et al. is not anon-naturally occurring seed plant as defined herein.

Early reproductive development also has been observed in a transgenictobacco plant expressing an exogenous rice MADS domain gene. Althoughthe product of the rice MADS domain gene promotes early reproductivedevelopment, it does not specify the identity of floral meristem and,thus, cannot convert shoot meristem to floral meristem in an angiosperm(Chung et al., Plant Mol. Biol. 26:657-665 (1994)). Therefore, anearly-flowering transgenic plant containing this rice MADS domain gene,like an early-flowering transgenic plant containing CONSTANS, isdistinguishable from an early-flowering non-naturally occurring seedplant of the invention.

Mutations in a class of genes known as "early-flowering genes" alsoproduce plants characterized by early reproductive development. Suchearly-flowering genes include, for example, EARLY FLOWERING 1-3 (ELF1,ELF2, ELF3); EMBRYONIC FLOWER 1,2 (EMF1, EMF2); LONG HYPOCOTYL 1,2 (HY1,HY2); PHYTOCHROME B (PHYB), SPINDLY (SPY) and TERMINAL FLOWER (TFL)(Weigel, supra, 1995). The wild type product of an early-flowering generetards reproductive development and is distinguishable from a floralmeristem identity gene product in that an early-flowering gene productdoes not promote conversion of shoot meristem to floral meristem in anangiosperm. A plant that flowers early due to the loss of anearly-flowering gene product function is distinct from a non-naturallyoccurring seed plant of the invention characterized by earlyreproductive development since such a plant does not contain anectopically expressible nucleic acid molecule encoding a floral meristemidentity gene product.

An Arabidopsis plant having a mutation in the TERMINAL FLOWER (TFL) geneis characterized by early reproductive development and by the conversionof shoots to flowers (Alvarez et al., Plant J. 2:103-116 (1992), whichis incorporated herein by reference). However, TFL is not a floralmeristem identity gene product, as defined herein. Specifically, it isthe loss of TFL that promotes conversion of shoot meristem to floralmeristem. Since the function of TFL is to antagonize formation of floralmeristem, a tfl mutant, which lacks functional TFL, converts shootmeristem to floral meristem prematurely. Although TFL is not a floralmeristem identity gene product and does not itself convert shootmeristem to floral meristem, the loss of TFL can result in a plant withan ectopically expressed floral meristem identity gene product. However,such a tfl mutant, in which a mutation in an endogenous TERMINAL FLOWERgene results in conversion of shoot meristem to floral meristem, isexcluded explicitly from the present invention.

As used herein, the term "transgenic" refers to a seed plant thatcontains in its genome an exogenous nucleic acid molecule, which can bederived from the same or a different plant species. The exogenousnucleic acid molecule can be a gene regulatory element such as apromoter, enhancer or other regulatory element or can contain a codingsequence, which can be linked to a heterologous gene regulatory element.

As used herein, the term "seed plant" means an angiosperm or agymnosperm. The term "angiosperm," as used herein, means a seed-bearingplant whose seeds are borne in a mature ovary (fruit). An angiospermcommonly is recognized as a flowering plant. The term "gymnosperm," asused herein, means a seed-bearing plant with seeds not enclosed in anovary.

Angiosperms are divided into two broad classes based on the number ofcotyledons, which are seed leaves that generally store or absorb food.Thus, a monocotyledonous angiosperm is an angiosperm having a singlecotyledon, and a dicotyledonous angiosperm is an angiosperm having twocotyledons. Angiosperms are well known and produce a variety of usefulproducts including materials such as lumber, rubber, and paper; fiberssuch as cotton and linen; herbs and medicines such as quinine andvinblastine; ornamental flowers such as roses and orchids; andfoodstuffs such as grains, oils, fruits and vegetables.

Angiosperms encompass a variety of flowering plants, including, forexample, cereal plants, leguminous plants, oilseed plants, hardwoodtrees, fruit-bearing plants and ornamental flowers, which generalclasses are not necessarily exclusive. Such angiosperms include forexample, a cereal plant, which produces an edible grain cereal. Suchcereal plants include, for example, corn, rice, wheat, barley, oat, rye,orchardgrass, guinea grass, sorghum and turfgrass. In addition, aleguminous plant is an angiosperm that is a member of the pea family(Fabaceae) and produces a characteristic fruit known as a legume.Examples of leguminous plants include, for example, soybean, pea,chickpea, moth bean, broad bean, kidney bean, lima bean, lentil, cowpea,dry bean, and peanut. Examples of legumes also include alfalfa,birdsfoot trefoil, clover and sainfoin. An oilseed plant also is anangiosperm with seeds that are useful as a source of oil. Examples ofoilseed plants include soybean, sunflower, rapeseed and cottonseed.

An angiosperm also can be a hardwood tree, which is a perennial woodyplant that generally has a single stem (trunk). Examples of such treesinclude alder, ash, aspen, basswood (linden), beech, birch, cherry,cottonwood, elm, eucalyptus, hickory, locust, maple, oak, persimmon,poplar, sycamore, walnut and willow. Trees are useful, for example, as asource of pulp, paper, structural material and fuel.

An angiosperm also can be a fruit-bearing plant, which produces amature, ripened ovary (usually containing seeds) that is suitable forhuman or animal consumption. For example, hops are a member of themulberry family prized for their flavoring in malt liquor. Fruit-bearingangiosperms also include grape, orange, lemon, grapefruit, avocado,date, peach, cherry, olive, plum, coconut, apple and pear trees andblackberry, blueberry, raspberry, strawberry, pineapple, tomato,cucumber and eggplant plants. An ornamental flower is an angiospermcultivated for its decorative flower. Examples of commercially importantornamental flowers include rose, orchid, lily, tulip and chrysanthemum,snapdragon, camellia, carnation and petunia plants. The skilled artisanwill recognize that the methods of the invention can be practiced usingthese or other angiosperms, as desired.

Gymnosperms encompass four divisions: cycads, ginkgo, conifers andgnetophytes. The conifers are the most widespread of living gymnospermsand frequently are cultivated for structural wood or for pulp or paper.Conifers include redwood trees, pines, firs, spruces, hemlocks, Douglasfirs, cypresses, junipers and yews. The skilled artisan will recognizethat the methods of the invention can be practiced with these and othergymnosperms.

As used herein, the term "non-naturally occurring seed plant" means aseed plant containing a genome that has been modified by man. Atransgenic seed plant, for example, is a non-naturally occurring seedplant that contains an exogenous nucleic acid molecule and, therefore,has a genome that has been modified by man. Furthermore, a seed plantthat contains, for example, a mutation in an endogenous floral meristemidentity gene regulatory element as a result of calculated exposure to amutagenic agent also contains a genome that has been modified by man. Incontrast, a seed plant containing a spontaneous or naturally occurringmutation is not a "non-naturally occurring seed plant" and, therefore,is not encompassed within the invention.

In various embodiments, the present invention provides a non-naturallyoccurring seed plant containing a first ectopically expressible nucleicacid molecule encoding a first floral meristem identity gene product,provided that the first nucleic acid molecule is not ectopicallyexpressed due to a mutation in an endogenous TERMINAL FLOWER gene. Ifdesired, a non-naturally occurring seed plant of the invention cancontain a second ectopically expressible nucleic acid molecule encodinga second floral meristem identity gene product that is different fromthe first floral meristem identity gene product, provided that the firstor second nucleic acid molecule is not ectopically expressed due to amutation in an endogenous TERMINAL FLOWER gene.

An ectopically expressible nucleic acid molecule encoding a floralmeristem identity gene product can be expressed, as desired, eitherconstitutively or inducibly. Such an ectopically expressible nucleicacid molecule encoding a floral meristem identity gene product can be anendogenous floral meristem identity gene that has, for example, amutation in a gene regulatory element. An ectopically expressiblenucleic acid molecule encoding a floral meristem identity gene productalso can be an endogenous nucleic acid molecule encoding a floralmeristem identity gene product that is linked to an exogenous,heterologous gene regulatory element that confers ectopic expression. Inaddition, an ectopically expressible nucleic acid molecule encoding afloral meristem identity gene product can be an exogenous nucleic acidmolecule that encodes a floral meristem identity gene product undercontrol of a heterologous gene regulatory element.

A non-naturally occurring seed plant of the invention can contain anendogenous floral meristem identity gene having a modified generegulatory element. The term "modified gene regulatory element," as usedherein in reference to the regulatory element of a floral meristemidentity gene, means a regulatory element having a mutation that resultsin ectopic expression of the linked endogenous floral meristem identitygene. Such a gene regulatory element can be, for example, a promoter orenhancer element and can be positioned 5' or 3' to the coding sequenceor within an intronic sequence of the floral meristem identity gene. Amodified gene regulatory element can have, for example, a nucleotideinsertion, deletion or substitution that is produced, for example, bychemical mutagenesis using a mutagen such as ethylmethane sulfonate orby insertional mutagenesis using a transposable element. A modified generegulatory element can be a functionally inactivated binding site forTFL or a functionally inactivated binding site for a gene productregulated by TFL, such that modification of the gene regulatory elementresults in ectopic expression of the linked floral meristem identitygene product, for example, in the shoot meristem of an angiosperm.

The present invention also provides a transgenic seed plant containing afirst exogenous gene promoter that regulates a first ectopicallyexpressible nucleic acid molecule encoding a first floral meristemidentity gene product and a second exogenous gene promoter thatregulates a second ectopically expressible nucleic acid moleculeencoding a second floral meristem identity gene product.

The present invention further provides a transgenic seed plantcontaining a first exogenous ectopically expressible nucleic acidmolecule encoding a first floral meristem identity gene product and asecond exogenous gene promoter that regulates a second ectopicallyexpressible nucleic acid molecule encoding a second floral meristemidentity gene product, provided that the first nucleic acid molecule isnot ectopically expressed due to a mutation in an endogenous TERMINALFLOWER gene.

In addition, the invention provides a transgenic seed plant containing afirst exogenous ectopically expressible nucleic acid molecule encoding afirst floral meristem identity gene product, provided that the firstsecond nucleic acid molecule is not ectopically expressed due to amutation in an endogenous TERMINAL FLOWER gene, and further containing asecond exogenous ectopically expressible nucleic acid molecule encodinga second floral meristem identity gene product, where the first floralmeristem identity gene product is different from the second floralmeristem identity gene product.

As disclosed herein, ectopic expression of two different floral meristemidentity gene products can be particularly useful. A transgenicArabidopsis line constitutively expressing AP1 under control of thecauliflower mosaic virus 35S promoter (see Example I) was crossed with atransgenic Arabidopsis line constitutively expressing LFY under controlof the cauliflower mosaic virus 35S promoter (see Example III), and theresulting progeny were analyzed. A fraction of the progeny flowered werecharacterized by enhanced early reproductive development as compared tothe early reproductive development of 35S-AP1 transgenic lines or35S-LFY transgenic lines. PCR-based analyses demonstrated that all ofthe transgenic plants that were characterized by enhanced earlyreproductive development contained both the 35S-AP1 and 35S-LFYtransgenes. These results indicate that ectopic expression of thecombination of AP1 and LFY in a seed plant can result in enhanced earlyreproductive development as compared to the early reproductivedevelopment obtained by ectopic expression of AP1 or LFY alone. Thus, byusing a combination of two different floral meristem identity geneproducts, plant breeding, for example, can be accelerated further ascompared to the use of a single floral meristem identity gene product.

A useful combination of first and second floral meristem identity geneproducts can be, for example, AP1 and LFY, CAL and LFY, or AP1 and CAL.A particularly useful combination of first and second floral meristemidentity gene products is the combination of AP1 with LFY, as disclosedabove, or the combination of CAL with LFY. Where a transgenic seed plantof the invention contains first and second exogenous nucleic acidmolecules encoding different floral meristem identity gene products, itwill be recognized that the order of introducing the first and secondnucleic acid molecules into the seed plant is not important for purposesof the present invention. Thus, a transgenic seed plant of the inventionhaving, for example, AP1 as a first floral meristem identity geneproduct and LFY as a second floral meristem identity gene product isequivalent to a transgenic seed plant having LFY as a first floralmeristem identity gene product and AP1 as a second floral meristemidentity gene product.

The invention also provides methods of converting shoot meristem tofloral meristem in an angiosperm by ectopically expressing a firstectopically expressible nucleic acid molecule encoding a first floralmeristem identity gene product in the angiosperm. Thus, the inventionprovides, for example, a method of converting shoot meristem to floralmeristem in an angiosperm by introducing an exogenous, ectopicallyexpressible nucleic acid molecule encoding a floral meristem identitygene product into the angiosperm, thereby producing a transgenicangiosperm. A floral meristem identity gene product such as AP1, CAL orLFY, or a chimeric protein containing, in part, a floral meristemidentity gene product, as disclosed below, is useful in converting shootmeristem to floral meristem according to the methods of the invention.

As used herein, the term "introducing," when used in reference to anucleic acid molecule and a seed plant such as an angiosperm or agymnosperm, means transferring an exogenous nucleic acid molecule intothe seed plant. For example, an exogenous nucleic acid molecule encodinga floral meristem identity gene product can be introduced into a seedplant by a variety of methods including Agrobacterium-mediatedtransformation or direct gene transfer methods such as electroporationor microprojectile-mediated transformation.

Transformation methods based upon the soil bacterium Agrobacteriumtumefaciens, known as "agro-infection," are useful for introducing anucleic acid molecule into a broad range of angiosperms and gymnosperms.The wild type form of Agrobacterium contains a Ti (tumor-inducing)plasmid that directs production of tumorigenic crown gall growth on hostplants. Transfer of the tumor-inducing T-DNA region of the Ti plasmid toa plant genome requires the Ti plasmid-encoded virulence genes as wellas T-DNA borders, which are a set of direct DNA repeats that delineatethe region to be transferred. Agrobacterium-based vector is a modifiedform of a Ti plasmid, in which the tumor inducing functions are replacedby nucleic acid sequence of interest to be introduced into the planthost.

Current protocols for Agrobacterium-mediated transformation employcointegrate vectors or, preferably, binary vector systems in which thecomponents of the Ti plasmid are divided between a helper vector, whichresides permanently in the Agrobacterium host and carries the virulencegenes, and a shuttle vector, which contains the gene of interest boundedby T-DNA sequences. A variety of binary vectors are well known in theart and are commercially available from, for example, Clontech (PaloAlto, Calif.). Methods of coculturing Agrobacterium with cultured plantcells or wounded tissue such as leaf tissue, root explants,hypocotyledons, stem pieces or tubers, for example, also are well knownin the art (Glick and Thompson (eds.), Methods in Plant MolecularBiology and Biotechnology, Boca Raton, Fla.: CRC Press (1993), which isincorporated herein by reference). Wounded cells within the plant tissuethat have been infected by Agrobacterium can develop organs de novo whencultured under the appropriate conditions; the resulting transgenicshoots eventually give rise to transgenic plants containing theexogenous nucleic acid molecule of interest, as described in Example I.

Agrobacterium-mediated transformation has been used to produce a varietyof transgenic seed plants (see, for example, Wang et al. (eds),Transformation of Plants and Soil Microorganisms, Cambridge, UK:University Press (1995), which is incorporated herein by reference). Forexample, Agrobacterium-mediated transformation can be used to producetransgenic crudiferous plants such as Arabidopsis, mustard, rapeseed andflax; transgenic leguminous plants such as alfalfa, pea, soybean,trefoil and white clover; and transgenic solanaceous plants such aseggplant, petunia, potato, tobacco and tomato. In addition,Agrobacterium-mediated transformation can be used to introduce exogenousnucleic acids into apple, aspen, belladonna, black currant, carrot,celery, cotton, cucumber, grape, horseradish, lettuce, morning glory,muskmelon, neem, poplar, strawberry, sugar beet, sunflower, walnut andasparagus plants (see, for example, Glick and Thompson, supra, 1993).

Microprojectile-mediated transformation also is a well known method ofintroducing an exogenous nucleic acid molecule into a variety of seedplant species. This method, first described by Klein et al., Nature327:70-73 (1987), which is incorporated herein by reference, relies onmicroprojectiles such as gold or tungsten that are coated with thedesired nucleic acid molecule by precipitation with calcium chloride,spermidine or PEG. The microprojectile particles are accelerated at highspeed into seed plant tissue using a device such as the Biolistic™PD-1000 (Biorad, Hercules, Calif.).

Microprojectile-mediated delivery or "particle bombardment" isespecially useful to transform seed plants that are difficult totransform or regenerate using other methods. Microprojectile-mediatedtransformation has been used, for example, to generate a variety oftransgenic seed plant species, including cotton, tobacco, corn, hybridpoplar and papaya (see, for example, Glick and Thompson, supra, 1993).The transformation of important cereal crops such as wheat, oat, barley,sorghum and rice also has been achieved using microprojectile-mediateddelivery (Duan et al., Nature Biotech. 14:494-498 (1996); Shimamoto,Curr. Opin. Biotech. 5:158-162 (1994), each of which is incorporatedherein by reference). A rapid transformation regeneration system for theproduction of transgenic plants, such as transgenic wheat, in two tothree months also can be useful in producing a transgenic seed plant ofthe invention (European Patent No. EP 0 709 462 A2, Application number95870117.9, filed Oct. 25, 1995, which is incorporated herein byreference).

Thus, a variety of methods for introducing a nucleic acid molecule intoa seed plant are well known in the art. Important crop species such asrice, for example, have been transformed using microprojectile delivery,Agrobacterium-mediated transformation or protoplast transformation (Hieiet al., The Plant J. 6(2):271-282 (1994); Shimamoto, Science270:1772-1773 (1995), each of which is incorporated herein byreference). Fertile transgenic maize has been obtained, for example, bymicroparticle bombardment (see Wang et al., supra, 1995). As discussedabove, barley, wheat, oat and other small-grain cereal crops also havebeen transformed, for example, using microparticle bombardment (see Wanget al., supra, 1995).

Methods of transforming forest trees including both angiosperms andgymnosperms also are well known in the art. Transgenic angiosperms suchas members of the genus Populus, which includes aspens and poplars, havebeen generated using Agrobacterium-mediated transformation, for example.In addition, transgenic Populus and sweetgum, which are of interest forbiomass production for fuel, also have been produced. Transgenicgymnosperms, including conifers such as white spruce and larch, alsohave been obtained, for example, using microprojectile bombardment (Wanget al., supra, 1995). The skilled artisan will recognize thatAgrobacterium-mediated or microprojectile-mediated transformation, asdisclosed herein, or other methods known in the art can be used tointroduce a nucleic acid molecule encoding a floral meristem identitygene product into a seed plant according to the methods of theinvention.

The term "converting shoot meristem to floral meristem," as used herein,means promoting the formation of flower progenitor tissue where shootprogenitor tissue otherwise would be formed in the angiosperm. As aresult of the conversion of shoot meristem to floral meristem, flowersform in an angiosperm where shoots normally would form. The conversionof shoot meristem to floral meristem can be identified using well knownmethods, such as scanning electron microscopy, light microscopy orvisual inspection (see, for example, Mandel and Yanofsky, Plant Cell7:1763-1771 (1995), which is incorporated herein by reference or Weigeland Nilsson, supra, 1995).

Provided herein are methods of converting shoot meristem to floralmeristem in an angiosperm by introducing a first ectopically expressiblenucleic acid molecule encoding a first floral meristem identity geneproduct and a second ectopically expressible nucleic acid moleculeencoding a second floral meristem identity gene product into theangiosperm, where the first floral meristem identity gene product isdifferent from the second floral meristem identity gene product. Asdiscussed above, first and second floral meristem identity gene productsuseful in converting shoot meristem to floral meristem in an angiospermcan be, for example, AP1 and LFY, CAL and LFY, or AP1 and CAL.

Also provided herein are methods of promoting early reproductivedevelopment in a seed plant by ectopically expressing a first nucleicacid molecule encoding a first floral meristem identity gene product inthe seed plant, provided that the first nucleic acid molecule is notectopically expressed due to a mutation in an endogenous TERMINAL FLOWERgene. For example, the invention provides a method of promoting earlyreproductive development in a seed plant by introducing an ectopicallyexpressible nucleic acid molecule encoding a floral meristem identitygene product into the seed plant, thus producing a transgenic seedplant. A floral meristem identity gene product such as AP1, CAL or LFY,or a chimeric protein containing, in part, a floral meristem identitygene product, as disclosed below, is useful in methods of promotingearly reproductive development.

The term "promoting early reproductive development," as used herein inreference to a seed plant, means promoting the formation of areproductive structure earlier than the time when a reproductivestructure would form on a corresponding seed plant that is grown underthe same conditions and that does not ectopically express a floralmeristem identity gene product. As discussed above, the time whenreproductive structures form on a particular seed plant that does notectopically express a floral meristem identity gene product isrelatively fixed and depends, in part, on genetic factors as well asenvironmental conditions, such as day length and temperature. Thus,given a defined set of environmental conditions, a naturally occurringangiosperm, for example, will flower at a relatively fixed time.Similarly, given a defined set of environmental conditions, a naturallyoccurring coniferous gymnosperm, for example, will produce cones at arelatively fixed time.

As disclosed herein, ectopic expression of a nucleic acid moleculeencoding a floral meristem identity gene product in an angiospermconverts shoot meristem to floral meristem in the angiosperm.Furthermore, ectopic expression of a nucleic acid molecule encoding afloral meristem identity gene product such as AP1, CAL or LFY in anangiosperm prior to the time when endogenous floral meristem identitygene products are expressed in the angiosperm can convert shoot meristemto floral meristem precociously, resulting in early reproductivedevelopment in the angiosperm, as indicated by early flowering. In thesame manner, ectopic expression of a nucleic acid molecule encoding AP1,CAL, or LFY, for example, in a gymnosperm prior to the time whenendogenous floral meristem identity gene products are expressed in thegymnosperm results in early reproductive development in the gymnosperm.

For a given seed plant species and particular set of growth conditions,constitutive expression of a floral meristem identity gene productresults in a relatively invariant time of early reproductivedevelopment, which is the earliest time when all factors necessary forreproductive development are active. For example, as shown in ExampleID, constitutive expression of AP1 in transgenic Arabidopsis plantsgrown under "long-day" light conditions results in early reproductivedevelopment at day 10 as compared to the normal time of reproductivedevelopment, which is day 18 in non-transgenic Arabidopsis plants grownunder the same conditions. Thus, under these conditions, day 10 is therelatively invariant time of early reproductive development forArabidopsis transgenics that constitutively express a floral meristemidentity gene product.

However, in addition to methods of constitutively expressing a floralmeristem identity gene product, the present invention provides methodsof selecting the time of early reproductive development. As disclosedherein, floral meristem gene product expression or activity can beregulated in response to an inducing agent or cognate ligand, forexample, such that the time of early reproductive development can beselected. For example, in Arabidopsis transgenics grown under theconditions described above, the time of early reproductive developmentneed not necessarily be the relatively invariant day 10 at which earlyreproductive development occurs as a consequence of constitutive floralmeristem identity gene product expression. If floral meristem identitygene product expression is rendered dependent upon the presence of aninducing agent, early reproductive development can be selected to occur,for example, on day 14, by contacting the seed plant with an inducingagent on or slightly before day 14.

Thus, the present invention provides recombinant nucleic acid molecules,transgenic seed plant containing such recombinant nucleic acid moleculesand methods for selecting the time of early reproductive development.These methods allow a farmer or horticulturist, for example, todetermine the time of early reproductive development. The methods of theinvention can be useful, for example, in allowing a grower to respond toan approaching storm or impending snap-freeze by selecting the time ofearly reproductive development such that the crop can be harvestedbefore being harmed by the adverse weather conditions. The methods ofthe invention for selecting the time of early reproductive developmentalso can be useful to spread out the time period over which transgenicseed plants are ready to be harvested. For example, the methods of theinvention can be used to increase floral meristem identity gene productexpression in different crop fields at different times, resulting in astaggered time of harvest for the different fields.

Thus, the present invention provides a recombinant nucleic acid moleculecontaining an inducible regulatory element operably linked to a nucleicacid molecule encoding a floral meristem identity gene product. Thefloral meristem identity gene product encoded within a recombinantnucleic acid molecule of the invention can be, for example, AP1 or CAL.In addition, the floral meristem identity gene product encoded within arecombinant nucleic acid molecule of the invention can be LFY. Asdisclosed herein, a recombinant nucleic acid molecule of the inventioncan contain an inducible regulatory element such as a copper inducibleelement, tetracycline inducible element, ecdysone inducible element orheat shock inducible element.

The invention also provides a transgenic seed plant containing arecombinant nucleic acid molecule comprising an inducible regulatoryelement operably linked to a nucleic acid molecule encoding a floralmeristem identity gene product. Such a transgenic seed plant can be anangiosperm or gymnosperm and can contain, for example, a recombinantnucleic acid molecule comprising an inducible regulatory elementoperably linked to a nucleic acid molecule encoding AP1 or CAL. Atransgenic seed plant of the invention can contain, for example, arecombinant nucleic acid molecule comprising a copper inducible element,tetracycline inducible element, ecdysone inducible element or heat shockinducible element operably linked to a nucleic acid molecule encodingAP1. In addition, a transgenic seed plant of the invention can contain arecombinant nucleic acid molecule comprising a copper inducible elementtetracycline inducible element, ecdysone inducible element or heat shockinducible element operably linked to a nucleic acid molecule encodingCAL. A transgenic seed plant of the invention also can contain arecombinant nucleic acid molecule comprising a copper inducible element,tetracycline inducible element, ecdysone inducible element or heat shockinducible element operably linked to a nucleic acid molecule encodingLFY.

The term "recombinant nucleic acid molecule," as used herein, means anon-naturally occurring nucleic acid molecule that has been manipulatedin vitro such that it is genetically distinguishable from a naturallyoccurring nucleic acid molecule. A recombinant nucleic acid molecule ofthe invention comprises two nucleic acid molecules that have beenmanipulated in vitro such that the two nucleic acid molecules areoperably linked.

As used herein, the term "inducible regulatory element" means a nucleicacid molecule that confers conditional expression upon an operablylinked nucleic acid molecule, where expression of the operably linkednucleic acid molecule is increased in the presence of a particularinducing agent as compared to expression of the nucleic acid molecule inthe absence of the inducing agent. In a method of the invention, auseful inducible regulatory element has the following characteristics:confers low level expression upon an operably linked nucleic acidmolecule in the absence of an inducing agent; confers high levelexpression upon an operably linked nucleic acid molecule in the presenceof an appropriate inducing agent; and utilizes an inducing agent thatdoes not interfere substantially with the normal physiology of atransgenic seed plant treated with the inducing agent. It is recognized,for example, that, subsequent to introduction into a seed plant, aparticularly useful inducible regulatory element is one that confers anextremely low level of expression upon an operably linked nucleic acidmolecule in the absence of inducing agent. Such an inducible regulatoryelement is considered to be tightly regulated.

The term "operably linked," as used in reference to a regulatoryelement, such as a promoter or inducible regulatory element, and anucleic acid molecule encoding a floral meristem identity gene product,means that the regulatory element confers regulated expression upon theoperably linked nucleic acid molecule encoding the floral meristemidentity gene product. Thus, the term operably linked, as used herein inreference to an inducible regulatory element and a nucleic acid moleculeencoding a floral meristem identity gene product, means that theinducible regulatory element is linked to the nucleic acid moleculeencoding a floral meristem identity gene product such that the inducibleregulatory element increases expression of the floral meristem identitygene product in the presence of the appropriate inducing agent. It isrecognized that two nucleic acid molecules that are operably linkedcontain, at a minimum, all elements essential for transcription,including, for example, a TATA box. One skilled in the art knows, forexample, that an inducible regulatory element that lacks minimalpromoter elements can be combined with a nucleic acid molecule havingminimal promoter elements and a nucleic acid molecule encoding a floralmeristem identity gene product such that expression of the floralmeristem identity gene product can be increased in the presence of theappropriate inducing agent.

A particularly useful inducible regulatory element can be, for example,a copper-inducible promoter (Mett et al., Proc. Natl. Acad. Sci, USA90:4567-4571 (1993), which is incorporated herein by reference);tetracycline-inducible regulatory element (Gatz et al., Plant J.2:397-404 (1992); Roder et al., Mol. Gen. Genet. 243:32-38 (1994), eachof which is incorporated herein by reference); ecdysone inducibleelement (Christopherson et al., Proc. Natl. Acad. Sci. USA 89:6314-6318(1992), which is incorporated herein by reference); or heat shockinducible element (Takahashi et al., Plant Physiol. 99:383-390 (1992),which is incorporated herein by reference). Another useful inducibleregulatory element can be a lac operon element, which is used incombination with a constitutively expressed lac repressor to confer, forexample, IPTG-inducible expression, as described by Wilde et al., (EMBOJ. 11:1251-1259 (1992), which is incorporated herein by reference).

An inducible regulatory element useful in a method of the invention alsocan be, for example, a nitrate-inducible promoter derived from thespinach nitrite reductase gene (Back et al., Plant Mol. Biol. 17:9(1991), which is incorporated herein by reference) or a light-induciblepromoter, such as that associated with the small subunit of RuBPcarboxylase or the LHCP gene families (Feinbaum et al., Mol. Gen. Genet.226:449 (1991); Lam and Chua, Science 248:471 (1990), each of which isincorporated herein by reference). An inducible regulatory elementuseful in constructing a transgenic seed plant also can be a salicylicacid inducible element (Uknes et al., Plant Cell 5:159-169 (1993); Bi etal., Plant J. 8:235-245 (1995), each of which is incorporated herein byreference) or a plant hormone-inducible element (Yamaguchi-Shinozaki etal., Plant Mol. Biol. 15:905 (1990); Kares et al., Plant Mol. Biol.15:225 (1990), each of which is incorporated herein by reference). Ahuman glucocorticoid response element also is an inducible regulatoryelement that can confer hormone-dependent gene expression in seed plants(Schena et al., Proc. Natl. Acad. Sci. USA 88:10421 (1991), which isincorporated herein by reference).

An inducible regulatory element that is particularly useful forincreasing expression of a floral meristem identity gene product in atransgenic seed plant of the invention is a copper inducible regulatoryelement (see, for example, Mett et al., supra, 1993). Thus, theinvention provides a recombinant nucleic acid molecule comprising acopper inducible regulatory element operably linked to a nucleic acidmolecule encoding a floral meristem identity gene product and atransgenic seed plant containing such a recombinant nucleic acidmolecule. Copper, which is a natural part of the nutrient environment ofa seed plant, can be used to increase expression of a nucleic acidmolecule encoding a floral meristem identity gene product operablylinked to a copper inducible regulatory element. For example, an ACE1binding site in conjunction with constitutively expressed yeast ACE1protein confers copper inducible expression upon an operably linkednucleic acid molecule. The ACE1 protein, a metalloresponsivetranscription factor, is activated by copper or silver ions, resultingin increased expression of a nucleic acid molecule operably linked to anACE1 element.

Such a copper inducible regulatory element can be an ACE1 binding sitefrom the metallothionein gene promoter (SEQ ID NO: 21; Furst et al.,Cell 55:705-717 (1988), which is incorporated herein by reference). Forexample, the ACE1 binding site can be combined with the 90 base-pairdomain A of the cauliflower mosaic virus 35S promoter and operablylinked to a nucleic acid molecule encoding AP1, CAL or LFY to produce arecombinant nucleic acid molecule of the invention. In a transgenic seedplant constitutively expressing ACE1 under control of such a modifiedCaMV 35S promoter, for example, copper inducible expression is conferredupon an operably linked nucleic acid molecule encoding a floral meristemidentity gene product.

The expression of a nucleic acid encoding a floral meristem identitygene product operably linked to a copper inducible regulatory element,such as 5'-AGCTTAGCGATGCGTCTTTTCCGCTGAACCGTTCCAGCAAAAAGACTAG-3' (SEQ IDNO: 21), can be increased in a transgenic seed plant grown under copperion-depleted conditions, for example, and contacted with 50 μM coppersulfate in a nutrient solution or with 0.5 μM copper sulfate applied byfoliar spraying of the transgenic seed plant (see, for example, Mett etal., supra, 1993). A single application of 0.5 μM copper sulfate can besufficient to sustain increased floral meristem identity gene productexpression over a period of several days. If desired, a transgenic seedplant of the invention also can be contacted with multiple applicationsof an inducing agent such as copper sulfate.

An inducible regulatory element also can confer tetracycline-dependentfloral meristem identity gene expression in a transgenic seed plant ofthe invention. Thus, the present invention provides a recombinantnucleic acid molecule comprising a tetracycline inducible regulatoryelement operably linked to a nucleic acid molecule encoding a floralmeristem identity gene product as well as a transgenic seed plant intowhich such a recombinant nucleic acid molecule has been introduced. Atetracycline inducible regulatory element is particularly useful forconferring tightly regulated gene expression as indicated by theobservation that a phenotype that results from even low amounts of agene product expression is suppressed from such an inducible system inthe absence of inducing agent (see, for example, Roder et al., supra,1994).

A transgenic seed plant constitutively expressing Tn10-encoded Tetrepressor (TetR), for example, can be contacted with tetracycline toincrease expression of a nucleic acid molecule encoding a floralmeristem identity gene product operably linked to the cauliflower mosaicvirus promoter containing several tet operator sequences(5'-ACTCTATCAGTGATAGAGT-3'; SEQ ID NO: 22) positioned close to the TATAbox (see, for example, Gatz, Meth. Cell Biol. 50:411-424 (1995), whichis incorporated herein by reference; Gatz et al., supra, 1992). Such atetracycline-inducible system can increase expression of an operablylinked nucleic acid molecule as much as 200 to 500-fold in a transgenicangiosperm or gymnosperm of the invention.

A high level of Tet repressor expression (about 1×10⁶ molecules percell) is critical for tight regulation. Thus, a seed plant preferably istransformed first with a plasmid encoding the Tet repressor, andscreened for high level expression. For example, plasmid pBinTet (Gatz,supra, 1995) contains the Tet repressor coding region, which isexpressed under control of the CaMV 35S promoter, and the neomycinphosphotransferase gene for selection of transformants. To screentransformants for a high level of Tet repressor expression, a plasmidcontaining a reporter gene under control of a promoter with tetoperators, such as pTX-Gus-int (Gatz, supra, 1995), can be transientlyintroduced into a seed plant cell and assayed for activity in thepresence and absence of tetracycline. High β-glucouronidase (GUS)expression that is dependent on the presence of tetracycline isindicative of high Tet repressor expression.

A particularly useful tetracycline inducible regulatory element ispresent in plasmid pBIN-HygTX, which has a CaMV 35S promoter, into whichthree tet operator sites have been inserted, and an octopine synthasepolyadenylation site (Gatz, supra, 1995). A multiple cloning sitebetween the promoter and polyadenylation signal in pBIN-HygTX allows forconvenient insertion of a nucleic acid molecule encoding the desiredfloral meristem identity gene product, and the hygromycinphosphotransferase gene allows for selection of transformants containingthe construct. In a preferred embodiment of the invention, previouslyselected Tet repressor positive cells are transformed with a plasmidsuch as pBIN-HygTX, into which a nucleic acid molecule encoding a floralmeristem identity gene product has been inserted.

To increase floral meristem identity gene product expression using atetracycline-inducible regulatory element, a transgenic seed plant ofthe invention can be contacted with tetracycline or, preferably, withchlor-tetracycline (SIGMA), which is a more efficient inducer thantetracycline. In addition, a useful inducing agent can be a tetracyclineanalog that binds the Tet repressor to function as an inducer but thatdoes not act as an antibiotic (Gatz, supra, 1995). A transgenic seedplant of the invention can be contacted, for example, by watering withabout 1 mg/liter chlor-tetracycline or tetracycline. Similarly, a plantgrown in hydroponic culture can be contacted with a solution containingabout 1 mg/liter chlor-tetracycline or tetracycline (Gatz, supra, 1995).If desired, a transgenic angiosperm or gymnosperm can be contactedrepeatedly with chlor-tetracycline or tetracycline every other day forabout 10 days (Roder et al., supra, 1994). Floral meristem identity geneproduct expression is increased efficiently at a tetracyclineconcentration that does not inhibit the growth of bacteria, indicatingthat the use of tetracycline as an inducing agent will not presentenvironmental concerns.

An ecdysone inducible regulatory element also can be useful inpracticing the methods of the invention. For example, an ecdysoneinducible regulatory element can contain four copies of an ecdysoneresponse element having the sequence 5'-GATCCGACAAGGGTTCAATGCACTTGTCA-3'(EcRE; SEQ ID NO: 23) as described in Christopherson et al., supra,1992. In a transgenic seed plant into which a nucleic acid encoding anecdysone receptor has been introduced, an ecdysone inducible regulatoryelement can confer ecdysone-dependent expression on a nucleic acidmolecule encoding a floral meristem identity gene product. Anappropriate inducing agent for increasing expression of a nucleic acidmolecule operably linked to an ecdysone inducible regulatory element canbe, for example, α-ecdysone, 20-hydroxyecdysone, polypodine B,ponasterone A, muristerone A or RH-5992, which is an ecdysone agonistthat mimics 20-hydroxyecdysone (see, for example, Kreutzweiser et al.,Ecotoxicol. Environ. Safety 28:14-24 (1994), which is incorporatedherein by reference and Christopherson et al., supra, 1992). Methods fordetermining an appropriate inducing agent for use with an ecdysoneinducible regulatory element are well known in the art. As disclosedherein, compound RH-5992 can be a particularly useful inducing agent forincreasing floral meristem gene product expression in a transgenic seedplant containing an ecdysone inducible regulatory element.

An inducible regulatory element also can be derived from the promoter ofa heat shock gene, such as HSP81-1 (SEQ ID NO: 24; Takahashi, supra,1992). Thus, the invention also provides a recombinant nucleic acidmolecule comprising a heat shock inducible regulatory element operablylinked to a nucleic acid molecule encoding a floral meristem identitygene product and a transgenic seed plant containing such a recombinantnucleic acid molecule. The HSP81-1 promoter (SEQ ID NO: 24) confers lowlevel expression upon an operably linked nucleic acid molecule in partsof roots under unstressed conditions and confers high level expressionin most Arabidopsis tissues following heat shock (see, for example, Yabeet al., Plant Cell Physiol. 35:1207-1219 (1994), which is incorporatedherein by reference). After growth of Arabidopsis at 23° C., a singleheat shock treatment at 37° C. for two hours is sufficient to induceexpression of a nucleic acid molecule operably linked to the HSP81-1gene regulatory element (see Ueda et al., Mol. Gen. Genet. 250:533-539(1996), which is incorporated herein by reference).

The use of a heat shock inducible regulatory element is particularlyuseful for a transgenic seed plant of the invention grown in an enclosedenvironment such as a green house, where temperature can be readilymanipulated. The use of a heat shock inducible regulatory elementespecially is applicable to a transplantable or potted transgenic seedplant of the invention, which can be moved conveniently from anenvironment having a low temperature to an environment having a hightemperature. A transgenic angiosperm or gymnosperm of the inventioncontaining a recombinant nucleic acid molecule comprising a HSP81-1 heatshock regulatory element operably linked to a nucleic acid moleculeencoding a floral meristem identity gene product also can be induced,for example, by altering the ambient temperature, watering with heatedwater or submersing the transgenic seed plant in a sealed plastic baginto a heated water bath (see, for example, Ueda et al., supra, 1996).

A recombinant nucleic acid molecule of the invention comprising aninducible gene regulatory element can be expressed variably in differentlines of transgenic seed plants. In some transgenic lines, for example,leaky expression of the introduced recombinant nucleic acid molecule canoccur in the absence of the appropriate inducing agent due to phenomenasuch as position effects (see, for example, Ueda et al., supra, 1996).Thus, a transgenic seed plant containing a recombinant nucleic acidmolecule comprising an inducible gene regulatory element operably linkedto a nucleic acid encoding a floral meristem identity gene product canbe screened, if desired, to obtain a particular transgenic seed plant inwhich expression of the operably linked nucleic acid molecule isdesirably low in the absence of the appropriate inducing agent.

The present invention also provides a method of converting shootmeristem to floral meristem in an angiosperm by introducing into theangiosperm a recombinant nucleic acid molecule comprising an inducibleregulatory element operably linked to a nucleic acid molecule encoding afloral meristem identity gene product to produce a transgenicangiosperm, and contacting the transgenic angiosperm with an inducingagent, thereby increasing expression of the floral meristem identitygene product and converting shoot meristem to floral meristem in thetransgenic angiosperm. In such a method of the invention, the inducibleregulatory element can be, for example, a copper inducible element,tetracycline inducible element, ecdysone inducible element or heat shockinducible element, and the floral meristem identity gene product can be,for example, AP1, CAL or LFY.

In addition, the invention provides a method of promoting earlyreproductive development in a seed plant such as an angiosperm orgymnosperm by introducing into the seed plant a recombinant nucleic acidmolecule comprising an inducible regulatory element operably linked to anucleic acid molecule encoding a floral meristem identity gene productto produce a transgenic seed plant, and contacting the transgenic seedplant with an inducing agent, thereby increasing expression of thefloral meristem identity gene product and promoting early reproductivedevelopment in the transgenic seed plant.

In a method of the invention for promoting early reproductivedevelopment in a seed plant, the inducible regulatory element can be,for example, a copper inducible element, tetracycline inducible element,ecdysone inducible element or heat shock inducible element, and thefloral meristem identity gene product can be, for example, AP1, CAL orLFY.

The term "inducing agent," as used herein, means a substance orcondition that effects increased expression of a nucleic acid moleculeoperably linked to a particular inducible regulatory element as comparedto the level of expression of the nucleic acid molecule in the absenceof the inducing agent. An inducing agent can be, for example, anaturally occurring or synthetic chemical or biological molecule such asa simple or complex organic molecule, a peptide, a protein or anoligonucleotide that increases expression of a nucleic acid moleculeoperably linked to a particular inducible regulatory element. An exampleof such an inducing agent is a compound such as copper sulfate,tetracycline or an ecdysone. An inducing agent also can be a conditionsuch as heat of a certain temperature or light of a certain wavelength.When used in reference to a particular inducible regulatory element, an"appropriate" inducing agent means an inducing agent that results inincreased expression of a nucleic acid molecule operably linked to theparticular inducible regulatory element.

An inducing agent of the invention can be used alone or in solution orcan be used in conjunction with an acceptable carrier that can serve tostabilize the inducing agent or to promote absorption of the inducingagent by a seed plant. If desired, a transgenic seed plant of theinvention can be contacted with an inducing agent in combination with anunrelated substance such as a plant nutrient, pesticide or insecticide.

One skilled in the art can readily determine the optimum concentrationof an inducing agent needed to produce increased expression of a nucleicacid molecule operably linked to an inducible regulatory element in atransgenic seed plant of the invention. For conveniently determining theoptimum concentration of inducing agent from a range of usefulconcentrations, one skilled in the art can operably link the particularinducible regulatory element to a nucleic acid molecule encoding areporter gene product such as β-glucouronidase (GUS) and assay forreporter gene product activity in the presence of various concentrationsof inducing agent (see, for example, Jefferson et al., EMBO J.6:3901-3907 (1987), which is incorporated herein by reference).

As used herein, the term "contacting," in reference to a transgenic seedplant of the invention, means exposing the transgenic seed plant to aninducing agent, or to a cognate ligand as disclosed below, such that theagent can induce expression of a nucleic acid molecule operably linkedto the particular inducible regulatory element. A transgenic seed plantsuch as an angiosperm or gymnosperm, which contains a recombinantnucleic acid molecule of the invention, can be contacted with aninducing agent in a variety of manners. Expression of a floral meristemidentity gene product can be increased conveniently, for example, byspraying a transgenic seed plant with an aqueous solution containing anappropriate inducing agent or by adding an appropriate inducing agent tothe water supply of a transgenic seed plant grown using irrigation or tothe water supply of a transgenic seed plant grown hydroponically. Atransgenic seed plant containing a recombinant nucleic acid molecule ofthe invention also can be contacted by spraying the seed plant with aninducing agent in aerosol form. In addition, a transgenic seed plant canbe contacted with an appropriate inducing agent by adding the agent tothe soil or other solid nutrient media in which the seed plant is grown,whereby the inducing agent is absorbed into the seed plant. Other modesof contacting a transgenic seed plant with an inducing agent, such asinjecting or immersing the seed plant in a solution containing aninducing agent, are well known in the art. For an inducing agent that istemperature or light, for example, contacting can be effected byaltering the temperature or light to which the transgenic seed plant isexposed, or, if desired, by moving the transgenic seed plant from anenvironment of one temperature or light source to an environment havingthe appropriate inducing temperature or light source.

If desired, a transgenic seed plant of the invention can be contactedindividually with an inducing agent. Furthermore, a group of transgenicseed plants that, for example, are located together in a garden plot,hot house or field, can be contacted en masse with an inducing agent,such that floral meristem identity gene product expression is increasedcoordinately in all transgenic seed plants of the group.

A transgenic seed plant of the invention can be contacted with aninducing agent using one of several means. For example, a transgenicseed plant can be contacted with an inducing agent by non-automatedmeans such as with a hand held spraying apparatus. Such manual means canbe useful when the methods of the invention are applied to particularlydelicate or valuable seed plant varieties or when it is desirable, forexample, to promote early reproductive development in a particulartransgenic seed plant without promoting early reproductive developmentin a neighboring transgenic seed plant. Furthermore, a transgenic seedplant of the invention can be contacted with an inducing agent bymechanical means such as with a conventional yard "sprinkler" for atransgenic seed plant grown, for example, in a garden; a mechanicalspraying system in a green house; traditional farm machinery forspraying field crops; or "crop dusting" for conveniently contacting anentire field of transgenic seed plants with a particulate or gaseousinducing agent. The skilled practitioner, whether home gardener orcommercial farmer, recognizes that these and other manual or mechanicalmeans can be used to contact a transgenic seed plant with an inducingagent according to the methods of the invention.

Furthermore, it is recognized that a transgenic seed plant of theinvention can be contacted with a single treatment of an inducing agentor, if desired, can be contacted with multiple applications of theinducing agent. In a preferred embodiment of the invention, a transgenicseed plant of the invention is contacted once with an inducing agent toeffectively increase floral meristem identity gene product expression,thereby promoting early reproductive development in the transgenic seedplant. Similarly, a transgenic angiosperm of the invention preferably iscontacted once with an inducing agent to effectively increase floralmeristem identity gene product expression and convert shoot meristem tofloral meristem in the transgenic angiosperm.

A single application of an inducing agent is preferable when a transientincrease in floral meristem identity gene product expression from arecombinant nucleic acid molecule of the invention promotes irreversibleearly reproductive development in a seed plant. In many seed plantspecies, early reproductive development is irreversible. Transientexpression of a floral meristem identity gene product from an introducedrecombinant nucleic acid molecule, for example, results in sustainedectopic expression of endogenous floral meristem identity gene products,resulting in irreversible early reproductive development. For example,ectopic expression of AP1 in a transgenic plant induces endogenous LFYgene expression, and ectopic expression of LFY induces endogenous AP1gene expression (Mandel and Yanofsky, Nature 377:522-524 (1995), whichis incorporated herein by reference; Weigel and Nilsson, supra, 1995).Genetic studies also indicate that CAL can act directly or indirectly toincrease expression of AP1 and LFY. Thus, ectopic expression of CAL froman exogenous nucleic acid molecule, for example, can induce endogenousAP1 and LFY expression (see Bowman et al., supra, 1993). Enhancedexpression of endogenous AP1, LFY or CAL following a transient increasein expression of an introduced floral meristem identity gene productinduced by a single application of an inducing agent can make repeatedapplications of an inducing agent unnecessary.

In some seed plants, however, such as angiosperms characterized by thephenomenon of floral reversion, repeated applications of the inducingagent can be desirable. In species such as impatiens, an initiatedflower can revert into a shoot such that the center of the developingflower behaves as an indeterminate shoot (see, for example, Battey andLyndon, Ann. Bot. 61:9-16 (1988), which is incorporated by referenceherein). Thus, to prevent floral reversion in species such as impatiens,repeated applications of an inducing agent can be useful. Repeatedapplications of an inducing agent, as well as single applications, areencompassed within the scope of the present invention.

The invention further provides a nucleic acid molecule encoding achimeric protein, which comprises a nucleic acid molecule encoding afloral meristem identity gene product such as AP1, CAL or LFY linked inframe to a nucleic acid molecule encoding a ligand binding domain.Expression of a chimeric protein of the invention in a seed plant isuseful because the ligand binding domain renders the activity of alinked gene product dependent on the presence of cognate ligand.Specifically, in a chimeric protein of the invention, floral meristemgene product activity is increased in the presence of cognate ligand, ascompared to activity in the absence of cognate ligand.

A nucleic acid molecule encoding a chimeric protein of the inventioncomprises a nucleic acid molecule encoding a floral meristem identitygene product, such as a nucleic acid molecule having the nucleic acidsequence SEQ ID NO: 1, SEQ ID NO: 9 or SEQ ID NO: 15, which encodes AP1,CAL or LFY, respectively, any of which is linked in frame to a nucleicacid molecule encoding a ligand binding domain. The expression of such anucleic acid molecule results in the production of a chimeric proteincontaining a floral meristem identity gene product fused to a ligandbinding domain. Thus, the invention also provides a chimeric proteincontaining a floral meristem identity gene product fused to a ligandbinding domain and an antibody that specifically binds such a chimericprotein.

The invention further provides a transgenic seed plant, such asangiosperm or gymnosperm, that contains a nucleic acid molecule encodinga chimeric protein of the invention. The invention provides, forexample, a transgenic seed plant containing a nucleic acid moleculeencoding a chimeric protein, which comprises a nucleic acid moleculeencoding AP1, CAL or LFY linked in frame to a nucleic acid moleculeencoding a ligand binding domain. A particularly useful transgenic seedplant contains a nucleic acid molecule encoding AP1 linked in frame to anucleic acid molecule encoding an ecdysone receptor ligand bindingdomain or a glucocorticoid receptor ligand binding domain. The inventionalso provides a transgenic seed plant containing a nucleic acid moleculeencoding a chimeric protein, which comprises a nucleic acid moleculeencoding CAL linked in frame to a nucleic acid molecule encoding anecdysone receptor ligand binding domain or a glucocorticoid receptorligand binding domain. In addition, there is provided a transgenic seedplant containing a nucleic acid molecule encoding a chimeric protein,which comprises a nucleic acid molecule encoding LFY linked in frame toa nucleic acid molecule encoding an ecdysone receptor ligand bindingdomain or a glucocorticoid receptor ligand binding domain.

Any floral meristem identity gene product, as defined herein, is usefulin a chimeric protein of the invention. Thus, a nucleic acid moleculeencoding Arabidopsis thaliana AP1 (SEQ ID NO: 2), Brassica oleracea AP1(SEQ ID NO: 4), Brassica oleracea var. Botrytis AP1 (SEQ ID NO: 8) orZea mays AP1 (SEQ ID NO: 10), each of which have activity in convertingshoot meristem to floral meristem, can be used to construct a nucleicacid molecule encoding a chimeric protein of the invention. Similarly, anucleic acid molecule encoding, for example, Arabidopsis thaliana CAL(SEQ ID NO: 10), Brassica oleracea CAL (SEQ ID NO: 12), or a nucleicacid molecule encoding Arabidopsis thaliana LFY (SEQ ID NO: 16) isuseful when linked in frame to a nucleic acid molecule encoding a ligandbinding domain to produce a nucleic acid molecule encoding aligand-dependent chimeric protein of the invention.

A ligand binding domain useful in a chimeric protein of the invention isa domain that, when fused in frame to a heterologous gene product,renders the activity of the fused gene product dependent on cognateligand such that the activity of the fused gene product is increased inthe presence of cognate ligand as compared to its activity in theabsence of ligand. Such a ligand binding domain can be a steroid bindingdomain such as the ligand binding domain of an ecdysone receptor,glucocorticoid receptor, estrogen receptor, progesterone receptor,androgen receptor, thyroid receptor, vitamin D receptor or retinoic acidreceptor. A particularly useful ligand binding domain is the ecdysonereceptor ligand binding domain contained within amino acids 329 to 878of the Drosophila ecdysone receptor (SEQ ID NO: 18); Koelle et al., Cell67:59-77 (1991); Thummel, Cell 83:871-877 (1995), each of which isincorporated herein by reference) or a glucocorticoid receptor ligandbinding domain, encompassed, for example, within amino acids 512 to 795of the rat glucocorticoid receptor (SEQ ID NO: 20; Miesfeld et al., Cell46:389-399 (1986), which is incorporated herein by reference).

A chimeric protein of the invention containing an ecdysone receptorligand binding domain has floral meristem identity gene product activitythat can be increased in the presence of ecdysone ligand. Similarly, achimeric protein of the invention containing a glucocorticoid receptorligand binding domain has floral meristem identity gene product activitythat is increased in the presence of glucocorticoid ligand. It is wellknown that in a chimeric protein containing a heterologous gene productsuch as adenovirus E1A, c-myc, c-fos, the HIV-1 Rev transactivator, MyoDor maize regulatory factor R fused to the rat glucocorticoid receptorligand binding domain, activity of the fused heterologous gene productcan be increased by glucocorticoid ligand (Eilers et al., Nature 340:66(1989); Superti-Furga et al., Proc. Natl. Acad. Sci., U.S.A. 88:5114(1991); Hope et al., Proc. Natl. Acad. Sci., U.S.A. 87:7787 (1990);Hollenberg et al., Proc. Natl. Acad. Sci., U.S.A. 90:8028 (1993), eachof which is incorporated herein by reference).

A nucleic acid molecule encoding a chimeric protein of the invention canbe introduced into a seed plant where, under appropriate conditions, thechimeric protein is expressed. In such a transgenic seed plant, floralmeristem identity gene product activity can be increased by contactingthe transgenic seed plant with cognate ligand. For example, activity ofa heterologous protein fused to a rat glucocorticoid receptor ligandbinding domain (amino acids 512 to 795) expressed under the control ofthe constitutive cauliflower mosaic virus 35S promoter in Arabidopsiswas low in the absence of glucocorticoid ligand; whereas, uponcontacting the transformed plants with a synthetic glucocorticoid,dexamethasone, activity of the protein was increased greatly (Lloyd etal., Science 266:436-439 (1994), which is incorporated herein byreference). As disclosed herein, a ligand binding domain fused to afloral meristem identity gene product renders the activity of a fusedfloral meristem identity gene product ligand-dependent such that, uponcontacting the transgenic seed plant with cognate ligand, floralmeristem identity gene product activity is increased.

Methods for constructing a nucleic acid molecule encoding a chimericprotein of the invention are routine and well known in the art (Sambrooket al., supra, 1989). Methods of constructing, for example, a nucleicacid encoding an AP1-glucocorticoid receptor ligand binding domainchimeric protein are described in Example IV. For example, the skilledartisan recognizes that a stop codon encoded by the nucleic acidmolecule must be removed and that the two nucleic acid molecules must belinked in frame such that the reading frame of the 3' nucleic acidmolecule coding sequence is preserved. Methods of transforming a seedplant such as an angiosperm or gymnosperm with a nucleic acid moleculeare disclosed above and well known in the art (see Examples I, II andIII; see, also, Mohoney et al., U.S. Pat. No. 5,463,174, and Barry etal., U.S. Pat. No. 5,463,175, each of which is incorporated herein byreference).

As used herein, the term "linked in frame," when used in reference totwo nucleic acid molecules that make up a nucleic acid molecule encodinga chimeric protein, means that the two nucleic acid molecules are linkedin the correct reading frame such that, under appropriate conditions, afull-length chimeric protein is expressed. In particular, a 5' nucleicacid molecule, which encodes the amino-terminal portion of the chimericprotein, must be linked to a 3' nucleic acid molecule, which encodes thecarboxyl-terminal portion of the chimeric protein, such that thecarboxyl-terminal portion of the chimeric protein is translated in thecorrect reading frame. One skilled in the art would recognize that anucleic acid molecule encoding a chimeric protein of the invention cancomprise, for example, a 5' nucleic acid molecule encoding a floralmeristem identity gene product linked in frame to a 3' nucleic acidmolecule encoding a ligand binding domain or can comprise a 5' nucleicacid molecule encoding a ligand binding domain linked in frame to a 3'nucleic acid molecule encoding a floral meristem identity gene product.Preferably, a nucleic acid molecule encoding a chimeric protein of theinvention comprises a 5' nucleic acid molecule encoding a floralmeristem identity gene product linked in frame to a 3' nucleic acidmolecule encoding a ligand binding domain.

In a transgenic angiosperm containing a chimeric protein of theinvention, conversion of shoot meristem to floral meristem can beinduced by contacting the transgenic angiosperm with a cognate ligandthat is absorbed by the angiosperm and binds the chimeric protein withinits ligand binding domain. Thus, the present invention provides a methodof converting shoot meristem to floral meristem in an angiosperm byintroducing into the angiosperm a nucleic acid molecule encoding achimeric protein to produce a transgenic angiosperm, where, underappropriate conditions, the chimeric protein containing a floralmeristem identity gene product fused to a ligand binding domain isexpressed; and contacting the transgenic angiosperm with cognate ligand,where, upon binding of the cognate ligand to the ligand binding domain,floral meristem identity gene product activity is increased, therebyconverting shoot meristem to floral meristem in the transgenicangiosperm.

The present invention provides, for example, a method of convertingshoot meristem to floral meristem in an angiosperm by introducing intothe angiosperm a nucleic acid molecule encoding a chimeric protein,which comprises a nucleic acid molecule encoding AP1, CAL or LFY linkedin frame to a nucleic acid molecule encoding an ecdysone receptor ligandbinding domain, to produce a transgenic angiosperm, where, underappropriate conditions, the chimeric protein is expressed; andcontacting the transgenic angiosperm with ecdysone ligand, where, uponbinding of the ecdysone ligand to the ecdysone receptor ligand bindingdomain, floral meristem identity gene product activity is increased,thereby converting shoot meristem to floral meristem in the transgenicangiosperm. Similarly, the invention provides, for example, a method ofconverting shoot meristem to floral meristem in an angiosperm byintroducing into the angiosperm a nucleic acid molecule encoding achimeric protein, which comprises a nucleic acid molecule encoding AP1,CAL or LFY linked in frame to a nucleic acid molecule encoding aglucocorticoid receptor ligand binding domain, to produce a transgenicangiosperm, where, under appropriate conditions, the chimeric protein isexpressed; and contacting the transgenic angiosperm with glucocorticoidligand, where, upon binding of the glucocorticoid ligand to theglucocorticoid receptor ligand binding domain, floral meristem identitygene product activity is increased, thereby converting shoot meristem tofloral meristem in the transgenic angiosperm.

In addition, the invention provides a method of promoting earlyreproductive development in a seed plant by introducing into the seedplant a nucleic acid molecule encoding a chimeric protein of theinvention to produce a transgenic seed plant, where, under appropriateconditions, the chimeric protein containing a floral meristem identitygene product fused to a ligand binding domain is expressed; andcontacting the transgenic seed plant with cognate ligand, where, uponbinding of the cognate ligand to the ligand binding domain, floralmeristem identity gene product activity is increased, thereby promotingearly reproductive development in the transgenic seed plant. The methodsof the invention can be practiced with numerous seed plant varieties.The seed plant can be, for example, an angiosperm such as a cerealplant, leguminous plant, hardwood tree or coffee plant, or can be agymnosperm such as a pine, fir, spruce or redwood tree.

There is provided, for example, a method of promoting early reproductivedevelopment in a seed plant by introducing into the seed plant a nucleicacid molecule encoding a chimeric protein, which comprises a nucleicacid molecule encoding a floral meristem identity gene product linked inframe to a nucleic acid molecule encoding an ecdysone receptor ligandbinding domain, to produce a transgenic seed plant, where, underappropriate conditions, the chimeric protein is expressed; andcontacting the transgenic seed plant with ecdysone ligand, where, uponbinding of the ecdysone ligand to the ecdysone receptor ligand bindingdomain, floral meristem identity gene product activity is increased,thereby promoting early reproductive development in the transgenic seedplant. Similarly, the invention provides, for example, a method ofpromoting early reproductive development in a seed plant by introducinginto the seed plant a nucleic acid molecule encoding a chimeric protein,which comprises a nucleic acid molecule encoding AP1, CAL or LFY linkedin frame to a nucleic acid molecule encoding a glucocorticoid receptorligand binding domain, to produce a transgenic seed plant, where, underappropriate conditions, the chimeric protein is expressed; andcontacting the transgenic seed plant with glucocorticoid ligand, where,upon binding of the glucocorticoid ligand to the glucocorticoid receptorligand binding domain, floral meristem identity gene product activity isincreased, thereby promoting early reproductive development in thetransgenic seed plant.

As used herein, the term "ligand" means a naturally occurring orsynthetic chemical or biological molecule such as a simple or complexorganic molecule, a peptide, a protein or an oligonucleotide thatspecifically binds a ligand binding domain. In the methods of thepresent invention, a ligand can be used alone or in solution or can beused in conjunction with an acceptable carrier that can serve tostabilize the ligand or promote absorption of the ligand by a seedplant. If desired, a transgenic seed plant of the invention can becontacted with a ligand for increasing floral meristem identity geneproduct activity in combination with an unrelated molecule such as aplant nutrient, pesticide or insecticide. When used in reference to aparticular ligand binding domain, the term "cognate ligand" means aligand that, under suitable conditions, specifically binds theparticular ligand binding domain.

One skilled in the art readily can determine the optimum concentrationof cognate ligand needed to bind a ligand binding domain and increasefloral meristem identity gene product activity in a transgenic seedplant of the invention. Generally, a concentration of about 1 nM to 10μM cognate ligand is useful for increasing floral meristem identity geneproduct activity in a transgenic seed plant expressing a chimericprotein of the invention. Preferably, a concentration of about 100 nM to1 μM cognate ligand is useful for increasing floral meristem identitygene product activity in a transgenic seed plant containing a chimericprotein of the invention (see, for example, Christopherson et al., Proc.Natl. Acad. Sci. USA 89:6314-6318 (1992), which is incorporated hereinby reference; also, see Lloyd et al., supra, 1994). For example, aconcentration of about 100 nM to 1 AM dexamethasone can be useful forincreasing floral meristem identity gene product activity in atransgenic seed plant of the invention containing a nucleic acidmolecule encoding a chimeric protein, which comprises a nucleic acidmolecule encoding a floral meristem identity gene product, such as AP1or CAL, linked in frame to a nucleic acid molecule encoding aglucocorticoid receptor ligand binding domain, as described in ExampleIV.

As discussed above, a transgenic seed plant of the invention, such as atransgenic seed plant expressing a chimeric protein of the invention,can be contacted in a variety of manners. A transgenic seed plant can becontacted with cognate ligand, for example, by spraying the seed plantwith a gaseous ligand or with solution such as an aqueous solutioncontaining the appropriate ligand; or by adding the cognate ligand tothe water supply of a seed plant grown using irrigation or grownhydroponically; or by adding the cognate ligand to the soil or othersolid nutrient medium in which a seed plant is grown, whereby thecognate ligand is absorbed into the seed plant to increase floralmeristem identity gene product activity. A transgenic seed plantexpressing a chimeric protein of the invention also can be contactedwith a cognate ligand in aerosol form. In addition, a transgenic seedplant can be contacted with cognate ligand by injecting the seed plantor by immersing the seed plant in a solution containing the cognateligand.

A transgenic seed plant expressing a chimeric protein of the inventioncan be contacted individually with cognate ligand, or a group oftransgenic seed plants can be contacted en masse to increase floralmeristem gene product activity synchronously in all seed plants of thegroup. Furthermore, a variety of means can be used to contact atransgenic seed plant of the invention with cognate ligand to increasefloral meristem identity gene product activity. A transgenic seed plantcan be contacted with cognate ligand using, for example, a hand heldspraying apparatus; conventional yard "sprinkler"; mechanical sprayingsystem, such as an overhead spraying system in a green house;traditional farm machinery, or "crop dusting." As discussed above inregard to the application of inducing agents, the methods of theinvention can be practiced using these and other manual or mechanicalmeans to contact a transgenic seed plant with single or multipleapplications of cognate ligand.

The nucleic acid molecules encoding floral meristem identity geneproducts provided herein also can be useful in generating steriletransgenic seed plants and in methods of producing reproductivesterility in seed plants. The methods of the invention involvecosuppression metholodology, where a nucleic acid molecule in the senseorientation is introduced into a seed plant to suppress expression of ahomologous endogenous gene, or involve antisense metholodology. Thus,the present invention provides cosuppression and antisense methods ofproducing reproductively sterile transgenic seed plants as well as thetwo types of sterile transgenic seed plants produced by these methods.

A method of the invention for producing a reproductively steriletransgenic seed plant has a variety of uses including safely growingtransgenic trees in close contact with interfertile wild trees,increasing wood production and reducing allergenic pollen production. Amethod for producing reproductive sterility in seed plants, which isuseful for transgene containment, can allow, for example, theintroduction of transgenic trees into the environment. Of particularconcern to the introduction of transgenic trees into the environment isthe possibility of enhanced "weediness" or the movement of transgenes bycross-fertilization into gene pools of wild relatives. Most commerciallygrown forest trees, for example, are grown in close proximity tointerfertile wild populations, and gene flow within and among treepopulations usually is extensive, making the probability of transgeneescape from plantations of fertile transgenic trees high. Regulatoryagencies have based approval of transgenic tree planting on sexualisolation of the transgenic species; for example, approval of two fieldtests for transgenic poplars by the Animal and Plant Health InspectionService (APHIS) was contingent on the trees not being allowed to flower(see, for example, Strauss et al., Molec. Breed 1:5-26 (1995), which isincorporated herein by reference). Thus, transgene containment through,for example, the use of sterile transgenic trees is central to theusefulness of improved transgenic varieties.

Methods of producing reproductively sterile seed plants also can beuseful for increasing wood production, since substantial energy andnutrients are committed to reproductive development in trees. Forexample, in trees such as radiata pine, white spruce, balsam fir andDouglas fir, reduced growth, as measured by height or stem volume, iscorrelated with the early production of cones (Strauss et al., supra,1995). Thus, the methods of the invention, which prevent flowering orcone development, for example, by producing reproductive sterility, areuseful for growing substantially larger trees, thus increasing woodproduction.

A method for producing reproductively sterile seed plants also can beuseful for alleviating allergies caused by tree pollen. For example, inJapan many people suffer from allergies caused by the most commonlyplanted forest tree, the conifer sugi (Strauss et al., supra, 1995). Themethods of the invention, therefore, can be advantageous for preventingpollen formation in seed plants such as the conifer sugi.

Cosuppression, which relies on expression of a nucleic acid molecule inthe sense orientation, is a well known methodology that producescoordinate silencing of the introduced nucleic acid molecule and thehomologous endogenous gene (see, for example, Flavell, Proc. Natl. Acad.Sci., USA 91:3490-3496 (1994), which is incorporated herein byreference; Kooter and Mol, supra, 1993). Although the mechanism ofcosuppression is unknown, cosuppression is induced most strongly by alarge number of transgene copies or by overexpression of transgene RNA;cosuppression also can be enhanced by modification of the transgene suchthat it fails to be translated. Cosuppression has been used successfullyto produce sterile plants; for example, a sense nucleic acid moleculecontaining a full-length fbp1 coding sequence under control of thestrong CaMV 35S promoter has been introduced into petunia. Two oftwenty-one transformants exhibited an abnormal phenotype and containedmultiple copies of the fbp1 transgene. Furthermore, fbp1 expression wasundetectable in these sterile transgenic plants, indicating thatexpression of endogenous fbpl was suppressed (Angenent et al., The PlantJournal 4:101-112 (1993), which is incorporated herein by reference).

Antisense nucleic acid molecules, which can act by reducing mRNAtranslation or by increasing mRNA degradation, for example, also cansuppress gene expression of diverse genes and seed plant species (see,for example, Kooter and Mol, Current Opin. Biol. 4:166-171 (1993), whichis incorporated herein by reference; see also Strauss et al., supra,1995). Antisense nucleic acid molecules previously have been used tosuccessfully suppress the expression of a homologous endogenous gene,thereby generating sterile plants. For example, an antisense chalconesynthase gene under control of the CaMV 35S promoter with ananther-specific enhancer sequence effectively suppressed endogenouschalcone synthase expression levels, resulting in male sterility intransgenic petunia plants (van der Meer et al., The Plant Cell Vol4:253-262 (1992), which is incorporated herein by reference). Similarly,the full-length tomato TM5 MADS box gene, when placed in antisenseorientation under control of the CaMV 35S promoter, was used to producesterile transgenic tomato plants (Pnuell et al., The Plant Cell Vol. 6,175-186 (1994), which is incorporated herein by reference). Antisensenucleic acid molecules encoding floral meristem identity gene productssimilarly can be used to produce reproductive sterility in seed plants;however, by preventing reproductive development at the earliest stage,the methods of the invention result in an advantageous energy savings.

Thus, the present invention provides a sterile transgenic seed plantsuch as an angiosperm or gymnosperm containing one or more sense orantisense nucleic acid molecules encoding a floral meristem identitygene product, or a fragment thereof, such that expression of AP1 and LFYgene products, including expression of endogenous AP1 and LFY geneproducts, is suppressed in the transgenic seed plant. The invention alsoprovides, for example, a sterile transgenic seed plant containing asense or antisense nucleic acid molecule encoding AP1, or a fragmentthereof; a sense or antisense nucleic acid molecule encoding CAL, or afragment thereof; and a sense or antisense nucleic acid moleculeencoding LFY, or a fragment thereof, such that expression of AP1 and LFYgene products, including expression of endogenous AP1 and LFY geneproducts, is suppressed in the transgenic seed plant. The inventionfurther provides a sterile transgenic seed plant containing a sense orantisense nucleic acid molecule encoding AP1, or a fragment thereof, anda sense or antisense nucleic acid molecule encoding LFY, or a fragmentthereof, such that expression of AP1 and LFY gene products, includingexpression of endogenous AP1 and LFY gene products, is suppressed in thetransgenic seed plant.

The present invention also provides methods of producing reproductivesterility in a seed plant such as a tree by introducing into a seedplant one or more sense or antisense nucleic acid molecules encoding afloral meristem identity gene product, or a fragment thereof, to producea transgenic seed plant, such that expression of AP1 and LFY geneproducts, including expression of endogenous AP1 and LFY gene products,is suppressed in the transgenic seed plant. In a preferred embodiment ofthe invention, there are provided methods of producing reproductivesterility in a seed plant by introducing into a seed plant a sense orantisense nucleic acid molecule encoding AP1, or a fragment thereof; asense or antisense nucleic acid molecule encoding CAL, or a fragmentthereof; and a sense or antisense nucleic acid molecule encoding LFY, ora fragment thereof, to produce a transgenic seed plant, such thatexpression of AP1 and LFY gene products, including expression ofendogenous AP1 and LFY gene products, is suppressed in the transgenicseed plant. In another embodiment, the invention provides methods ofproducing reproductive sterility in a seed plant by introducing into aseed plant a sense or antisense nucleic acid molecule encoding AP1, or afragment thereof, and a sense or antisense nucleic acid moleculeencoding LFY, or a fragment thereof, to produce a transgenic seed plant,such that expression of AP1 and LFY gene products, including expressionof endogenous AP1 and LFY gene products, is suppressed in the transgenicseed plant.

Sterile seed plants that lack expression of functional AP1 and LFY geneproducts have been described previously. For example, a non-floweringArabidopsis lfy ap1 double mutant has been described in which flowerswere transformed into shoot-like structures (see, for example, Bowman etal., supra, 1993, and Weigel, supra, 1995). However, in contrast topreviously described methods of generating sterile seed plants usingmutagenesis, a methodology that is cumbersome or unfeasible in higherplants, the present invention provides a convenient method of producingreproductive sterility in a seed plant using sense or antisense nucleicacid molecules encoding floral meristem identity gene products.

The methods of the invention for producing reproductive sterility relyupon introducing into a seed plant one or more sense or antisensenucleic acid molecules encoding a floral meristem identity gene product,or a fragment thereof, such that expression of AP1 and LFY geneproducts, including expression of endogenous AP1 and LFY gene products,is suppressed in the transgenic seed plant. The skilled artisan willrecognize that effective suppression of endogenous AP1 and LFY geneproduct expression depends upon the one or more introduced nucleic acidmolecules having a high percentage of homology with the correspondingendogenous gene loci.

The homology requirement for effective suppression using sense orantisense nucleic acid molecules can be determined empirically. Ingeneral, a minimum of about 80-90% nucleic acid sequence identity ispreferred for effective suppression of endogenous floral meristemidentity gene product expression. Thus, a nucleic acid molecule encodinga gene ortholog from the family or genus of the seed plant species intowhich the nucleic acid molecule is to be introduced is preferable inpracticing the methods of the invention. More preferably, a nucleic acidmolecule encoding a gene ortholog from the same seed plant species intowhich the nucleic acid molecule is to be introduced is used in themethods of the invention. Although a highly homologous nucleic acidmolecule is preferred in the methods of the invention, the sense orantisense nucleic acid molecule need not contain the entire codingsequence of the floral meristem identity gene sequence to be suppressed.Thus, a sense or antisense nucleic acid molecule encoding only afragment of AP1, CAL or LFY coding sequence, for example, also can beuseful in the methods of the invention.

As used herein in reference to a nucleic acid molecule encoding a floralmeristem identity gene product, the terms "sense" and "antisense" havetheir commonly understood meanings.

As used herein in reference to a nucleic acid molecule encoding a floralmeristem identity gene product, the term "fragment" means a portion ofthe nucleic acid sequence containing at least about 50 base pairs to thefull-length of the nucleic acid molecule encoding the floral meristemidentity gene product. In contrast to an active fragment, as definedherein, a fragment of a nucleic acid molecule encoding a floral meristemidentity gene product need not encode a functional portion of a geneproduct.

In the methods of the invention for producing reproductive sterility,the sense or antisense nucleic acid molecule is expressed under controlof a strong promoter that is expressed, at least in part, in floralmeristem. The constitutive cauliflower mosaic virus 35S promoter (Odellet al., supra, 1985), for example, or other strong promoters asdisclosed herein, can be useful in the methods of the invention. Inaddition, an RNA polymerase III promoter can be useful in methods ofproducing reproductive sterility using an antisense nucleic acidmolecule (see, for example, Bourque and Folk, Plant Mol. Biol.19:641-647 (1992), which is incorporated herein by reference).

The present invention also provides novel substantially purified nucleicacid molecules encoding floral meristem identity gene products. Theinvention provides a substantially purified nucleic acid moleculeencoding Brassica oleracea AP1 having the amino acid sequence SEQ ID NO:4; a substantially purified nucleic acid molecule encoding Brassicaoleracea var. botrytis AP1 having the amino acid sequence SEQ ID NO: 6;or a substantially purified nucleic acid molecule encoding Zea mays AP1having the amino acid sequence SEQ ID NO: 8. In addition, the inventionprovides a substantially purified nucleic acid molecule that encodes aBrassica oleracea AP1, Brassica oleracea var. botrytis AP1 or Zea maysAP1 and that contains additional 5' or 3' noncoding sequence. Forexample, a substantially purified nucleic acid molecule having anucleotide sequence such as SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7is provided.

As used herein in reference to a particular nucleic acid molecule orgene product, the term "substantially purified" means that theparticular nucleic acid molecule or gene product is in a form that isrelatively free from contaminating lipids, unrelated gene products,unrelated nucleic acids or other cellular material normally associatedwith the particular nucleic acid molecule or gene product in a cell.

The present invention also provides a nucleotide sequence having atleast ten contiguous nucleotides of a nucleic acid molecule encodingBrassica oleracea AP1, Brassica oleracea var. botrytis AP1 or Zea maysAP1, provided that said nucleotide sequence is not present in a nucleicacid molecule encoding a MADS domain containing protein. In particular,such a nucleotide sequence can have at least ten contiguous nucleotidesof a nucleic acid molecule encoding an AP1 gene product having the aminoacid sequence of SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8. Anucleotide sequence of the invention can have, for example, at least tencontiguous nucleotides of the nucleic acid sequence of SEQ ID NO: 3, SEQID NO: 5 or SEQ ID NO: 7.

As used herein, the term "contiguous," as used in reference to thenucleotides of a nucleic acid molecule means that the nucleotides of thenucleic acid molecule follow continuously in sequence. Thus, anucleotide sequence of the invention has at least ten contiguousnucleotides of one of the recited nucleic acid molecules without anyextraneous intervening nucleotides.

Explicitly excluded from a nucleotide sequence of the present inventionis a nucleotide sequence having at least ten contiguous nucleotides thatis present in a nucleic acid molecule encoding a MADS domain containingprotein. MADS domain containing proteins are well known in the art asdescribed in Purugganan et al., supra, 1995.

In general, a nucleotide sequence of the invention can range in sizefrom about 10 nucleotides to the full-length of a cDNA. Such anucleotide sequence can be chemically synthesized, using routine methodsor can be purchased from a commercial source. In addition, such anucleotide sequence can be obtained by enzymatic methods such as randompriming methods, polymerase chain reaction (PCR) methods or by standardrestriction endonuclease digestion, followed by denaturation (Sambrooket al., supra, 1989).

A nucleotide sequence of the invention can be useful, for example, as aprimer for PCR (Innis et al. (ed.) PCR Protocols: A Guide to Methods andApplications, San Diego, Calif.: Academic Press, Inc. (1990)). Such anucleotide sequence generally contains from about 10 to about 50nucleotides.

A nucleotide sequence of the invention also can be useful in screening acDNA or genomic library to obtain a related nucleotide sequence. Forexample, a cDNA library that is prepared from rice or wheat can bescreened with a nucleotide sequence having at least ten contiguousnucleotides of the nucleic acid molecule encoding Zea mays AP1 (SEQ IDNO: 7) in order to isolate a rice or wheat ortholog of AP1. Generally, anucleotide sequence useful for screening a cDNA or genomic librarycontains at least about 14 to 16 contiguous nucleotides depending, forexample, on the hybridization conditions to be used. A nucleotidesequence containing at least 18 to 20 nucleotides, or containing atleast 21 to 25 nucleotides, also can be useful.

A nucleotide sequence having at least ten contiguous nucleotides of anucleic acid molecule encoding Zea mays AP1 (SEQ ID NO: 7) also can beused to screen a Zea mays cDNA library to isolate a sequence that isrelated to but distinct from AP1. Similarly, a nucleotide sequencehaving at least ten contiguous nucleotides of a nucleic acid moleculeencoding Brassica oleracea AP1 (SEQ ID NO: 3) or a nucleotide sequencehaving at least ten contiguous nucleotides of a nucleic acid moleculeencoding Brassica oleracea var. botrytis AP1 (SEQ ID NO: 5) can be usedto screen a Brassica oleracea or Brassica oleracea var. botrytis cDNAlibrary to isolate a novel sequence that is related to but distinct fromAP1. In addition, a nucleotide sequence of the invention can be usefulin analyzing RNA levels or patterns of expression, as by northernblotting or by in situ hybridization to a tissue section. Such anucleotide sequence also can be used in Southern blot analysis toevaluate gene structure and identify the presence of related genesequences.

The invention also provides a vector containing a nucleic acid moleculeencoding a Brassica oleracea AP1 gene product, Brassica oleracea var.botrytis AP1 gene product or Zea mays AP1 gene product. A vector can bea cloning vector or an expression vector and provides a means totransfer an exogenous nucleic acid molecule into a host cell, which canbe a prokaryotic or eukaryotic cell. Such vectors are well known andinclude plasmids, phage vectors and viral vectors. Various vectors andmethods for introducing such vectors into a cell are described, forexample, by Sambrook et al., supra, 1989, and by Glick and Thompson,supra, 1993).

The invention further provides a method of producing an AP1 gene productby expressing a nucleic acid molecule encoding an AP1 gene product.Thus, a Brassica oleracea AP1 gene product can be produced according toa method of the invention by expressing a nucleic acid molecule havingthe amino acid sequence of SEQ ID NO: 4 or by expressing a nucleic acidmolecule having the nucleic acid sequence of SEQ ID NO: 3. Similarly, aBrassica oleracea var. botrytis AP1 gene product can be producedaccording to a method of the invention by expressing a nucleic acidmolecule having the amino acid sequence of SEQ ID NO: 6 or by expressinga nucleic acid molecule having the nucleic acid sequence of SEQ ID NO:5. A Zea mays AP1 gene product can be produced by expressing a nucleicacid molecule having the amino acid sequence of SEQ ID NO: 8 or byexpressing a nucleic acid molecule having the nucleic acid sequence ofSEQ ID NO: 7.

The invention also provides a substantially purified AP1 gene product,such as a substantially purified Brassica oleracea AP1 gene producthaving amino acid sequence SEQ ID NO: 4; a substantially purifiedBrassica oleracea var. botrytis AP1 gene product having amino acidsequence SEQ ID NO: 6; or a substantially purified Zea mays AP1 geneproduct having amino acid sequence SEQ ID NO: 8. As used herein, theterm "gene product" is used in its broadest sense and includes proteins,polypeptides and peptides, which are related in that each consists of asequence of amino acids joined by peptide bonds. For convenience, theterms "gene product," "protein" and "polypeptide" are usedinterchangeably. While no specific attempt is made to distinguish thesize limitations of a protein and a peptide, one skilled in the artwould understand that proteins generally consist of at least about 50 to100 amino acids and that peptides generally consist of at least twoamino acids up to a few dozen amino acids. The term gene product as usedherein includes any such amino acid sequence.

An active fragment of a floral meristem identity gene product also canbe useful in the methods of the invention. As used herein, the term"active fragment," means a polypeptide portion of a floral meristemidentity gene product that can convert shoot meristem to floral meristemin an angiosperm. An active fragment of an AP1 gene product can consist,for example, of an amino acid sequence that is derived from SEQ ID NO:2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8 and has activity inconverting shoot meristem to floral meristem in an angiosperm. An activefragment can be, for example, an amino terminal, carboxyl terminal orinternal fragment of Zea mays AP1 (SEQ ID NO: 8) that has activity inconverting shoot meristem to floral meristem in an angiosperm. Theskilled artisan will recognize that an active fragment of a floralmeristem identity gene product, as defined herein, can be useful in themethods of the invention for converting shoot meristem to floralmeristem in an angiosperm, for producing early reproductive developmentin a seed plant, or for producing reproductive sterility in a seedplant.

Such an active fragment can be produced using well known recombinant DNAmethods (Sambrook et al., supra, 1989). Similarly, an active fragmentcan be, for example, an amino terminal, carboxyl terminal or internalfragment of Arabidopsis thaliana CAL (SEQ ID NO: 10) or Brassicaoleracea CAL (SEQ ID NO: 12) that has activity, for example, inconverting shoot meristem to floral meristem in an angiosperm. Theproduct of the BobCAL gene (SEQ ID NO: 24), which is truncated at aminoacid 150, lacks activity in converting shoot meristem to floral meristemand, therefore, is an example of a polypeptide portion of a CAL floralmeristem identity gene product that is not an "active fragment" of afloral meristem identity gene product.

An active fragment of a floral meristem identity gene product, which canconvert shoot meristem to floral meristem in an angiosperm, can beidentified using the methods described in Examples I, II and III.Briefly, an angiosperm such as Arabidopsis can be transformed with anucleic acid molecule encoding a portion of a floral meristem identitygene product in order to determine whether the portion can convert shootmeristem to floral meristem and, therefore, is an active fragment of afloral meristem identity gene product.

The invention further provides an antibody that specifically binds anAP1 gene product having the amino acid sequence of Brassica oleracea AP1(SEQ ID NO: 4); the amino acid sequence of Brassica oleracea var.botrytis AP1 (SEQ ID NO: 6); or the amino acid sequence of Zea mays AP1(SEQ ID NO: 8). As used herein, the term "antibody" is used in itsbroadest sense to include naturally occurring and non-naturallyoccurring polyclonal and monoclonal antibodies, as well as a polypeptidefragment of an antibody that retains a specific binding activity of atleast about 1×10⁵ M⁻¹, and preferably about 1×10⁶ M⁻¹, for an AP1 geneproduct having amino acid sequence SEQ ID NO: 4, SEQ ID NO: 6 or SEQ IDNO: 8. One skilled in the art would know that an antibody fragment suchas a Fab, F(ab')₂ or Fv fragment can retain specific binding activityfor an AP1 gene product and, thus, is included within the definition ofan antibody. A non-naturally occurring antibody, or fragment thereof,such as a chimeric antibody or humanized antibody also is includedwithin the meaning of the term antibody. Such a non-naturally occurringantibody can be constructed using solid phase peptide synthesis,produced recombinantly or obtained, for example, by screening acombinatorial library consisting of variable heavy chains and variablelight chains as described by Huse et al., Science 246:1275-1281 (1989),which is incorporated herein by reference.

An antibody "specific for" a gene product, or that "specifically binds"a gene product, binds with substantially higher affinity to that geneproduct than to an unrelated gene product. An antibody specific for agene product also can have specificity for a related gene product. Forexample, an antibody specific for a Zea mays AP1 gene product also canspecifically bind an Arabidopsis thaliana AP1 gene product or a Brassicaoleracea AP1 gene product.

An antibody that specifically binds a Zea mays AP1 gene product (SEQ IDNO: 8), for example, can be prepared using a Zea mays AP1 fusion proteinor a synthetic peptide encoding a portion of Zea mays AP1 (SEQ ID NO: 8)as an immunogen. One skilled in the art would know that purified Zeamays AP1 gene product, which can be prepared from a natural source orproduced recombinantly according to a method of the invention, or afragment of a Zea mays AP1 gene product, including a peptide portion ofZea mays AP1 such as a synthetic peptide, can be used as an immunogen.For example, preparation of antisera that specifically binds an AP1 geneproduct is described in Example VI using a GST-AP1 fusion proteincontaining amino acids 190 to 251 of AP1 as an immunogen. In addition, anon-immunogenic fragment or synthetic peptide derived from Zea mays AP1,for example, can be made immunogenic by coupling the non-immunogenicfragment or peptide (hapten) to a carrier molecule such as bovine serumalbumin (BSA) or keyhole limpet hemocyanin (KLH). In addition, variousother carrier molecules and methods for coupling a hapten to a carriermolecule are well known in the art as described, for example, by Harlowand Lane, Antibodies: A Laboratory Manual (Cold Spring Harbor LaboratoryPress, 1988), which is incorporated herein by reference.

The invention also provides an expression vector containing a nucleicacid molecule encoding a floral meristem identity gene product such asAP1, CAL or LFY operably linked to a heterologous regulatory element.Expression vectors are well known in the art and provide a means totransfer and express an exogenous nucleic acid molecule into a hostcell. Thus, an expression vector contains, for example, transcriptionstart and stop sites such as a TATA sequence and a poly-A signalsequence, as well as a translation start site such as a ribosome bindingsite and a stop codon, if not present in the coding sequence.

As used herein, the term "heterologous regulatory element" means aregulatory element derived from a different gene than the gene encodingthe floral meristem identity gene product to which it is operablylinked. A vector containing a floral meristem identity gene, however,contains a nucleic acid molecule encoding a floral meristem identitygene product operably linked to a homolgous regulatory element. Such avector does not contain a nucleic acid molecule encoding a floralmeristem identity gene product operably linked to a heterologousregulatory element and, thus, is not an expression vector of theinvention.

The invention further provides a plant expression vector containing afloral meristem identity gene product operably linked to a heterologousregulatory element. For example, a plant expression vector containing anucleic acid molecule encoding an AP1 gene product having at least about70 percent amino acid identity with an amino acid sequence ofArabidopsis thaliana AP1 (SEQ ID NO: 2) in the region from amino acid 1to amino acid 163 or with the amino acid sequence of Zea mays AP1 (SEQID NO: 8) in the region from amino acid 1 to amino acid 163 is provided.A plant expression vector containing a floral meristem identity geneproduct operably linked to a constitutive regulatory element, such asthe cauliflower mosaic virus 35S promoter, is provided. In addition, aplant expression vector containing a floral meristem identity geneproduct operably linked to an inducible regulatory element is provided.

A useful plant expression vector can contain a constitutive regulatoryelement for expression of an exogenous nucleic acid molecule in all ormost tissues of a seed plant. The use of a constitutive regulatoryelement can be particularly advantageous because expression from theelement is relatively independent of developmentally regulated ortissue-specific factors. For example, the cauliflower mosaic virus 35Spromoter (CaMV 35S) is a well-characterized constitutive regulatoryelement that produces a high level of expression in all plant tissues(Odell et al., Nature 313:810-812 (1985), which is incorporated hereinby reference). Furthermore, the CaMV 35S promoter can be particularlyuseful due to its activity in numerous different seed plant species(Benfey and Chua, Science 250:959-966 (1990), which is incorporatedherein by reference; Odell et al., supra, 1985). Other constitutiveregulatory elements useful for expression in a seed plant include, forexample, the cauliflower mosaic virus 19S promoter; the Figwort mosaicvirus promoter (Singer et al., Plant Mol. Biol. 14:433 (1990), which isincorporated herein by reference); and the nopaline synthase (nos) genepromoter (An, Plant Physiol. 81:86 (1986), which is incorporated hereinby reference).

In addition, an expression vector of the invention can contain aregulated gene regulatory element such as a promoter or enhancerelement. A particularly useful regulated promoter is a tissue-specificpromoter such as the shoot meristem-specific CDC2 promoter (Hemerly etal., Plant Cell 5:1711-1723 (1993), which is incorporated herein byreference), or the AGL8 promoter, which is active in the apical shootmeristem immediately after the transition to flowering (Mandel andYanofsky, supra, 1995). The promoter of the SHOOTMERISTEMLESS gene,which is expressed exclusively in the shoot meristem beginning within anembryo and throughout the angiosperm life cycle, also can be aparticularly useful tissue-specific gene regulatory element (see Long etal., Nature 379:66-69 (1996), which is incorporated herein byreference).

An appropriate regulatory element such as a promoter is selecteddepending on the desired pattern or level of expression of a nucleicacid molecule linked thereto. For example, a constitutive promoter,which is active in all tissues, would be appropriate if expression of agene product in all plant tissues is desired. In addition, adevelopmentally regulated or tissue-specific regulatory element can beuseful to direct floral meristem identity gene expression to specifictissues, for example. As discussed above, inducible expression also canbe particularly useful to manipulate the timing of gene expression suchthat, for example, a population of transgenic seed plants of theinvention that contain an expression vector comprising a floral meristemidentity gene linked to an inducible regulatory element can undergoearly reproductive development at essentially the same time. Selectingthe time of reproductive development can be useful, for example, inmanipulating the time of crop harvest.

Using nucleic acid molecules encoding AP1 provided herein, the skilledartisan can isolate, if desired, a novel ortholog of AP1. For example,one would choose a region of AP1 that is highly conserved among knownAP1 sequences such as a region that is highly conserved betweenArabidopsis AP1 (SEQ ID NO: 1) and Zea mays AP1 (GenBank accessionnumber L46400; SEQ ID NO: 7) to screen a cDNA or genomic library ofinterest for a novel AP1 ortholog. One can use a full-length ArabidopsisAP1 (SEQ ID NO: 1), for example, to isolate a novel ortholog of AP1 (seeExample V). If desired, the region encoding the MADS domain, which iscommon to a number of genes, can be excluded, from the sequence used asa probe. Similarly, the skilled artisan knows that a nucleic acidmolecule encoding a full-length CAL cDNA such as Arabidopsis CAL (SEQ IDNO: 9) or Brassica oleracea CAL (SEQ ID NO: 11) can be useful inisolating a novel CAL ortholog.

For example, the Arabidopsis AP1 cDNA (SEQ ID NO: 1) can be used as aprobe to identify and isolate a novel AP1 ortholog. Using a nucleotidesequence derived from a conserved region of SEQ ID NO: 1, SEQ ID NO: 3,SEQ ID NO: 5 or SEQ ID NO: 7, for example, a nucleic acid moleculeencoding a novel AP1 ortholog can be isolated from other plant species.Using methods such as those described by Purugganan et al., supra, 1995,one can readily confirm that the newly isolated molecule is an AP1ortholog. Thus, a nucleic acid molecule encoding an AP1 gene product,which has at least about 70 percent amino acid identity with the aminoacid sequence of SEQ ID NO: 2 (Arabidopsis AP1) in the region from aminoacid 1 to amino acid 163 or with the amino acid sequence of SEQ ID NO: 8(Zea mays AP1) in the region from amino acid 1 to amino acid 163 can beisolated and identified using well known methods.

Similarly, in order to isolate an ortholog of CAL, one can choose aregion of CAL that is highly conserved among known CAL cDNAs, such as aregion conserved between Arabidopsis CAL (SEQ ID NO: 9) and Brassicaoleracea CAL (SEQ ID NO: 11). The Arabidopsis CAL cDNA (SEQ ID NO: 9) orBrassica oleracea CAL cDNA (SEQ ID NO: 11), or a nucleotide fragmentthereof, can be used to identify and isolate a novel CAL ortholog usingmethods such as those described in Example V. In order to identifyrelated MADS domain genes, a nucleotide sequence derived from the MADSdomain of AP1 or CAL, for example, can be useful to isolate a relatedgene sequence encoding this DNA-binding motif.

Hybridization conditions for isolating a gene ortholog, for example, arerelatively stringent such that non-specific hybridization is minimized.Appropriate hybridization conditions can be determined empirically, orcan be estimated based, for example, on the relative G+C content of theprobe and the number of mismatches between the probe and targetsequence, if known. Hybridization conditions can be adjusted as desiredby varying, for example, the temperature of hybridizing or the saltconcentration (Sambrook, supra, 1989).

The invention also provides a kit for converting shoot meristem tofloral meristem in an angiosperm, which contains a plant expressionvector having a nucleic acid molecule encoding a floral meristemidentity gene product. A kit for promoting early reproductivedevelopment in a seed plant, which contains a plant expression vectorhaving a nucleic acid molecule encoding a floral meristem identity geneproduct, also is provided. If desired, such kits can contain appropriatereagents to facilitate high efficiency transformation of a seed plantwith a plant expression vector of the invention. Furthermore, ifdesired, a control vector lacking a floral meristem identity gene can beincluded in the kits to determine, for example, the efficiency oftransformation.

The following examples are intended to illustrate but not limit thepresent invention.

EXAMPLE I Conversion of shoot meristem to floral meristem and earlyreproductive development in an APETALA1 transgenic plant

This example describes methods for producing a transgenic Arabidopsisplant containing ectopically expressed AP1.

A. Ectopic expression of APETALA1 converts inflorescence shoots intoflowers

Transgenic plants that constitutively express AP1 from the cauliflowermosaic virus 35S (CaMV 35S) promoter were produced to determine whetherectopic AP1 expression was sufficient to convert shoot meristem tofloral meristem. The AP1 coding sequence was placed under control of theCaMV 35S promoter (Odell et al., supra, 1985) as follows. Bam HI linkerswere ligated to the Hinc II site of the full-length AP1 complementaryDNA (Mandel et al., supra, (1992), which is incorporated herein byreference) in pAM116, and the resulting Bam HI fragment was fused to theCaMV 35S promoter (Jack et al., Cell 76:703-716 (1994), which isincorporated herein by reference) in pCGN18 to create pAM563.

Transgenic 35S-AP1 Arabidopsis plants of the Columbia ecotype weregenerated by selecting kanamycin-resistant plants afterAgrobacterium-mediated plant transformation using the in planta method(Bechtold et al., C.R, Acad. Sci. Paris 316:1194-1199 (1993), which isincorporated herein by reference). All analyses were performed insubsequent generations. Approximately 120 independent transgenic linesthat displayed the described phenotypes were obtained.

Remarkably, in 35S-AP1 transgenic plants, the normally indeterminateshoot apex prematurely terminated as a floral meristem and formed aterminal flower. Generally, lateral meristems that normally wouldproduce inflorescence shoots also were converted into solitary flowers.These results demonstrate that ectopic expression of AP1 in shootmeristem is sufficient to convert shoot meristem to floral meristem,even though AP1 normally is not absolutely required to specify floralmeristem identity.

B. LEAFY is not required for the conversion of inflorescence shoots toflowers in an APETALA1 transgenic plant

To determine whether the 35S-AP1 transgene causes ectopic LFY activity,and whether ectopic LFY activity is required for the conversion of shootmeristem to floral meristem, the 35S-AP1 transgene was introduced intoArabidopsis lfy mutants. The 35S-AP1 transgene was crossed into thestrong lfy-6 mutant background and the F₂ progeny were analyzed.

Mutant lfy plants containing the 35S-AP1 transgene displayed the sameconversion of apical and lateral shoot meristem to floral meristem aswas observed in transgenics containing wild type LFY. However, theresulting flowers had the typical lfy mutant phenotype, in which floralorgans developed as sepaloid and carpelloid structures, with an absenceof petals and stamens. These results demonstrate that LFY is notrequired for the conversion of shoot meristem to floral meristem in atransgenic angiosperm that ectopically expresses AP1.

C. APETALA1 is not sufficient to specify organ fate

As well as being involved in the early step of specifying floralmeristem identity, AP1 also is involved in specifying sepal and petalidentity at a later stage in flower development. Although AP1 RNAinitially is expressed throughout the young flower primordium, it islater excluded from stamen and carpel primordia (Mandel et al., supra,1992). Since the CaMV 35S promoter is active in all floral organs,35S-AP1 transgenic plants are likely to ectopically express AP1 instamens and carpels. However, the normal stamens and carpels 35S-AP1 intransgenic plants indicate that AP1 is not sufficient to specify sepaland petal organ fate.

D. Ectopic expression of APETALA1 causes early reproductive development

In addition to its ability to alter inflorescence meristem identity,ectopic expression of AP1 also influences the vegetative phase of plantgrowth. Wild-type Arabidopsis plants have a vegetative phase duringwhich a basal rosette of leaves is produced, followed by the transitionto reproductive growth. The transition from vegetative to reproductivegrowth was measured both in terms of the number of days post-germinationuntil the first visible flowers were observed, and by counting thenumber of leaves. Under continuous light, wild-type and 35S-AP1transgenic plants flowered after producing 9.88±1.45 and 4.16±0.97leaves, respectively. Under short-day growth conditions (8 hours light,16 hours dark, 24 C), wild-type and 35S-AP1 transgenic plants floweredafter producing 52.42±3.47 and 7.4±1.18 leaves, respectively.

Under continuous light growth conditions, flowers appear on wild-typeArabidopsis plants after approximately 18 days, whereas the 35S-AP1transgenic plants flowered after an average of only 10 days.Furthermore, under short-day growth conditions, flowering is delayed inwild-type Arabidopsis plants until approximately 10 weeks aftergermination, whereas 35S-AP1 transgenic plants flowered in less thanabout five weeks. Thus, ectopic AP1 expression significantly reduced thetime of reproductive development, as indicated by the time of flowering.Ecotopic AP1 expression also reduced the delay of flowering caused byshort day growth conditions.

EXAMPLE II Conversion of inflorescence shoots into flowers in anCAULIFLOWER transgenic plant

This example describes methods for producing a transgenic Arabidopsisplant that ectopically expresses CAL.

Transgenic Arabidopsis plants that ectopically express CAL in shootmeristem were generated. The full-length CAL cDNA was inserteddownstream of the CaMV 35S promoter in the Eco RI site of pMON530(Monsanto Co., St. Louis, Mo.) This plasmid was introduced intoAgrobacterium strain ASE and used to transform the Columbia ecotype ofArabidopsis using the modified vacuum infiltration method described byBechtold et al., supra, 1993. The 96 transgenic lines that harbored the35S-CAL construct had a range of weak to strong phenotypes. Transgenicplants with the strongest phenotypes (27 lines) had a phenotype thatclosely resembled the tfl mutant phenotype.

The apical and lateral inflorescence shoots of 35S-CAL transgenic plantswere converted into flowers. Furthermore, the 35S-CAL transgenic plantswere characterized by early reproductive development, as indicated by anearly flowering phenotype. These results demonstrate that ectopicexpression of CAL is sufficient for the conversion of shoots to flowersand for promoting early reproductive development.

EXAMPLE III Conversion of shoots into flowers and early reproductivedevelopemnt in a LEAFY transgenic plant

This example describes methods for producing transgenic Arabidopsisectopically expressing LFY and transgenic aspen ectopically expressingLFY.

A. Conversion of Arabidopsis shoots and early Arabidopsis reproductivedevelopment by LEAFY

Transgenic Arabidopsis plants were generated by transforming Arabidopsiswith LFY under the control of the CaMV 35S promoter (Odell et al.,supra, (1985)). A LFY complementary DNA (Weigel et al, Cell 69:843-859(1992), which is incorporated herein by reference) was inserted into aT-DNA transformation vector containing a CaMV 35S promoter and a 3' noscassette (Jack et al., supra, 1994). Transformed seedlings were selectedfor kanamycin resistance. Several hundred Arabidopsis transformants inthree different genetic backgrounds (Nossen, Wassilewskija and Columbia)were recovered, and several lines were characterized in detail.

High levels of LFY RNA expression were detected by northern blotanalysis in 35S-LFY transgenics. In general, Nossen lines had weakerphenotypes, especially when grown under short day conditions. The35S-LFY transgene of line DW151.117 (ecotype Wassilewskija) wasintrogressed into the erecta background by backcrossing to a Landsbergerecta strain. Plants were grown under 16 hours light and 8 hours dark.The 35S-LFY transgene provided at least as much LFY activity as theendogenous gene and completely suppressed the lfy mutant phenotype whencrossed into the background of the lfy-6 null allele.

Most 35S-LFY transgenic plants lines demonstrated a very similar,dominant and heritable phenotype. Secondary shoots that arose in lateralpositions were consistently replaced by solitary flowers, andhigher-order shoots were absent. Although the number of rosette leaveswas unchanged from the wild type, 35S-LFY plants flowered earlier thanwild type: the solitary flowers in the axils of the rosette leavesdeveloped and opened precociously. In addition, the primary shootterminated with a flower. In 35S-LFY transgenics having the most extremephenotypes, a terminal flower was formed immediately above the rosette.This gain of function phenotype (conversion of shoots to flowers) is theopposite of the lfy loss of function phenotype (conversion of flowers toshoots). These results demonstrate that LFY encodes a developmentalswitch that is both sufficient and necessary to convert shoot meristemto flower meristem in an angiosperm.

The effects of constitutive LFY expression differ for primary andsecondary shoot meristems. Secondary meristems were transformed intoflower meristem, apparently as soon as it developed, and produced only asingle, solitary flower. In contrast, primary shoot meristem producedleaves and lateral flowers before being consumed in the formation of aterminal flower. These developmental differences indicate that ameristem must acquire competence to respond to the activity of a floralmeristem identity gene such as LFY.

B. Conversion of aspen shoots by LEAFY

Given that constitutive expression of LFY induced early reproductivedevelopment as indicated by precocious flowering during the vegetativephase of Arabidopsis, the effect of LFY on the flowering of other seedplant species was examined. The perennial tree, hybrid aspen, is derivedfrom parental species that flower naturally only after 8-20 years ofgrowth (Schopmeyer (ed.), USDA Agriculture Handbook 450: Seeds of WoodyPlants in the United States, Washington DC, USA: US Government PrintingOffice, pp. 645-655 (1974)). 35S-LFY transgenic aspen plants wereobtained by Agrobacterium-mediated transformation of stem segments andsubsequent regeneration of transgenic shoots in tissue culture.

Hybrid aspen was transformed exactly as described by Nilsson et al.(Transgen, Res. 1:209-220 (1992), which is incorporated herein byreference). Levels of LFY RNA expression were similar to those of35S-LFY Arabidopsis, as determined by northern blot analysis. The numberof vegetative leaves varied between different regenerating shoots, andthose with a higher number of vegetative leaves formed roots, allowingfor transfer to the greenhouse. Individual flowers were removed eitherfrom primary transformants that had been transferred to the greenhouse,or from catkins collected in spring, 1995, at Carlshem, Umea, Sweden)from a tree whose age was determined by counting the number of annualrings in a core extracted with an increment borer at 1.5 meters aboveground level. Flowers were fixed in formaldehyde/acetic acid/ethanol anddestained in ethanol before photography.

The overall phenotype of 35S-LFY transgenic aspen was similar to that of35S-LFY Arabidopsis. In wild-type plants of both species, flowersnormally are formed in lateral positions on inflorescence shoots. Inaspen, these inflorescence shoots, called catkins, arise from the leafaxils of adult trees. In both 35S-LFY Arabidopsis and 35S-LFY aspen,solitary flowers were formed instead of shoots in the axils ofvegetative leaves. Moreover, as in Arabidopsis, the secondary shoots oftransgenic aspen were more severely affected than the primary shoot.

Regenerating 35S-LFY aspen shoots initially produced solitary flowers inthe axils of normal leaves. However, the number of vegetative leaves waslimited, and the shoot meristem was prematurely consumed in theformation of an aberrant terminal flower. Early reproductive developmentas demonstrated by precocious flowering was specific to 35S-LFYtransformants and was not observed in non-transgenic controls.Furthermore, not a single instance of precocious flower development hasbeen observed in more than 1,500 other lines of transgenic aspengenerated with various constructs from 1989 to 1995 at the SwedishUniversity of Agricultural Sciences. These results demonstrate that afloral meristem identity gene product can promote early reproductivedevelopment in a heterologous angiosperm species.

EXAMPLE IV Dexamethasone-inducible floral meristem identity geneactivity in transgenic plants

This example describes the construction and characterization of anAP1-glucocorticoid receptor ligand binding domain chimera and itsdexamethasone-inducible activity in Arabidopsis.

A. Construction and characterization of an AP1-glucocorticoid receptorligand binding domain chimera

A nucleic acid molecule encoding an AP1-glucocorticoid receptor ligandbinding domain chimera was prepared as follows. Primers corresponding tothe translation initiation and termination codons of AP1 weresynthesized for PCR amplification of the Arabidopsis AP1 cDNA. Primer5'-GGATCCGGATCAAAAATGGGAAGGGGTAG-3' (SEQ ID NO: 25) contains atranslation initiation codon, which is indicated by underlining. Primer5'-GGATCCGCTGCGGCGAAGCAGCCAAGGTTG-3' (SEQ ID NO: 26) contains a modifiedtranslation termination site, which is indicated by underlining andallows the nucleic acid molecule encoding AP1 to be linked in frame tothe nucleic acid molecule encoding the glucocorticoid receptor (GR)ligand binding domain.

The full length Arabidopsis AP1 cDNA in pAM116 (see Example I) was usedas the template for PCR amplification with primers SEQ ID NOS: 25 and26, each of which contain a Bam Hl site. The resulting Bam HI fragment,which encodes the full-length Arabidopsis AP1 cDNA except for thetranslation termination codon, was cloned into the unique Bam HI site ofthe GR fusion vector constructed by Lloyd et al., supra, 1994. DNAsequence analyses confirmed that the construct contained the predictednucleotide sequence.

The resulting AP1-GR construct was introduced into Agrobacterium strainASE, and ap1-15 mutant plants were transformed using the vacuuminfiltration method described in Example I. Approximately 100independently derived lines were selected in kanamycin for furtheranalysis.

B. Dexamethasone-inducible activity of an AP1-glucocorticoid receptorligand binding domain chimera in Arabidopsis

Kanamycin-resistant transgenic Arabidopsis lines are analyzed insubsequent generations for AP1 activity. After application ofdexamethasone to transgenic plants, AP1 activity is monitored by visualinspection for 1) flowering that is earlier than wild-type or 2) partialor complete rescue of the ap1 mutant phenotype.

To assay for dexamethasone-inducible activity, plants are watered withvarying concentrations of dexamethasone. A range of dexamethasoneconcentrations are tested to determine overall levels of AP1 activityand to determine the resulting phenotypes. A concentration of 1 μM orless dexamethasone preferably is used for induction of AP1 activity.

In addition, dexamethasone is applied directly to plants by spraying.Spraying, like watering, leads to a significant induction of AP1activity, resulting in the corresponding rescue of the ap1 mutantphenotype and early reproductive development. Although a singleapplication of dexamethasone is sufficient to increase AP1 activity andpromote early reproductive development, dexamethasone is applied eitheronce, or repeatedly, and the treatments compared for any observeddifferences under long or short day conditions as disclosed below.

Dexamethasone is applied to plants at various times post-germination.For example, a large number of AP1-GR transgenic Arabidopsis plants aregrown, some of which are treated with dexamethasone on day 1post-germination, some on day 2, etc., all the way up until and beyondthe time at which Arabidopsis plants normally flower. These analysesinclude plants grown under long day, short day, and under a variety oftemperatures. For example, Arabidopsis plants, which typically are grownat 25° C., also can be analyzed for AP1 activity at 20° C. and 15° C.(see, for example, Bowman et al. (ed.), Arabidopsis: An Atlas ofMorphology and Development, New York: Springer (1994), which isincorporated by reference herein).

EXAMPLE V Identification and characterization of the Zea mays APETALA1cDNA

This example describes the isolation and characterization of Zea maysZAP1 complementary DNA, which is an ortholog of the Arabidopsis floralmeristem identity gene AP1.

A. Identification and characterization of a nucleic acid sequenceencoding ZAP1

The utility of using a cloned floral homeotic gene from Arabidopsis toidentify the putative ortholog in maize has been demonstrated previously(Schmidt et al., supra, (1993), which is incorporated herein byreference). As described in Mena et al. (Plant J. 8(6):845-854 (1995)),the maize ortholog of the Arabidopsis AP1 floral meristem identity gene,was isolated by screening a Zea mays ear cDNA library using theArabidopsis AP1 cDNA (SEQ ID NO: 1) as a probe. A cDNA library wasprepared from wild-type immature ears as described by Schmidt et al.,supra, 1993, and screened using the Arabidopsis AP1 cDNA SEQ ID NO: 1 asthe probe. Low-stringency hybridizations with the AP1 probe wereconducted as described previously for the isolation of ZAG1 using the AGcDNA as a probe (Schmidt et al., supra, 1993). Positive plaques wereisolated and cDNAs were recovered in Bluescript by in vivo excision.Double-stranded sequencing was performed using the Sequenase Version 2.0kit (U.S. Biochemical, Cleveland, Ohio) according to the manufacturer'sprotocol.

The nucleotide sequence and deduced amino acid sequence of the ZAP1 cDNAare provided as SEQ ID NOS: 7 and 8. The deduced amino acid sequence forZAP1 shares 89% identity with Arabidopsis AP1 through the MADS domain(amino acids 1 to 57) and 70% identity through the first 160 aminoacids, which includes the K domain. The high level of amino acidsequence identity between ZAP1 and AP1 (SEQ ID NOS: 8 and 2), as well asthe expression pattern of ZAP1 in maize florets (see below), indicatethat ZAP1 is the maize ortholog of Arabidopsis AP1.

B. RNA expression pattern of ZAP1

Total RNA was isolated from different maize tissues as described by Coneet al., Proc. Natl. Acad. Sci. USA 83:9631-9635 (1986), which isincorporated herein by reference. RNA was prepared from ears or tasselsat early developing stages (approximately 2 cm in size), husk leavesfrom developing ear shoots, shoots and roots of germinated seedlings,leaves from 2 to 3 week old plants and endosperm, and embryos at 18 daysafter pollination. Mature floral organs were dissected from ears at thetime of silk emergence or from tassels at several days pre-emergence. Tostudy expression patterns in the mature female flower, carpels wereisolated and the remaining sterile organs were pooled and analyzedtogether. In the same way, stamens were dissected and collected frommale florets and the remaining organs (excluding the glumes) were pooledas one sample.

RNA concentration and purity was determined by absorbance at 260/280 nM,and equal amounts (10 μg) were fractionated on formaldehyde-agarosegels. Gels were stained in a solution of 0.125 μg ml⁻¹ acridine orangeto confirm the integrity of the RNA samples and the uniformity of gelloading, then RNA was blotted on to Hybond-N® membranes (AmershamInternational, Arlington Heights, Ill.) according to the manufacturer'sinstructions. Prehybridization and hybridization solutions were preparedas previously described (Schmidt et al., Science 238:960-963 (1987),which is incorporated herein by reference). The probe for ZAP1 RNAexpression studies was a 445 bp Sac I/Nsi I fragment from the 3' end ofthe cDNA. Southern blot analyses were conducted to establish conditionsfor specific hybridization of this probe. No cross-hybridization wasdetected using hybridization at 60° C. in 50% formamide and washes at65° C. in 0.1× SSC and 0.5% SDS.

The strong sequence similarity between ZAP1 and AP1 indicated that ZAP1was the ortholog of this Arabidopsis floral meristem identity gene. As afirst approximation of whether the pattern of ZAP1 expression paralleledthat of AP1, a blot of total RNA from vegetative and reproductive organswas hybridized with a gene-specific fragment of the ZAP1 cDNA(nucleotides 370 to 820 of SEQ ID NO: 7). ZAP1 RNA was detected only inmale and female inflorescences and in the husk leaves that surround thedeveloping ear. No ZAP1 RNA expression was detectable in RNA isolatedfrom root, shoot, leaf, endosperm, or embryo tissue. The restriction ofZAP1 expression to terminal and axillary inflorescences is consistentwith ZAP1 being the Arabidopsis AP1 ortholog.

Male and female florets were isolated from mature inflorescences, andthe reproductive organs were separated from the remainder of the floret.RNA was isolated from the reproductive and the sterile portions of theflorets. ZAP1 RNA expression was not detected in maize stamens orcarpels, whereas high levels of ZAP1 RNA were present in developing earand tassel florets from which stamens and carpels had been removed.Thus, the exclusion of ZAP1 expression from stamens and carpels and itsinclusion in the RNA of the non-reproductive portions of the floret(lodicules, lemma and palea) is similar to the pattern of expression ofAP1 in flowers of Arabidopsis.

EXAMPLE VI Production and characterization of anti-AP1 antisera

This example demonstrates the production and characterization ofantisera that specifically binds the Arabidopsis AP1 gene product.

Western blotting was performed with plant tissue extracts and crudeantisera from rabbits immunized with a GST-AP1 fusion protein encodingamino acids 190 to 251 of Arabidopsis thaliana AP1 (SEQ ID NO: 2). TheC-terminal region of AP1 spanning amino acids 190 to 251 does notinclude the MADS domain, which is common to a number of proteins. Asshown in FIG. 1, the anti-AP1 sera reacted with a 90 kDa protein ininflorescence tissue extracts prepared from wild type Arabidopsisthaliana (Landsburg ecotype). As expected, this reactivity was absentfrom Arabidopsis mutants lacking AP1 such as ap1-1 or ap1-15 (comparelanes 3 and 4 to lane 2).

AP1 expression was reduced significantly in inflorescence tissueextracts from the Arabidopsis ap2-2 mutant as compared to wild typeplants, indicating that AP2 normally functions to increase or maintainthe level of AP1 RNA or protein expression (see lanes 2 and 5).Similarly, reduced AP1 expression in lfy-6 mutant plants indicates thatLFY normally functions to enhance expression of AP1 at the RNA orprotein level (see lanes 2 and 6). In contrast to the results seen inap2-2 or lfy-6 mutant inflorescences, AP1 protein expression ininflorescence tissue from ag-2 mutants is enhanced strikingly ascompared to the level of AP1 protein seen in wild type inflorescences(see lanes 1 and 2). These results indicate that the AGAMOUS geneproduct (AG) negatively regulates AP1 RNA or protein expression.

Western analysis further demonstrated that AP1 protein expression isspecific to inflorescence tissue since AP1 reactivity is absent fromleaf tissue prepared from wild type Arabidopsis plants (Columbiaecotype; lane 7). In transgenic plants constitutively expressing AP1from the CaMV promoter, however, AP1 protein expression readily wasdetectable in leaf tissue as shown in lane 8. Reactivity of the anti-AP1antisera in 35S-AP1 transgenic leaves but not in wild type Arabidopsisleaves confirmed the specificity of the anti-AP1 sera.

Specificity of the anti-AP1 sera also was demonstrated by specificbinding of the antisera to AP1 but not to the closely related CAL geneproduct. For example, inflorescence tissue extract from an ap1-1 orap1-15 mutant plant (lane 3 or 4, respectively), which contains CAL butnot AP1, was not reactive with the anti-AP1 rabbit sera. These dataindicate that the anti-AP1 sera does not react with the CAL geneproduct.

For production of anti-AP1 sera, a Sty I fragment of the Arabidopsisthaliana AP1 cDNA, which encodes amino acids 190 to 251, was gelpurified, blunt ended with Klenow fragment and ligated into the Sma Isite of pGEX3X (Pharmacia, Piscataway, N.J.) to make pGEX-AP1₁₉₀₋₂₅₁ forexpression of a GST-AP1₁₉₀₋₂₅₁ fusion protein. DH5α E. coli weretransformed with the resulting vector by standard techniques (Sambrook,supra, 1989).

A bacterial culture of a pGEX-AP1₁₉₀₋₂₅₁ transformant was grown to anOD₆₀₀ of 0.5, and GST-AP1₁₉₀₋₂₅₁ expression was induced by addition of 1mM IPTG. The GST-AP₁ ₁₉₀₋₂₅₁ bacterial pellet was harvested after threehours growth at 37° C., washed once with phosphate-buffered saline (PBS;pH 7.2) and lysed by two cycles of freeze-thawing. The cell lysate wasresuspended in one-fiftieth of the culture volume in ice cold EB (2 mMEDTA, 2 mM DTT, 1 mM PMSF, 5 μg/ml leupeptin, 7.5 μg/ml pepstatin, 1%aprotinin in PBS pH 7.2) with 2 mg/ml lysozyme and incubated on ice for30 minutes. Triton X-100 was added to 1%, and the solution was sonicatedmildly. The extract was clarified by two successive centrifugations of 1and 15 minutes, respectively, at 13,000× g in a microfuge.

The GST-AP₁ ₁₉₀₋₂₅₁ fusion protein was purified from the bacterialextract as follows. Glutathione-Sepharose beads (150 μl), which had beenpre-equilibrated in EB with 1% Triton X-100, were added to 1 ml ofsoluble extract in an Eppendorf tube and incubated on a rotating wheelfor 60 minutes at 4° C. The beads were washed five times in 1 ml EB with1% Triton X-100; resuspended in protein sample buffer and loaded on apreparative SDS-PAGE gel (Laemmli, Nature 227:680-685 (1970), which isincorporated herein by reference). Following electrophoresis, the gelwas stained for five minutes in 0.05% Coomassie R250 (Fisher Scientific,Pittsburgh, Pennsylvania) in distilled water and subsequently destainedin distilled water. GST-APl₁₉₀₋₂₅₁ fusion protein was cut out of the geland electroeluted in 0.5× transfer buffer for 3 hours at 100V asdescribed in Harlow and Lane, supra, 1988. The GST-AP1₁₉₀₋₂₅₁ fusionprotein was emulsified with Freund's adjuvant and injected into rabbitsby Immunodynamics (La Jolla, Calif.).

Crude rabbit serum was used for western analysis at a dilution of 1 to2000. Binding was detected using a secondary antibody coupled toperoxidase (Promega, Madison, Wis.; 1 to 2500 dilution) and revealedusing an enhanced chemiluminesence kit (Amersham).

Plant protein extracts for western analysis were prepared byhomogenizing 100 μl plant tissue with 200 μl 2XFSB (Laemmli, supra,1970) in a Kontes microfuge tube with a pistil. The extract wasdenatured in boiling water bath for 5 minutes, sonicated for 1 minuteand clarified by two successive spins of 5 and 15 minutes in a microfugeat 13,000× g prior to electophoresis.

EXAMPLE VII Cosuppression of AP1 activity

This example demonstrates the use of cosuppression to inhibit endogenousAP1 activity in Arabidopsis.

The full length AP1 cDNA from pAM116 (see Example I) was inserted intothe Eco RI site of pMON530, and the resulting construct was introducedinto Agrobacterium strain ASE. Wild type Arabidopsis was transformed asdescribed in Example I and analyzed for ap1 mutant phenotypes. In thisway, a large number of independently generated cosuppressed lines weregenerated. Each of the cosuppressed lines had a phenotype similar oridentical to ap1-1 mutant plants, which lack AP1 activity, indicatingthat the activity of both the introduced and endogenous copies of AP1was suppressed. Analysis of AP1 expression levels by RNA in situhybridization demonstrated that AP1 expression was reduced and delayedin the cosuppressed transgenic lines having the ap1 mutant phenotype.Futhermore, in a samll fraction of the cosuppressed transgenic lines, aenhanced phenotype resembling the cauliflower phenotype was observed.This enhanced phenotype indicated that introduction of an AP1 constructcan supress expression of both endogenous AP1 and CAL.

Although the invention has been described with reference to the examplesabove, it should be understood that various modifications can be madewithout departing from the spirit of the invention. Accordingly, theinvention is limited only by the following claims.

    __________________________________________________________________________    #             SEQUENCE LISTING                                                  - -  - - (1) GENERAL INFORMATION:                                             - -    (iii) NUMBER OF SEQUENCES: 26                                          - -  - - (2) INFORMATION FOR SEQ ID NO:1:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 1057 base - #pairs                                                (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 124..893                                               - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..1057                                                         (D) OTHER INFORMATION: - #/note= "product = Arabidopsis                            thaliana - #AP1."                                               - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                               - - CTTTCCAATT GGTTCATACC AAAGTCTGAG CTCTTCTTTA TATCTCTCTT GT -             #AGTTTCTT     60                                                                 - - ATTGGGGGTC TTTGTTTTGT TTGGTTCTTT TAGAGTAAGA AGTTTCTTAA AA -            #AAGGATCA    120                                                                 - - AAA ATG GGA AGG GGT AGG GTT CAA TTG AAG AG - #G ATA GAG AAC AAG        ATC      168                                                                        Met Gly Arg Gly Arg Val Gln Leu - #Lys Arg Ile Glu Asn Lys Ile                 1            - #   5               - #   10               - #   15       - - AAT AGA CAA GTG ACA TTC TCG AAA AGA AGA GC - #T GGT CTT TTG AAG AAA          216                                                                       Asn Arg Gln Val Thr Phe Ser Lys Arg Arg Al - #a Gly Leu Leu Lys Lys                            20 - #                 25 - #                 30              - - GCT CAT GAG ATC TCT GTT CTC TGT GAT GCT GA - #A GTT GCT CTT GTT GTC          264                                                                       Ala His Glu Ile Ser Val Leu Cys Asp Ala Gl - #u Val Ala Leu Val Val                        35     - #             40     - #             45                  - - TTC TCC CAT AAG GGG AAA CTC TTC GAA TAC TC - #C ACT GAT TCT TGT ATG          312                                                                       Phe Ser His Lys Gly Lys Leu Phe Glu Tyr Se - #r Thr Asp Ser Cys Met                    50         - #         55         - #         60                      - - GAG AAG ATA CTT GAA CGC TAT GAG AGG TAC TC - #T TAC GCC GAA AGA CAG          360                                                                       Glu Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Se - #r Tyr Ala Glu Arg Gln                65             - #     70             - #     75                          - - CTT ATT GCA CCT GAG TCC GAC GTC AAT ACA AA - #C TGG TCG ATG GAG TAT          408                                                                       Leu Ile Ala Pro Glu Ser Asp Val Asn Thr As - #n Trp Ser Met Glu Tyr            80                 - # 85                 - # 90                 - # 95       - - AAC AGG CTT AAG GCT AAG ATT GAG CTT TTG GA - #G AGA AAC CAG AGG CAT          456                                                                       Asn Arg Leu Lys Ala Lys Ile Glu Leu Leu Gl - #u Arg Asn Gln Arg His                           100  - #               105  - #               110              - - TAT CTT GGG GAA GAC TTG CAA GCA ATG AGC CC - #T AAA GAG CTT CAG AAT          504                                                                       Tyr Leu Gly Glu Asp Leu Gln Ala Met Ser Pr - #o Lys Glu Leu Gln Asn                       115      - #           120      - #           125                  - - CTG GAG CAG CAG CTT GAC ACT GCT CTT AAG CA - #C ATC CGC ACT AGA AAA          552                                                                       Leu Glu Gln Gln Leu Asp Thr Ala Leu Lys Hi - #s Ile Arg Thr Arg Lys                   130          - #       135          - #       140                      - - AAC CAA CTT ATG TAC GAG TCC ATC AAT GAG CT - #C CAA AAA AAG GAG AAG          600                                                                       Asn Gln Leu Met Tyr Glu Ser Ile Asn Glu Le - #u Gln Lys Lys Glu Lys               145              - #   150              - #   155                          - - GCC ATA CAG GAG CAA AAC AGC ATG CTT TCT AA - #A CAG ATC AAG GAG AGG          648                                                                       Ala Ile Gln Glu Gln Asn Ser Met Leu Ser Ly - #s Gln Ile Lys Glu Arg           160                 1 - #65                 1 - #70                 1 -      #75                                                                              - - GAA AAA ATT CTT AGG GCT CAA CAG GAG CAG TG - #G GAT CAG CAG AAC        CAA      696                                                                    Glu Lys Ile Leu Arg Ala Gln Gln Glu Gln Tr - #p Asp Gln Gln Asn Gln                          180  - #               185  - #               190              - - GGC CAC AAT ATG CCT CCC CCT CTG CCA CCG CA - #G CAG CAC CAA ATC CAG          744                                                                       Gly His Asn Met Pro Pro Pro Leu Pro Pro Gl - #n Gln His Gln Ile Gln                       195      - #           200      - #           205                  - - CAT CCT TAC ATG CTC TCT CAT CAG CCA TCT CC - #T TTT CTC AAC ATG GGT          792                                                                       His Pro Tyr Met Leu Ser His Gln Pro Ser Pr - #o Phe Leu Asn Met Gly                   210          - #       215          - #       220                      - - GGT CTG TAT CAA GAA GAT GAT CCA ATG GCA AT - #G AGG AGG AAT GAT CTC          840                                                                       Gly Leu Tyr Gln Glu Asp Asp Pro Met Ala Me - #t Arg Arg Asn Asp Leu               225              - #   230              - #   235                          - - GAA CTG ACT CTT GAA CCC GTT TAC AAC TGC AA - #C CTT GGC TGC TTC GCC          888                                                                       Glu Leu Thr Leu Glu Pro Val Tyr Asn Cys As - #n Leu Gly Cys Phe Ala           240                 2 - #45                 2 - #50                 2 -      #55                                                                              - - GCA TG AAGCATTTCC ATATATATAT TTGTAATCGT CAACAATAAA AAC - #AGTTTGC            943                                                                      Ala                                                                            - - CACATACATA TAAATAGTGG CTAGGCTCTT TTCATCCAAT TAATATATTT TG -             #GCAAATGT   1003                                                                 - - TCGATGTTCT TATATCATCA TATATAAATT AGCAGGCTCC TTTCTTTTTT TG - #TA             1057                                                                       - -  - - (2) INFORMATION FOR SEQ ID NO:2:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 256 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                               - - Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn        1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                   20     - #             25     - #             30                  - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe               35         - #         40         - #         45                      - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Th - #r Asp Ser Cys Met Glu           50             - #     55             - #     60                          - - Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu       65                 - # 70                 - # 75                 - # 80       - - Ile Ala Pro Glu Ser Asp Val Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                       85 - #                 90 - #                 95              - - Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                  100      - #           105      - #           110                  - - Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu              115          - #       120          - #       125                      - - Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Thr Arg Lys Asn          130              - #   135              - #   140                          - - Gln Leu Met Tyr Glu Ser Ile Asn Glu Leu Gl - #n Lys Lys Glu Lys Ala      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg        Glu                                                                                             165  - #               170  - #               175             - - Lys Ile Leu Arg Ala Gln Gln Glu Gln Trp As - #p Gln Gln Asn Gln Gly                  180      - #           185      - #           190                  - - His Asn Met Pro Pro Pro Leu Pro Pro Gln Gl - #n His Gln Ile Gln His              195          - #       200          - #       205                      - - Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly          210              - #   215              - #   220                          - - Leu Tyr Gln Glu Asp Asp Pro Met Ala Met Ar - #g Arg Asn Asp Leu Glu      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Leu Thr Leu Glu Pro Val Tyr Asn Cys Asn Le - #u Gly Cys Phe Ala        Ala                                                                                             245  - #               250  - #               255             - -  - - (2) INFORMATION FOR SEQ ID NO:3:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 794 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 36..794                                                - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..794                                                          (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                      AP1."                                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:                               - - TCTTAGAGGA AATAGTTCCT TTAAAAGGGA TAAAA ATG GGA AGG - #GGT AGG GTT            53                                                                                          - #                  - #   Met Gly Arg Gly Arg Val                            - #                  - #     1             - #  5            - - CAG TTG AAG AGG ATA GAA AAC AAG ATC AAT AG - #A CAA GTG ACA TTC TCG          101                                                                       Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn Ar - #g Gln Val Thr Phe Ser                        10     - #             15     - #             20                  - - AAA AGA AGA GCT GGT CTT ATG AAG AAA GCT CA - #T GAG ATC TCT GTT CTG          149                                                                       Lys Arg Arg Ala Gly Leu Met Lys Lys Ala Hi - #s Glu Ile Ser Val Leu                    25         - #         30         - #         35                      - - TGT GAT GCT GAA GTT GCG CTT GTT GTC TTC TC - #C CAT AAG GGG AAA CTC          197                                                                       Cys Asp Ala Glu Val Ala Leu Val Val Phe Se - #r His Lys Gly Lys Leu                40             - #     45             - #     50                          - - TTT GAA TAC TCC ACT GAT TCT TGT ATG GAG AA - #G ATA CTT GAA CGC TAT          245                                                                       Phe Glu Tyr Ser Thr Asp Ser Cys Met Glu Ly - #s Ile Leu Glu Arg Tyr            55                 - # 60                 - # 65                 - # 70       - - GAG AGA TAC TCT TAC GCC GAG AGA CAG CTT AT - #A GCA CCT GAG TCC GAC          293                                                                       Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu Il - #e Ala Pro Glu Ser Asp                            75 - #                 80 - #                 85              - - TCC AAT ACG AAC TGG TCG ATG GAG TAT AAT AG - #G CTT AAG GCT AAG ATT          341                                                                       Ser Asn Thr Asn Trp Ser Met Glu Tyr Asn Ar - #g Leu Lys Ala Lys Ile                        90     - #             95     - #            100                  - - GAG CTT TTG GAG AGA AAC CAG AGG CAC TAT CT - #T GGG GAA GAC TTG CAA          389                                                                       Glu Leu Leu Glu Arg Asn Gln Arg His Tyr Le - #u Gly Glu Asp Leu Gln                   105          - #       110          - #       115                      - - GCA ATG AGC CCT AAG GAA CTC CAG AAT CTA GA - #G CAA CAG CTT GAT ACT          437                                                                       Ala Met Ser Pro Lys Glu Leu Gln Asn Leu Gl - #u Gln Gln Leu Asp Thr               120              - #   125              - #   130                          - - GCT CTT AAG CAC ATC CGC TCT AGA AAA AAC CA - #A CTT ATG TAC GAC TCC          485                                                                       Ala Leu Lys His Ile Arg Ser Arg Lys Asn Gl - #n Leu Met Tyr Asp Ser           135                 1 - #40                 1 - #45                 1 -      #50                                                                              - - ATC AAT GAG CTC CAA AGA AAG GAG AAA GCC AT - #A CAG GAA CAA AAC        AGC      533                                                                    Ile Asn Glu Leu Gln Arg Lys Glu Lys Ala Il - #e Gln Glu Gln Asn Ser                          155  - #               160  - #               165              - - ATG CTT TCC AAG CAG ATT AAG GAG AGG GAA AA - #C GTT CTT AGG GCG CAA          581                                                                       Met Leu Ser Lys Gln Ile Lys Glu Arg Glu As - #n Val Leu Arg Ala Gln                       170      - #           175      - #           180                  - - CAA GAG CAA TGG GAC GAG CAG AAC CAT GGC CA - #T AAT ATG CCT CCG CCT          629                                                                       Gln Glu Gln Trp Asp Glu Gln Asn His Gly Hi - #s Asn Met Pro Pro Pro                   185          - #       190          - #       195                      - - CCA CCC CCG CAG CAG CAT CAA ATC CAG CAT CC - #T TAC ATG CTC TCT CAT          677                                                                       Pro Pro Pro Gln Gln His Gln Ile Gln His Pr - #o Tyr Met Leu Ser His               200              - #   205              - #   210                          - - CAG CCA TCT CCT TTT CTC AAC ATG GGG GGG CT - #G TAT CAA GAA GAA GAT          725                                                                       Gln Pro Ser Pro Phe Leu Asn Met Gly Gly Le - #u Tyr Gln Glu Glu Asp           215                 2 - #20                 2 - #25                 2 -      #30                                                                              - - CAA ATG GCA ATG AGG AGG AAC GAT CTC GAT CT - #G TCT CTT GAA CCC        GGT      773                                                                    Gln Met Ala Met Arg Arg Asn Asp Leu Asp Le - #u Ser Leu Glu Pro Gly                          235  - #               240  - #               245              - - TAT AAC TGC AAT CTC GGC TGC       - #                  - #                     794                                                                     Tyr Asn Cys Asn Leu Gly Cys                                                               250                                                                - -  - - (2) INFORMATION FOR SEQ ID NO:4:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 253 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:                               - - Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn        1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Met Lys Lys Ala                   20     - #             25     - #             30                  - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe               35         - #         40         - #         45                      - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Th - #r Asp Ser Cys Met Glu           50             - #     55             - #     60                          - - Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu       65                 - # 70                 - # 75                 - # 80       - - Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                       85 - #                 90 - #                 95              - - Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                  100      - #           105      - #           110                  - - Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu              115          - #       120          - #       125                      - - Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Ser Arg Lys Asn          130              - #   135              - #   140                          - - Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gl - #n Arg Lys Glu Lys Ala      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg        Glu                                                                                             165  - #               170  - #               175             - - Asn Val Leu Arg Ala Gln Gln Glu Gln Trp As - #p Glu Gln Asn His Gly                  180      - #           185      - #           190                  - - His Asn Met Pro Pro Pro Pro Pro Pro Gln Gl - #n His Gln Ile Gln His              195          - #       200          - #       205                      - - Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly          210              - #   215              - #   220                          - - Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Ar - #g Arg Asn Asp Leu Asp      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Leu Ser Leu Glu Pro Gly Tyr Asn Cys Asn Le - #u Gly Cys                                  245  - #               250                                     - -  - - (2) INFORMATION FOR SEQ ID NO:5:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 768 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 1..766                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..768                                                          (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                     var. botr - #ytis AP1."                                         - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:                               - - ATG GGA AGG GGT AGG GTT CAG TTG AAG AGG AT - #A GAA AAC AAG ATC AAT           48                                                                       Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn             1               5 - #                 10 - #                 15              - - AGA CAA GTG ACA TTC TCG AAA AGA AGA GCT GG - #T CTT ATG AAG AAA GCT           96                                                                       Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Met Lys Lys Ala                        20     - #             25     - #             30                  - - CAT GAG ATC TCT GTT CTG TGT GAT GCT GAA GT - #T GCG CTT GTT GTC TTC          144                                                                       His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe                    35         - #         40         - #         45                      - - TCC CAT AAG GGG AAA CTC TTT GAA TAC CCC AC - #T GAT TCT TGT ATG GAG          192                                                                       Ser His Lys Gly Lys Leu Phe Glu Tyr Pro Th - #r Asp Ser Cys Met Glu                50             - #     55             - #     60                          - - GAG ATA CTT GAA CGC TAT GAG AGA TAC TCT TA - #C GCC GAG AGA CAG CTT          240                                                                       Glu Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu            65                 - # 70                 - # 75                 - # 80       - - ATA GCA CCT GAG TCC GAC TCC AAT ACG AAC TG - #G TCG ATG GAG TAT AAT          288                                                                       Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                            85 - #                 90 - #                 95              - - AGG CTT AAG GCT AAG ATT GAG CTT TTG GAG AG - #A AAC CAG AGG CAC TAT          336                                                                       Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                       100      - #           105      - #           110                  - - CTT GGG GAA GAC TTG CAA GCA ATG AGC CCT AA - #G GAA CTC CAG AAT CTA          384                                                                       Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu                   115          - #       120          - #       125                      - - GAG CAA CAG CTT GAT ACT GCT CTT AAG CAC AT - #C CGC TCT AGA AAA AAC          432                                                                       Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Ser Arg Lys Asn               130              - #   135              - #   140                          - - CAA CTT ATG TAC GAC TCC ATC AAT GAG CTC CA - #A AGA AAG GAG AAA GCC          480                                                                       Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gl - #n Arg Lys Glu Lys Ala           145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - ATA CAG GAA CAA AAC AGC ATG CTT TCC AAG CA - #G ATT AAG GAG AGG        GAA      528                                                                    Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg Glu                          165  - #               170  - #               175              - - AAC GTT CTT AGG GCG CAA CAA GAG CAA TGG GA - #C GAG CAG AAC CAT GGC          576                                                                       Asn Val Leu Arg Ala Gln Gln Glu Gln Trp As - #p Glu Gln Asn His Gly                       180      - #           185      - #           190                  - - CAT AAT ATG CCT CCG CCT CCA CCC CCG CAG CA - #G CAT CAA ATC CAG CAT          624                                                                       His Asn Met Pro Pro Pro Pro Pro Pro Gln Gl - #n His Gln Ile Gln His                   195          - #       200          - #       205                      - - CCT TAC ATG CTC TCT CAT CAG CCA TCT CCT TT - #T CTC AAC ATG GGA GGG          672                                                                       Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly               210              - #   215              - #   220                          - - CTG TAT CAA GAA GAA GAT CAA ATG GCA ATG AG - #G AGG AAC GAT CTC GAT          720                                                                       Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Ar - #g Arg Asn Asp Leu Asp           225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - CTG TCT CTT GAA CCC GTT TAC AAC TGC AAC CT - #T GGC CGT CGC TGC T            766                                                                      Leu Ser Leu Glu Pro Val Tyr Asn Cys Asn Le - #u Gly Arg Arg Cys                               245  - #               250  - #               255              - - GA                  - #                  - #                  - #                 768                                                                   - -  - - (2) INFORMATION FOR SEQ ID NO:6:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 255 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:                               - - Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn        1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Met Lys Lys Ala                   20     - #             25     - #             30                  - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe               35         - #         40         - #         45                      - - Ser His Lys Gly Lys Leu Phe Glu Tyr Pro Th - #r Asp Ser Cys Met Glu           50             - #     55             - #     60                          - - Glu Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu       65                 - # 70                 - # 75                 - # 80       - - Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                       85 - #                 90 - #                 95              - - Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                  100      - #           105      - #           110                  - - Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu              115          - #       120          - #       125                      - - Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Ser Arg Lys Asn          130              - #   135              - #   140                          - - Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gl - #n Arg Lys Glu Lys Ala      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg        Glu                                                                                             165  - #               170  - #               175             - - Asn Val Leu Arg Ala Gln Gln Glu Gln Trp As - #p Glu Gln Asn His Gly                  180      - #           185      - #           190                  - - His Asn Met Pro Pro Pro Pro Pro Pro Gln Gl - #n His Gln Ile Gln His              195          - #       200          - #       205                      - - Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly          210              - #   215              - #   220                          - - Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Ar - #g Arg Asn Asp Leu Asp      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Leu Ser Leu Glu Pro Val Tyr Asn Cys Asn Le - #u Gly Arg Arg Cys                         245  - #               250  - #               255              - -  - - (2) INFORMATION FOR SEQ ID NO:7:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 1345 base - #pairs                                                (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 149..968                                               - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..1345                                                         (D) OTHER INFORMATION: - #/note= "product = Zea mays AP1."           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:                               - - GCACGAGTCC TCCTCCTCCT CGCATCCCAC CCCACCCCAC CTTCTCCTTA AA -             #GCTACCTG     60                                                                 - - CCTACCCGGC GGTTGCGCGC CGCAATCGAT CGACCGGAAG AGAAAGAGCA GC -            #TAGCTAGC    120                                                                 - - TAGCAGATCG GAGCACGGCA ACAAGGCG ATG GGG CGC GGC AAG - #GTA CAG CTG           172                                                                                         - #             Met Gly Arg - #Gly Lys Val Gln Leu                            - #               1   - #            5                       - - AAG CGG ATA GAG AAC AAG ATA AAC CGG CAG GT - #G ACC TTC TCC AAG CGC          220                                                                       Lys Arg Ile Glu Asn Lys Ile Asn Arg Gln Va - #l Thr Phe Ser Lys Arg                10             - #     15             - #     20                          - - CGG AAC GGC CTG CTC AAG AAG GCG CAC GAG AT - #C TCC GTC CTC TGC GAT          268                                                                       Arg Asn Gly Leu Leu Lys Lys Ala His Glu Il - #e Ser Val Leu Cys Asp            25                 - # 30                 - # 35                 - # 40       - - GCC GAG GTC GCC GTC ATC GTC TTC TCC CCC AA - #G GGC AAG CTC TAC GAG          316                                                                       Ala Glu Val Ala Val Ile Val Phe Ser Pro Ly - #s Gly Lys Leu Tyr Glu                            45 - #                 50 - #                 55              - - TAC GCC ACC GAC TCC CGC ATG GAC AAA ATT CT - #T GAA CGC TAT GAG CGA          364                                                                       Tyr Ala Thr Asp Ser Arg Met Asp Lys Ile Le - #u Glu Arg Tyr Glu Arg                        60     - #             65     - #             70                  - - TAT TCC TAT GCT GAA AAG GCT CTT ATT TCA GC - #T GAA TCT GAA AGT GAG          412                                                                       Tyr Ser Tyr Ala Glu Lys Ala Leu Ile Ser Al - #a Glu Ser Glu Ser Glu                    75         - #         80         - #         85                      - - GGA AAT TGG TGC CAC GAA TAC AGG AAA CTG AA - #G GCC AAA ATT GAG ACC          460                                                                       Gly Asn Trp Cys His Glu Tyr Arg Lys Leu Ly - #s Ala Lys Ile Glu Thr                90             - #     95             - #    100                          - - ATA CAA AAA TGC CAC AAG CAC CTG ATG GGA GA - #G GAT CTA GAG TCT TTG          508                                                                       Ile Gln Lys Cys His Lys His Leu Met Gly Gl - #u Asp Leu Glu Ser Leu           105                 1 - #10                 1 - #15                 1 -      #20                                                                              - - AAT CCC AAA GAG CTC CAG CAA CTA GAG CAG CA - #G CTG GAT AGC TCA        CTG      556                                                                    Asn Pro Lys Glu Leu Gln Gln Leu Glu Gln Gl - #n Leu Asp Ser Ser Leu                          125  - #               130  - #               135              - - AAG CAC ATC AGA TCA AGG AAG AGC CAC CTT AT - #G GCC GAG TCT ATT TCT          604                                                                       Lys His Ile Arg Ser Arg Lys Ser His Leu Me - #t Ala Glu Ser Ile Ser                       140      - #           145      - #           150                  - - GAG CTA CAG AAG AAG GAG AGG TCA CTG CAG GA - #G GAG AAC AAG GCT CTG          652                                                                       Glu Leu Gln Lys Lys Glu Arg Ser Leu Gln Gl - #u Glu Asn Lys Ala Leu                   155          - #       160          - #       165                      - - CAG AAG GAA CTT GCG GAG AGG CAG AAG GCC GT - #C GCG AGC CGG CAG CAG          700                                                                       Gln Lys Glu Leu Ala Glu Arg Gln Lys Ala Va - #l Ala Ser Arg Gln Gln               170              - #   175              - #   180                          - - CAG CAA CAG CAG CAG GTG CAG TGG GAC CAG CA - #G ACA CAT GCC CAG GCC          748                                                                       Gln Gln Gln Gln Gln Val Gln Trp Asp Gln Gl - #n Thr His Ala Gln Ala           185                 1 - #90                 1 - #95                 2 -      #00                                                                              - - CAG ACA AGC TCA TCA TCG TCC TCC TTC ATG AT - #G AGG CAG GAT CAG        CAG      796                                                                    Gln Thr Ser Ser Ser Ser Ser Ser Phe Met Me - #t Arg Gln Asp Gln Gln                          205  - #               210  - #               215              - - GGA CTG CCG CCT CCA CAC AAC ATC TGC TTC CC - #G CCG TTG ACA ATG GGA          844                                                                       Gly Leu Pro Pro Pro His Asn Ile Cys Phe Pr - #o Pro Leu Thr Met Gly                       220      - #           225      - #           230                  - - GAT AGA GGT GAA GAG CTG GCT GCG GCG GCG GC - #G GCG CAG CAG CAG CAG          892                                                                       Asp Arg Gly Glu Glu Leu Ala Ala Ala Ala Al - #a Ala Gln Gln Gln Gln                   235          - #       240          - #       245                      - - CCA CTG CCG GGG CAG GCG CAA CCG CAG CTC CG - #C ATC GCA GGT CTG CCA          940                                                                       Pro Leu Pro Gly Gln Ala Gln Pro Gln Leu Ar - #g Ile Ala Gly Leu Pro               250              - #   255              - #   260                          - - CCA TGG ATG CTG AGC CAC CTC AAT GCA T AAGG - #AGAGGG TCGATGAACA              988                                                                       Pro Trp Met Leu Ser His Leu Asn Ala                                           265                 2 - #70                                                    - - CATCGACCTC CTCTCTCTCT CTCTCTCGTC ATGGATCATG ACGTACGCGT AC -             #CATATGGT   1048                                                                 - - TGCTGTGCCT GCCCCCATCG ATCGCGAGCA ATGGCACGCT CATGCAAGTG AT -            #CATTGCTC   1108                                                                 - - CCCGTTGGTT AAACCCTAGC CTATGTTCAT GGCGTCAGCA ACTAAGCTAA AC -            #TATTGTTA   1168                                                                 - - TGTTTGCAAG AAAGGGTAAA CCCGCTAGCT GTGTAATCTT GTCCAGCTAT CA -            #GTATGCTT   1228                                                                 - - GTTACTGCCC AGTTACCCTT GAATCTAGCG GCGCTTTTGG TGAGAGGGTG CA -            #GTTTACTT   1288                                                                 - - TAAACATGGT TCGTGACTTG CTGTAAATAG TAGTATTAAT CGATTTGGGC AT - #CTAAA          1345                                                                       - -  - - (2) INFORMATION FOR SEQ ID NO:8:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 273 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:                               - - Met Gly Arg Gly Lys Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn        1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gl - #y Leu Leu Lys Lys Ala                   20     - #             25     - #             30                  - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Val Ile Val Phe               35         - #         40         - #         45                      - - Ser Pro Lys Gly Lys Leu Tyr Glu Tyr Ala Th - #r Asp Ser Arg Met Asp           50             - #     55             - #     60                          - - Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Ala Leu       65                 - # 70                 - # 75                 - # 80       - - Ile Ser Ala Glu Ser Glu Ser Glu Gly Asn Tr - #p Cys His Glu Tyr Arg                       85 - #                 90 - #                 95              - - Lys Leu Lys Ala Lys Ile Glu Thr Ile Gln Ly - #s Cys His Lys His Leu                  100      - #           105      - #           110                  - - Met Gly Glu Asp Leu Glu Ser Leu Asn Pro Ly - #s Glu Leu Gln Gln Leu              115          - #       120          - #       125                      - - Glu Gln Gln Leu Asp Ser Ser Leu Lys His Il - #e Arg Ser Arg Lys Ser          130              - #   135              - #   140                          - - His Leu Met Ala Glu Ser Ile Ser Glu Leu Gl - #n Lys Lys Glu Arg Ser      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Leu Gln Glu Glu Asn Lys Ala Leu Gln Lys Gl - #u Leu Ala Glu Arg        Gln                                                                                             165  - #               170  - #               175             - - Lys Ala Val Ala Ser Arg Gln Gln Gln Gln Gl - #n Gln Gln Val Gln Trp                  180      - #           185      - #           190                  - - Asp Gln Gln Thr His Ala Gln Ala Gln Thr Se - #r Ser Ser Ser Ser Ser              195          - #       200          - #       205                      - - Phe Met Met Arg Gln Asp Gln Gln Gly Leu Pr - #o Pro Pro His Asn Ile          210              - #   215              - #   220                          - - Cys Phe Pro Pro Leu Thr Met Gly Asp Arg Gl - #y Glu Glu Leu Ala Ala      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Ala Ala Ala Ala Gln Gln Gln Gln Pro Leu Pr - #o Gly Gln Ala Gln        Pro                                                                                             245  - #               250  - #               255             - - Gln Leu Arg Ile Ala Gly Leu Pro Pro Trp Me - #t Leu Ser His Leu Asn                  260      - #           265      - #           270                  - - Ala                                                                       - -  - - (2) INFORMATION FOR SEQ ID NO:9:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 779 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 10..775                                                - -     (ix) FEATURE:                                                                  (A) NAME/KEY: unsure                                                          (B) LOCATION: 778..779                                                        (D) OTHER INFORMATION: - #/note= "N = one or more                                  nucleotides. - #"                                               - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..779                                                          (D) OTHER INFORMATION: - #/note= "product = Arabidopsis                            thaliana - #CAL."                                               - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:                               - - TTAAGAGAA ATG GGA AGG GGT AGG GTT GAA TTG AAG - # AGG ATA GAG AAC             48                                                                                 Met Gly Arg Gly Arg - #Val Glu Leu Lys Arg Ile Glu Asn                          1      - #         5         - #         10                        - - AAG ATC AAT AGA CAA GTG ACA TTC TCG AAA AG - #A AGA ACT GGT CTT TTG           96                                                                       Lys Ile Asn Arg Gln Val Thr Phe Ser Lys Ar - #g Arg Thr Gly Leu Leu                15             - #     20             - #     25                          - - AAG AAA GCT CAG GAG ATC TCT GTT CTT TGT GA - #T GCC GAG GTT TCC CTT          144                                                                       Lys Lys Ala Gln Glu Ile Ser Val Leu Cys As - #p Ala Glu Val Ser Leu            30                 - # 35                 - # 40                 - # 45       - - ATT GTC TTC TCC CAT AAG GGC AAA TTG TTC GA - #G TAC TCC TCT GAA TCT          192                                                                       Ile Val Phe Ser His Lys Gly Lys Leu Phe Gl - #u Tyr Ser Ser Glu Ser                            50 - #                 55 - #                 60              - - TGC ATG GAG AAG GTA CTA GAA CGC TAC GAG AG - #G TAT TCT TAC GCC GAG          240                                                                       Cys Met Glu Lys Val Leu Glu Arg Tyr Glu Ar - #g Tyr Ser Tyr Ala Glu                        65     - #             70     - #             75                  - - AGA CAG CTG ATT GCA CCT GAC TCT CAC GTT AA - #T GCA CAG ACG AAC TGG          288                                                                       Arg Gln Leu Ile Ala Pro Asp Ser His Val As - #n Ala Gln Thr Asn Trp                    80         - #         85         - #         90                      - - TCA ATG GAG TAT AGC AGG CTT AAG GCC AAG AT - #T GAG CTT TTG GAG AGA          336                                                                       Ser Met Glu Tyr Ser Arg Leu Lys Ala Lys Il - #e Glu Leu Leu Glu Arg                95             - #    100             - #    105                          - - AAC CAA AGG CAT TAT CTG GGA GAA GAG TTG GA - #A CCA ATG AGC CTC AAG          384                                                                       Asn Gln Arg His Tyr Leu Gly Glu Glu Leu Gl - #u Pro Met Ser Leu Lys           110                 1 - #15                 1 - #20                 1 -      #25                                                                              - - GAT CTC CAA AAT CTG GAG CAG CAG CTT GAG AC - #T GCT CTT AAG CAC        ATT      432                                                                    Asp Leu Gln Asn Leu Glu Gln Gln Leu Glu Th - #r Ala Leu Lys His Ile                          130  - #               135  - #               140              - - CGC TCC AGA AAA AAT CAA CTC ATG AAT GAG TC - #C CTC AAC CAC CTC CAA          480                                                                       Arg Ser Arg Lys Asn Gln Leu Met Asn Glu Se - #r Leu Asn His Leu Gln                       145      - #           150      - #           155                  - - AGA AAG GAG AAG GAG ATA CAG GAG GAA AAC AG - #C ATG CTT ACC AAA CAG          528                                                                       Arg Lys Glu Lys Glu Ile Gln Glu Glu Asn Se - #r Met Leu Thr Lys Gln                   160          - #       165          - #       170                      - - ATA AAG GAG AGG GAA AAC ATC CTA AAG ACA AA - #A CAA ACC CAA TGT GAG          576                                                                       Ile Lys Glu Arg Glu Asn Ile Leu Lys Thr Ly - #s Gln Thr Gln Cys Glu               175              - #   180              - #   185                          - - CAG CTG AAC CGC AGC GTC GAC GAT GTA CCA CA - #G CCA CAA CCA TTT CAA          624                                                                       Gln Leu Asn Arg Ser Val Asp Asp Val Pro Gl - #n Pro Gln Pro Phe Gln           190                 1 - #95                 2 - #00                 2 -      #05                                                                              - - CAC CCC CAT CTT TAC ATG ATC GCT CAT CAG AC - #T TCT CCT TTC CTA        AAT      672                                                                    His Pro His Leu Tyr Met Ile Ala His Gln Th - #r Ser Pro Phe Leu Asn                          210  - #               215  - #               220              - - ATG GGT GGT TTG TAC CAA GGA GAA GAC CAA AC - #G GCG ATG AGG AGG AAC          720                                                                       Met Gly Gly Leu Tyr Gln Gly Glu Asp Gln Th - #r Ala Met Arg Arg Asn                       225      - #           230      - #           235                  - - AAT CTG GAT CTG ACT CTT GAA CCC ATT TAC AA - #T TAC CTT GGC TGT TAC          768                                                                       Asn Leu Asp Leu Thr Leu Glu Pro Ile Tyr As - #n Tyr Leu Gly Cys Tyr                   240          - #       245          - #       250                      - - GCC GCT T GANN             - #                  - #                      - #      779                                                                  Ala Ala                                                                           255                                                                        - -  - - (2) INFORMATION FOR SEQ ID NO:10:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 255 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:                              - - Met Gly Arg Gly Arg Val Glu Leu Lys Arg Il - #e Glu Asn Lys Ile Asn        1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Thr Gl - #y Leu Leu Lys Lys Ala                   20     - #             25     - #             30                  - - Gln Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe               35         - #         40         - #         45                      - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu           50             - #     55             - #     60                          - - Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu       65                 - # 70                 - # 75                 - # 80       - - Ile Ala Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Met Glu                       85 - #                 90 - #                 95              - - Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Le - #u Glu Arg Asn Gln Arg                  100      - #           105      - #           110                  - - His Tyr Leu Gly Glu Glu Leu Glu Pro Met Se - #r Leu Lys Asp Leu Gln              115          - #       120          - #       125                      - - Asn Leu Glu Gln Gln Leu Glu Thr Ala Leu Ly - #s His Ile Arg Ser Arg          130              - #   135              - #   140                          - - Lys Asn Gln Leu Met Asn Glu Ser Leu Asn Hi - #s Leu Gln Arg Lys Glu      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Lys Glu Ile Gln Glu Glu Asn Ser Met Leu Th - #r Lys Gln Ile Lys        Glu                                                                                             165  - #               170  - #               175             - - Arg Glu Asn Ile Leu Lys Thr Lys Gln Thr Gl - #n Cys Glu Gln Leu Asn                  180      - #           185      - #           190                  - - Arg Ser Val Asp Asp Val Pro Gln Pro Gln Pr - #o Phe Gln His Pro His              195          - #       200          - #       205                      - - Leu Tyr Met Ile Ala His Gln Thr Ser Pro Ph - #e Leu Asn Met Gly Gly          210              - #   215              - #   220                          - - Leu Tyr Gln Gly Glu Asp Gln Thr Ala Met Ar - #g Arg Asn Asn Leu Asp      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Leu Thr Leu Glu Pro Ile Tyr Asn Tyr Leu Gl - #y Cys Tyr Ala Ala                         245  - #               250  - #               255              - -  - - (2) INFORMATION FOR SEQ ID NO:11:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 756 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 1..754                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..756                                                          (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                      CAL."                                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:                              - - ATG GGA AGG GGT AGG GTT GAA ATG AAG AGG AT - #A GAG AAC AAG ATC AAC           48                                                                       Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile Asn             1               5 - #                 10 - #                 15              - - CGA CAA GTG ACG TTT TCG AAA AGA AGA GCT GG - #T CTT TTG AAG AAA GCC           96                                                                       Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                        20     - #             25     - #             30                  - - CAT GAG ATC TCG ATC CTT TGT GAT GCT GAG GT - #T TCC CTT ATT GTC TTC          144                                                                       His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                    35         - #         40         - #         45                      - - TCC CAT AAG GGG AAA CTG TTC GAG TAC TCG TC - #T GAA TCT TGC ATG GAG          192                                                                       Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu                50             - #     55             - #     60                          - - AAG GTA CTA GAA CAC TAC GAG AGG TAC TCT TA - #C GCC GAG AAA CAG CTA          240                                                                       Lys Val Leu Glu His Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu            65                 - # 70                 - # 75                 - # 80       - - AAA GTT CCA GAC TCT CAC GTC AAT GCA CAA AC - #G AAC TGG TCA GTG GAA          288                                                                       Lys Val Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Val Glu                            85 - #                 90 - #                 95              - - TAT AGC AGG CTT AAG GCT AAG ATT GAG CTT TT - #G GAG AGA AAC CAA AGG          336                                                                       Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Le - #u Glu Arg Asn Gln Arg                       100      - #           105      - #           110                  - - CAT TAT CTG GGC GAA GAT TTA GAA TCA ATC AG - #C ATA AAG GAG CTA CAG          384                                                                       His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln                   115          - #       120          - #       125                      - - AAT CTG GAG CAG CAG CTT GAC ACT TCT CTT AA - #A CAT ATT CGC TCG AGA          432                                                                       Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg               130              - #   135              - #   140                          - - AAA AAT CAA CTA ATG CAC GAG TCC CTC AAC CA - #C CTC CAA AGA AAG GAG          480                                                                       Lys Asn Gln Leu Met His Glu Ser Leu Asn Hi - #s Leu Gln Arg Lys Glu           145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - AAA GAA ATA CTG GAG GAA AAC AGC ATG CTT GC - #C AAA CAG ATA AGG        GAG      528                                                                    Lys Glu Ile Leu Glu Glu Asn Ser Met Leu Al - #a Lys Gln Ile Arg Glu                          165  - #               170  - #               175              - - AGG GAG AGT ATC CTA AGG ACA CAT CAA AAC CA - #A TCA GAG CAG CAA AAC          576                                                                       Arg Glu Ser Ile Leu Arg Thr His Gln Asn Gl - #n Ser Glu Gln Gln Asn                       180      - #           185      - #           190                  - - CGC AGC CAC CAT GTA GCT CCT CAG CCG CAA CC - #G CAG TTA AAT CCT TAC          624                                                                       Arg Ser His His Val Ala Pro Gln Pro Gln Pr - #o Gln Leu Asn Pro Tyr                   195          - #       200          - #       205                      - - ATG GCA TCA TCT CCT TTC CTA AAT ATG GGT GG - #C ATG TAC CAA GGA GAA          672                                                                       Met Ala Ser Ser Pro Phe Leu Asn Met Gly Gl - #y Met Tyr Gln Gly Glu               210              - #   215              - #   220                          - - TAT CCA ACG GCG GTG AGG AGG AAC CGT CTC GA - #T CTG ACT CTT GAA CCC          720                                                                       Tyr Pro Thr Ala Val Arg Arg Asn Arg Leu As - #p Leu Thr Leu Glu Pro           225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - ATT TAC AAC TGC AAC CTT GGT TAC TTT GCC GC - #A T GA                   - #      756                                                                   Ile Tyr Asn Cys Asn Leu Gly Tyr Phe Ala Al - #a                                               245  - #               250                                     - -  - - (2) INFORMATION FOR SEQ ID NO:12:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 251 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:                              - - Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile Asn        1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                   20     - #             25     - #             30                  - - His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe               35         - #         40         - #         45                      - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu           50             - #     55             - #     60                          - - Lys Val Leu Glu His Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu       65                 - # 70                 - # 75                 - # 80       - - Lys Val Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Val Glu                       85 - #                 90 - #                 95              - - Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Le - #u Glu Arg Asn Gln Arg                  100      - #           105      - #           110                  - - His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln              115          - #       120          - #       125                      - - Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg          130              - #   135              - #   140                          - - Lys Asn Gln Leu Met His Glu Ser Leu Asn Hi - #s Leu Gln Arg Lys Glu      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Lys Glu Ile Leu Glu Glu Asn Ser Met Leu Al - #a Lys Gln Ile Arg        Glu                                                                                             165  - #               170  - #               175             - - Arg Glu Ser Ile Leu Arg Thr His Gln Asn Gl - #n Ser Glu Gln Gln Asn                  180      - #           185      - #           190                  - - Arg Ser His His Val Ala Pro Gln Pro Gln Pr - #o Gln Leu Asn Pro Tyr              195          - #       200          - #       205                      - - Met Ala Ser Ser Pro Phe Leu Asn Met Gly Gl - #y Met Tyr Gln Gly Glu          210              - #   215              - #   220                          - - Tyr Pro Thr Ala Val Arg Arg Asn Arg Leu As - #p Leu Thr Leu Glu Pro      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Ile Tyr Asn Cys Asn Leu Gly Tyr Phe Ala Al - #a                                          245  - #               250                                     - -  - - (2) INFORMATION FOR SEQ ID NO:13:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 756 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 1..451                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..756                                                          (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                     var. botr - #ytis CAL."                                         - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:                              - - ATG GGA AGG GGT AGG GTT GAA ATG AAG AGG AT - #A GAG AAC AAG ATC AAC           48                                                                       Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile Asn             1               5 - #                 10 - #                 15              - - AGA CAA GTG ACG TTT TCG AAA AGA AGA GCT GG - #T CTT TTG AAG AAA GCC           96                                                                       Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                        20     - #             25     - #             30                  - - CAT GAG ATC TCG ATT CTT TGT GAT GCT GAG GT - #T TCC CTT ATT GTC TTC          144                                                                       His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                    35         - #         40         - #         45                      - - TCC CAT AAG GGG AAA CTG TTC GAG TAC TCG TC - #T GAA TCT TGC ATG GAG          192                                                                       Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu                50             - #     55             - #     60                          - - AAG GTA CTA GAA CGC TAC GAG AGG TAC TCT TA - #C GCC GAG AAA CAG CTA          240                                                                       Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu            65                 - # 70                 - # 75                 - # 80       - - AAA GCT CCA GAC TCT CAC GTC AAT GCA CAA AC - #G AAC TGG TCA ATG GAA          288                                                                       Lys Ala Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Met Glu                            85 - #                 90 - #                 95              - - TAT AGC AGG CTT AAG GCT AAG ATT GAG CTT TG - #G GAG AGG AAC CAA AGG          336                                                                       Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Tr - #p Glu Arg Asn Gln Arg                       100      - #           105      - #           110                  - - CAT TAT CTG GGA GAA GAT TTA GAA TCA ATC AG - #C ATA AAG GAG CTA CAG          384                                                                       His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln                   115          - #       120          - #       125                      - - AAT CTG GAG CAG CAG CTT GAC ACT TCT CTT AA - #A CAT ATT CGC TCC AGA          432                                                                       Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg               130              - #   135              - #   140                          - - AAA AAT CAA CTA ATG CAC T AGTCCCTCAA CCACCTCCAA - #AGAAAGGAGA               481                                                                        Lys Asn Gln Leu Met His                                                       145                 1 - #50                                                    - - AAGAAATACT GGAGGAAAAC AGCATGCTTG CCAAACAGAT AAAGGAGAGG GA -             #GAGTATCC    541                                                                 - - TAAGGACACA TCAAAACCAA TCAGAGCAGC AAAACCGCAG CCACCATGTA GC -            #TCCTCAGC    601                                                                 - - CGCAACCGCA GTTAAATCCT TACATGGCAT CATCTCCTTT CCTAAATATG GG -            #TGGCATGT    661                                                                 - - ACCAAGGAGA ATATCCAACG GCGGTGAGGA GGAACCGTCT CGATCTGACT CT -            #TGAACCCA    721                                                                 - - TTTACAACTG CAACCTTGGT TACTTTGCCG CATGA       - #                       - #      756                                                                     - -  - - (2) INFORMATION FOR SEQ ID NO:14:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 150 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:                              - - Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile        Asn                                                                               1               5 - #                 10 - #                 15             - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                   20     - #             25     - #             30                  - - His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe               35         - #         40         - #         45                      - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu           50             - #     55             - #     60                          - - Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu       65                 - # 70                 - # 75                 - # 80       - - Lys Ala Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Met Glu                       85 - #                 90 - #                 95              - - Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Tr - #p Glu Arg Asn Gln Arg                  100      - #           105      - #           110                  - - His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln              115          - #       120          - #       125                      - - Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg          130              - #   135              - #   140                          - - Lys Asn Gln Leu Met His                                                  145                 1 - #50                                                    - -  - - (2) INFORMATION FOR SEQ ID NO:15:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 1500 base - #pairs                                                (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: cDNA                                              - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 72..1343                                               - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..1500                                                         (D) OTHER INFORMATION: - #/note= "product = Arabidopsis                            thaliana - #LEAFY (LFY)."                                       - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:                              - - AAAGCAATCT GCTCAAAAGA GTAAAGAAAG AGAGAAAAAG AGAGTGATAG AG -             #AGAGAGAG     60                                                                 - - AAAAATAGAT T ATG GAT CCT GAA GGT TTC ACG AGT - #GGC TTA TTC CGG        TGG     110                                                                                  Met Asp Pro - #Glu Gly Phe Thr Ser Gly Leu Phe Arg Trp                         1   - #            5      - #            10                     - - AAC CCA ACG AGA GCA TTG GTT CAA GCA CCA CC - #T CCG GTT CCA CCT CCG          158                                                                       Asn Pro Thr Arg Ala Leu Val Gln Ala Pro Pr - #o Pro Val Pro Pro Pro                15             - #     20             - #     25                          - - CTG CAG CAA CAG CCG GTG ACA CCG CAG ACG GC - #T GCT TTT GGG ATG CGA          206                                                                       Leu Gln Gln Gln Pro Val Thr Pro Gln Thr Al - #a Ala Phe Gly Met Arg            30                 - # 35                 - # 40                 - # 45       - - CTT GGT GGT TTA GAG GGA CTA TTC GGT CCA TA - #C GGT ATA CGT TTC TAC          254                                                                       Leu Gly Gly Leu Glu Gly Leu Phe Gly Pro Ty - #r Gly Ile Arg Phe Tyr                            50 - #                 55 - #                 60              - - ACG GCG GCG AAG ATA GCG GAG TTA GGT TTT AC - #G GCG AGC ACG CTT GTG          302                                                                       Thr Ala Ala Lys Ile Ala Glu Leu Gly Phe Th - #r Ala Ser Thr Leu Val                        65     - #             70     - #             75                  - - GGT ATG AAG GAC GAG GAG CTT GAA GAG ATG AT - #G AAT AGT CTC TCT CAT          350                                                                       Gly Met Lys Asp Glu Glu Leu Glu Glu Met Me - #t Asn Ser Leu Ser His                    80         - #         85         - #         90                      - - ATC TTT CGT TGG GAG CTT CTT GTT GGT GAA CG - #G TAC GGT ATC AAA GCT          398                                                                       Ile Phe Arg Trp Glu Leu Leu Val Gly Glu Ar - #g Tyr Gly Ile Lys Ala                95             - #    100             - #    105                          - - GCC GTT AGA GCT GAA CGG AGA CGA TTG CAA GA - #A GAG GAG GAA GAG GAA          446                                                                       Ala Val Arg Ala Glu Arg Arg Arg Leu Gln Gl - #u Glu Glu Glu Glu Glu           110                 1 - #15                 1 - #20                 1 -      #25                                                                              - - TCT TCT AGA CGC CGT CAT TTG CTA CTC TCC GC - #C GCT GGT GAT TCC        GGT      494                                                                    Ser Ser Arg Arg Arg His Leu Leu Leu Ser Al - #a Ala Gly Asp Ser Gly                          130  - #               135  - #               140              - - ACT CAT CAC GCT CTT GAT GCT CTC TCC CAA GA - #A GAT GAT TGG ACA GGG          542                                                                       Thr His His Ala Leu Asp Ala Leu Ser Gln Gl - #u Asp Asp Trp Thr Gly                       145      - #           150      - #           155                  - - TTA TCT GAG GAA CCG GTG CAG CAA CAA GAC CA - #G ACT GAT GCG GCG GGG          590                                                                       Leu Ser Glu Glu Pro Val Gln Gln Gln Asp Gl - #n Thr Asp Ala Ala Gly                   160          - #       165          - #       170                      - - AAT AAC GGC GGA GGA GGA AGT GGT TAC TGG GA - #C GCA GGT CAA GGA AAG          638                                                                       Asn Asn Gly Gly Gly Gly Ser Gly Tyr Trp As - #p Ala Gly Gln Gly Lys               175              - #   180              - #   185                          - - ATG AAG AAG CAA CAG CAG CAG AGA CGG AGA AA - #G AAA CCA ATG CTG ACG          686                                                                       Met Lys Lys Gln Gln Gln Gln Arg Arg Arg Ly - #s Lys Pro Met Leu Thr           190                 1 - #95                 2 - #00                 2 -      #05                                                                              - - TCA GTG GAA ACC GAC GAA GAC GTC AAC GAA GG - #T GAG GAT GAC GAC        GGG      734                                                                    Ser Val Glu Thr Asp Glu Asp Val Asn Glu Gl - #y Glu Asp Asp Asp Gly                          210  - #               215  - #               220              - - ATG GAT AAC GGC AAC GGA GGT AGT GGT TTG GG - #G ACA GAG AGA CAG AGG          782                                                                       Met Asp Asn Gly Asn Gly Gly Ser Gly Leu Gl - #y Thr Glu Arg Gln Arg                       225      - #           230      - #           235                  - - GAG CAT CCG TTT ATC GTA ACG GAG CCT GGG GA - #A GTG GCA CGT GGC AAA          830                                                                       Glu His Pro Phe Ile Val Thr Glu Pro Gly Gl - #u Val Ala Arg Gly Lys                   240          - #       245          - #       250                      - - AAG AAC GGC TTA GAT TAT CTG TTC CAC TTG TA - #C GAA CAA TGC CGT GAG          878                                                                       Lys Asn Gly Leu Asp Tyr Leu Phe His Leu Ty - #r Glu Gln Cys Arg Glu               255              - #   260              - #   265                          - - TTC CTT CTT CAG GTC CAG ACA ATT GCT AAA GA - #C CGT GGC GAA AAA TGC          926                                                                       Phe Leu Leu Gln Val Gln Thr Ile Ala Lys As - #p Arg Gly Glu Lys Cys           270                 2 - #75                 2 - #80                 2 -      #85                                                                              - - CCC ACC AAG GTG ACG AAC CAA GTA TTC AGG TA - #C GCG AAG AAA TCA        GGA      974                                                                    Pro Thr Lys Val Thr Asn Gln Val Phe Arg Ty - #r Ala Lys Lys Ser Gly                          290  - #               295  - #               300              - - GCG AGT TAC ATA AAC AAG CCT AAA ATG CGA CA - #C TAC GTT CAC TGT TAC         1022                                                                       Ala Ser Tyr Ile Asn Lys Pro Lys Met Arg Hi - #s Tyr Val His Cys Tyr                       305      - #           310      - #           315                  - - GCT CTC CAC TGC CTA GAC GAA GAA GCT TCA AA - #T GCT CTC AGA AGA GCG         1070                                                                       Ala Leu His Cys Leu Asp Glu Glu Ala Ser As - #n Ala Leu Arg Arg Ala                   320          - #       325          - #       330                      - - TTT AAA GAA CGC GGT GAG AAC GTT GGC TCA TG - #G CGT CAG GCT TGT TAC         1118                                                                       Phe Lys Glu Arg Gly Glu Asn Val Gly Ser Tr - #p Arg Gln Ala Cys Tyr               335              - #   340              - #   345                          - - AAG CCA CTT GTG AAC ATC GCT TGT CGT CAT GG - #C TGG GAT ATA GAC GCC         1166                                                                       Lys Pro Leu Val Asn Ile Ala Cys Arg His Gl - #y Trp Asp Ile Asp Ala           350                 3 - #55                 3 - #60                 3 -      #65                                                                              - - GTC TTT AAC GCT CAT CCT CGT CTC TCT ATT TG - #G TAT GTT CCA ACA        AAG     1214                                                                    Val Phe Asn Ala His Pro Arg Leu Ser Ile Tr - #p Tyr Val Pro Thr Lys                          370  - #               375  - #               380              - - CTG CGT CAG CTT TGC CAT TTG GAG CGG AAC AA - #T GCG GTT GCT GCG GCT         1262                                                                       Leu Arg Gln Leu Cys His Leu Glu Arg Asn As - #n Ala Val Ala Ala Ala                       385      - #           390      - #           395                  - - GCG GCT TTA GTT GGC GGT ATT AGC TGT ACC GG - #A TCG TCG ACG TCT GGA         1310                                                                       Ala Ala Leu Val Gly Gly Ile Ser Cys Thr Gl - #y Ser Ser Thr Ser Gly                   400          - #       405          - #       410                      - - CGT GGT GGA TGC GGC GGC GAC GAC TTG CGT TT - #C TAGTTTGGTT TGGGTAGTT    G   1363                                                                       Arg Gly Gly Cys Gly Gly Asp Asp Leu Arg Ph - #e                                   415              - #   420                                                 - - TGGTTTGTTT AGTCGTTATC CTAATTAACT ATTAGTCTTT AATTTAGTCT TC -             #TTGGCTAA   1423                                                                 - - TTTATTTTTC TTTTTTTGTC AAAACCTTTA ATTTGTTATG GCTAATTTGT TA -            #TACACGCA   1483                                                                 - - GTTTTCTTAA TGCGTTA             - #                  - #                      - # 1500                                                                  - -  - - (2) INFORMATION FOR SEQ ID NO:16:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 424 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:                              - - Met Asp Pro Glu Gly Phe Thr Ser Gly Leu Ph - #e Arg Trp Asn Pro Thr        1               5 - #                 10 - #                 15              - - Arg Ala Leu Val Gln Ala Pro Pro Pro Val Pr - #o Pro Pro Leu Gln Gln                   20     - #             25     - #             30                  - - Gln Pro Val Thr Pro Gln Thr Ala Ala Phe Gl - #y Met Arg Leu Gly Gly               35         - #         40         - #         45                      - - Leu Glu Gly Leu Phe Gly Pro Tyr Gly Ile Ar - #g Phe Tyr Thr Ala Ala           50             - #     55             - #     60                          - - Lys Ile Ala Glu Leu Gly Phe Thr Ala Ser Th - #r Leu Val Gly Met Lys       65                 - # 70                 - # 75                 - # 80       - - Asp Glu Glu Leu Glu Glu Met Met Asn Ser Le - #u Ser His Ile Phe Arg                       85 - #                 90 - #                 95              - - Trp Glu Leu Leu Val Gly Glu Arg Tyr Gly Il - #e Lys Ala Ala Val Arg                  100      - #           105      - #           110                  - - Ala Glu Arg Arg Arg Leu Gln Glu Glu Glu Gl - #u Glu Glu Ser Ser Arg              115          - #       120          - #       125                      - - Arg Arg His Leu Leu Leu Ser Ala Ala Gly As - #p Ser Gly Thr His His          130              - #   135              - #   140                          - - Ala Leu Asp Ala Leu Ser Gln Glu Asp Asp Tr - #p Thr Gly Leu Ser Glu      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Glu Pro Val Gln Gln Gln Asp Gln Thr Asp Al - #a Ala Gly Asn Asn        Gly                                                                                             165  - #               170  - #               175             - - Gly Gly Gly Ser Gly Tyr Trp Asp Ala Gly Gl - #n Gly Lys Met Lys Lys                  180      - #           185      - #           190                  - - Gln Gln Gln Gln Arg Arg Arg Lys Lys Pro Me - #t Leu Thr Ser Val Glu              195          - #       200          - #       205                      - - Thr Asp Glu Asp Val Asn Glu Gly Glu Asp As - #p Asp Gly Met Asp Asn          210              - #   215              - #   220                          - - Gly Asn Gly Gly Ser Gly Leu Gly Thr Glu Ar - #g Gln Arg Glu His Pro      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Phe Ile Val Thr Glu Pro Gly Glu Val Ala Ar - #g Gly Lys Lys Asn        Gly                                                                                             245  - #               250  - #               255             - - Leu Asp Tyr Leu Phe His Leu Tyr Glu Gln Cy - #s Arg Glu Phe Leu Leu                  260      - #           265      - #           270                  - - Gln Val Gln Thr Ile Ala Lys Asp Arg Gly Gl - #u Lys Cys Pro Thr Lys              275          - #       280          - #       285                      - - Val Thr Asn Gln Val Phe Arg Tyr Ala Lys Ly - #s Ser Gly Ala Ser Tyr          290              - #   295              - #   300                          - - Ile Asn Lys Pro Lys Met Arg His Tyr Val Hi - #s Cys Tyr Ala Leu His      305                 3 - #10                 3 - #15                 3 -      #20                                                                              - - Cys Leu Asp Glu Glu Ala Ser Asn Ala Leu Ar - #g Arg Ala Phe Lys        Glu                                                                                             325  - #               330  - #               335             - - Arg Gly Glu Asn Val Gly Ser Trp Arg Gln Al - #a Cys Tyr Lys Pro Leu                  340      - #           345      - #           350                  - - Val Asn Ile Ala Cys Arg His Gly Trp Asp Il - #e Asp Ala Val Phe Asn              355          - #       360          - #       365                      - - Ala His Pro Arg Leu Ser Ile Trp Tyr Val Pr - #o Thr Lys Leu Arg Gln          370              - #   375              - #   380                          - - Leu Cys His Leu Glu Arg Asn Asn Ala Val Al - #a Ala Ala Ala Ala Leu      385                 3 - #90                 3 - #95                 4 -      #00                                                                              - - Val Gly Gly Ile Ser Cys Thr Gly Ser Ser Th - #r Ser Gly Arg Gly        Gly                                                                                             405  - #               410  - #               415             - - Cys Gly Gly Asp Asp Leu Arg Phe                                                      420                                                                - -  - - (2) INFORMATION FOR SEQ ID NO:17:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 1656 base - #pairs                                                (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 1..1651                                                - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..1656                                                         (D) OTHER INFORMATION: - #/note= "domain = ecdysone receptor                       ligand bi - #nding domain."                                     - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:                              - - ATG CGG CCG GAA TGC GTC GTC CCG GAG AAC CA - #A TGT GCG ATG AAG CGG           48                                                                       Met Arg Pro Glu Cys Val Val Pro Glu Asn Gl - #n Cys Ala Met Lys Arg             1               5 - #                 10 - #                 15              - - CGC GAA AAG AAG GCC CAG AAG GAG AAG GAC AA - #A ATG ACC ACT TCG CCG           96                                                                       Arg Glu Lys Lys Ala Gln Lys Glu Lys Asp Ly - #s Met Thr Thr Ser Pro                        20     - #             25     - #             30                  - - AGC TCT CAG CAT GGC GGC AAT GGC AGC TTG GC - #C TCT GGT GGC GGC CAA          144                                                                       Ser Ser Gln His Gly Gly Asn Gly Ser Leu Al - #a Ser Gly Gly Gly Gln                    35         - #         40         - #         45                      - - GAC TTT GTT AAG AAG GAG ATT CTT GAC CTT AT - #G ACA TGC GAG CCG CCC          192                                                                       Asp Phe Val Lys Lys Glu Ile Leu Asp Leu Me - #t Thr Cys Glu Pro Pro                50             - #     55             - #     60                          - - CAG CAT GCC ACT ATT CCG CTA CTA CCT GAT GA - #A ATA TTG GCC AAG TGT          240                                                                       Gln His Ala Thr Ile Pro Leu Leu Pro Asp Gl - #u Ile Leu Ala Lys Cys            65                 - # 70                 - # 75                 - # 80       - - CAA GCG CGC AAT ATA CCT TCC TTA ACG TAC AA - #T CAG TTG GCC GTT ATA          288                                                                       Gln Ala Arg Asn Ile Pro Ser Leu Thr Tyr As - #n Gln Leu Ala Val Ile                            85 - #                 90 - #                 95              - - TAC AAG TTA ATT TGG TAC CAG GAT GGC TAT GA - #G CAG CCA TCT GAA GAG          336                                                                       Tyr Lys Leu Ile Trp Tyr Gln Asp Gly Tyr Gl - #u Gln Pro Ser Glu Glu                       100      - #           105      - #           110                  - - GAT CTC AGG CGT ATA ATG AGT CAA CCC GAT GA - #G AAC GAG AGC CAA ACG          384                                                                       Asp Leu Arg Arg Ile Met Ser Gln Pro Asp Gl - #u Asn Glu Ser Gln Thr                   115          - #       120          - #       125                      - - GAC GTC AGC TTT CGG CAT ATA ACC GAG ATA AC - #C ATA CTC ACG GTC CAG          432                                                                       Asp Val Ser Phe Arg His Ile Thr Glu Ile Th - #r Ile Leu Thr Val Gln               130              - #   135              - #   140                          - - TTG ATT GTT GAG TTT GCT AAA GGT CTA CCA GC - #G TTT ACA AAG ATA CCC          480                                                                       Leu Ile Val Glu Phe Ala Lys Gly Leu Pro Al - #a Phe Thr Lys Ile Pro           145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - CAG GAG GAC CAG ATC ACG TTA CTA AAG GCC TG - #C TCG TCG GAG GTG        ATG      528                                                                    Gln Glu Asp Gln Ile Thr Leu Leu Lys Ala Cy - #s Ser Ser Glu Val Met                          165  - #               170  - #               175              - - ATG CTG CGT ATG GCA CGA CGC TAT GAC CAC AG - #C TCG GAC TCA ATA TTC          576                                                                       Met Leu Arg Met Ala Arg Arg Tyr Asp His Se - #r Ser Asp Ser Ile Phe                       180      - #           185      - #           190                  - - TTC GCG AAT AAT AGA TCA TAT ACG CGG GAT TC - #T TAC AAA ATG GCC GGA          624                                                                       Phe Ala Asn Asn Arg Ser Tyr Thr Arg Asp Se - #r Tyr Lys Met Ala Gly                   195          - #       200          - #       205                      - - ATG GCT GAT AAC ATT GAA GAC CTG CTG CAT TT - #C TGC CGC CAA ATG TTC          672                                                                       Met Ala Asp Asn Ile Glu Asp Leu Leu His Ph - #e Cys Arg Gln Met Phe               210              - #   215              - #   220                          - - TCG ATG AAG GTG GAC AAC GTC GAA TAC GCG CT - #T CTC ACT GCC ATT GTG          720                                                                       Ser Met Lys Val Asp Asn Val Glu Tyr Ala Le - #u Leu Thr Ala Ile Val           225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - ATC TTC TCG GAC CGG CCG GGC CTG GAG AAG GC - #C CAA CTA GTC GAA        GCG      768                                                                    Ile Phe Ser Asp Arg Pro Gly Leu Glu Lys Al - #a Gln Leu Val Glu Ala                          245  - #               250  - #               255              - - ATC CAG AGC TAC TAC ATC GAC ACG CTA CGC AT - #T TAT ATA CTC AAC CGC          816                                                                       Ile Gln Ser Tyr Tyr Ile Asp Thr Leu Arg Il - #e Tyr Ile Leu Asn Arg                       260      - #           265      - #           270                  - - CAC TGC GGC GAC TCA ATG AGC CTC GTC TTC TA - #C GCA AAG CTG CTC TCG          864                                                                       His Cys Gly Asp Ser Met Ser Leu Val Phe Ty - #r Ala Lys Leu Leu Ser                   275          - #       280          - #       285                      - - ATC CTC ACC GAG CTG CGT ACG CTG GGC AAC CA - #G AAC GCC GAG ATG TGT          912                                                                       Ile Leu Thr Glu Leu Arg Thr Leu Gly Asn Gl - #n Asn Ala Glu Met Cys               290              - #   295              - #   300                          - - TTC TCA CTA AAG CTC AAA AAC CGC AAA CTG CC - #C AAG TTC CTC GAG GAG          960                                                                       Phe Ser Leu Lys Leu Lys Asn Arg Lys Leu Pr - #o Lys Phe Leu Glu Glu           305                 3 - #10                 3 - #15                 3 -      #20                                                                              - - ATC TGG GAC GTT CAT GCC ATC CCG CCA TCG GT - #C CAG TCG CAC CTT        CAG     1008                                                                    Ile Trp Asp Val His Ala Ile Pro Pro Ser Va - #l Gln Ser His Leu Gln                          325  - #               330  - #               335              - - ATT ACC CAG GAG GAG AAC GAG CGT CTC GAG CG - #G GCT GAG CGT ATG CGG         1056                                                                       Ile Thr Gln Glu Glu Asn Glu Arg Leu Glu Ar - #g Ala Glu Arg Met Arg                       340      - #           345      - #           350                  - - GCA TCG GTT GGG GGC GCC ATT ACC GCC GGC AT - #T GAT TGC GAC TCT GCC         1104                                                                       Ala Ser Val Gly Gly Ala Ile Thr Ala Gly Il - #e Asp Cys Asp Ser Ala                   355          - #       360          - #       365                      - - TCC ACT TCG GCG GCG GCA GCC GCG GCC CAG CA - #T CAG CCT CAG CCT CAG         1152                                                                       Ser Thr Ser Ala Ala Ala Ala Ala Ala Gln Hi - #s Gln Pro Gln Pro Gln               370              - #   375              - #   380                          - - CCC CAG CCC CAA CCC TCC TCC CTG ACC CAG AA - #C GAT TCC CAG CAC CAG         1200                                                                       Pro Gln Pro Gln Pro Ser Ser Leu Thr Gln As - #n Asp Ser Gln His Gln           385                 3 - #90                 3 - #95                 4 -      #00                                                                              - - ACA CAG CCG CAG CTA CAA CCT CAG CTA CCA CC - #T CAG CTG CAA GGT        CAA     1248                                                                    Thr Gln Pro Gln Leu Gln Pro Gln Leu Pro Pr - #o Gln Leu Gln Gly Gln                          405  - #               410  - #               415              - - CTG CAA CCC CAG CTC CAA CCA CAG CTT CAG AC - #G CAA CTC CAG CCA CAG         1296                                                                       Leu Gln Pro Gln Leu Gln Pro Gln Leu Gln Th - #r Gln Leu Gln Pro Gln                       420      - #           425      - #           430                  - - ATT CAA CCA CAG CCA CAG CTC CTT CCC GTC TC - #C GCT CCC GTG CCC GCC         1344                                                                       Ile Gln Pro Gln Pro Gln Leu Leu Pro Val Se - #r Ala Pro Val Pro Ala                   435          - #       440          - #       445                      - - TCC GTA ACC GCA CCT GGT TCC TTG TCC GCG GT - #C AGT ACG AGC AGC GAA         1392                                                                       Ser Val Thr Ala Pro Gly Ser Leu Ser Ala Va - #l Ser Thr Ser Ser Glu               450              - #   455              - #   460                          - - TAC ATG GGC GGA AGT GCG GCC ATA GGA CCC AT - #C ACG CCG GCA ACC ACC         1440                                                                       Tyr Met Gly Gly Ser Ala Ala Ile Gly Pro Il - #e Thr Pro Ala Thr Thr           465                 4 - #70                 4 - #75                 4 -      #80                                                                              - - AGC AGT ATC ACG GCT GCC GTT ACC GCT AGC TC - #C ACC ACA TCA GCG        GTA     1488                                                                    Ser Ser Ile Thr Ala Ala Val Thr Ala Ser Se - #r Thr Thr Ser Ala Val                          485  - #               490  - #               495              - - CCG ATG GGC AAC GGA GTT GGA GTC GGT GTT GG - #G GTG GGC GGC AAC GTC         1536                                                                       Pro Met Gly Asn Gly Val Gly Val Gly Val Gl - #y Val Gly Gly Asn Val                       500      - #           505      - #           510                  - - AGC ATG TAT GCG AAC GCC CAG ACG GCG ATG GC - #C TTG ATG GGT GTA GCC         1584                                                                       Ser Met Tyr Ala Asn Ala Gln Thr Ala Met Al - #a Leu Met Gly Val Ala                   515          - #       520          - #       525                      - - CTG CAT TCG CAC CAA GAG CAG CTT ATC GGG GG - #A GTG GCG GTT AAG TCG         1632                                                                       Leu His Ser His Gln Glu Gln Leu Ile Gly Gl - #y Val Ala Val Lys Ser               530              - #   535              - #   540                          - - GAG CAC TCG ACG ACT GCA T AGCAG     - #                  - #                  1656                                                                     Glu His Ser Thr Thr Ala                                                       545                 5 - #50                                                    - -  - - (2) INFORMATION FOR SEQ ID NO:18:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 550 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:                              - - Met Arg Pro Glu Cys Val Val Pro Glu Asn Gl - #n Cys Ala Met Lys Arg        1               5 - #                 10 - #                 15              - - Arg Glu Lys Lys Ala Gln Lys Glu Lys Asp Ly - #s Met Thr Thr Ser Pro                   20     - #             25     - #             30                  - - Ser Ser Gln His Gly Gly Asn Gly Ser Leu Al - #a Ser Gly Gly Gly Gln               35         - #         40         - #         45                      - - Asp Phe Val Lys Lys Glu Ile Leu Asp Leu Me - #t Thr Cys Glu Pro Pro           50             - #     55             - #     60                          - - Gln His Ala Thr Ile Pro Leu Leu Pro Asp Gl - #u Ile Leu Ala Lys Cys       65                 - # 70                 - # 75                 - # 80       - - Gln Ala Arg Asn Ile Pro Ser Leu Thr Tyr As - #n Gln Leu Ala Val Ile                       85 - #                 90 - #                 95              - - Tyr Lys Leu Ile Trp Tyr Gln Asp Gly Tyr Gl - #u Gln Pro Ser Glu Glu                  100      - #           105      - #           110                  - - Asp Leu Arg Arg Ile Met Ser Gln Pro Asp Gl - #u Asn Glu Ser Gln Thr              115          - #       120          - #       125                      - - Asp Val Ser Phe Arg His Ile Thr Glu Ile Th - #r Ile Leu Thr Val Gln          130              - #   135              - #   140                          - - Leu Ile Val Glu Phe Ala Lys Gly Leu Pro Al - #a Phe Thr Lys Ile Pro      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Gln Glu Asp Gln Ile Thr Leu Leu Lys Ala Cy - #s Ser Ser Glu Val        Met                                                                                             165  - #               170  - #               175             - - Met Leu Arg Met Ala Arg Arg Tyr Asp His Se - #r Ser Asp Ser Ile Phe                  180      - #           185      - #           190                  - - Phe Ala Asn Asn Arg Ser Tyr Thr Arg Asp Se - #r Tyr Lys Met Ala Gly              195          - #       200          - #       205                      - - Met Ala Asp Asn Ile Glu Asp Leu Leu His Ph - #e Cys Arg Gln Met Phe          210              - #   215              - #   220                          - - Ser Met Lys Val Asp Asn Val Glu Tyr Ala Le - #u Leu Thr Ala Ile Val      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Ile Phe Ser Asp Arg Pro Gly Leu Glu Lys Al - #a Gln Leu Val Glu        Ala                                                                                             245  - #               250  - #               255             - - Ile Gln Ser Tyr Tyr Ile Asp Thr Leu Arg Il - #e Tyr Ile Leu Asn Arg                  260      - #           265      - #           270                  - - His Cys Gly Asp Ser Met Ser Leu Val Phe Ty - #r Ala Lys Leu Leu Ser              275          - #       280          - #       285                      - - Ile Leu Thr Glu Leu Arg Thr Leu Gly Asn Gl - #n Asn Ala Glu Met Cys          290              - #   295              - #   300                          - - Phe Ser Leu Lys Leu Lys Asn Arg Lys Leu Pr - #o Lys Phe Leu Glu Glu      305                 3 - #10                 3 - #15                 3 -      #20                                                                              - - Ile Trp Asp Val His Ala Ile Pro Pro Ser Va - #l Gln Ser His Leu        Gln                                                                                             325  - #               330  - #               335             - - Ile Thr Gln Glu Glu Asn Glu Arg Leu Glu Ar - #g Ala Glu Arg Met Arg                  340      - #           345      - #           350                  - - Ala Ser Val Gly Gly Ala Ile Thr Ala Gly Il - #e Asp Cys Asp Ser Ala              355          - #       360          - #       365                      - - Ser Thr Ser Ala Ala Ala Ala Ala Ala Gln Hi - #s Gln Pro Gln Pro Gln          370              - #   375              - #   380                          - - Pro Gln Pro Gln Pro Ser Ser Leu Thr Gln As - #n Asp Ser Gln His Gln      385                 3 - #90                 3 - #95                 4 -      #00                                                                              - - Thr Gln Pro Gln Leu Gln Pro Gln Leu Pro Pr - #o Gln Leu Gln Gly        Gln                                                                                             405  - #               410  - #               415             - - Leu Gln Pro Gln Leu Gln Pro Gln Leu Gln Th - #r Gln Leu Gln Pro Gln                  420      - #           425      - #           430                  - - Ile Gln Pro Gln Pro Gln Leu Leu Pro Val Se - #r Ala Pro Val Pro Ala              435          - #       440          - #       445                      - - Ser Val Thr Ala Pro Gly Ser Leu Ser Ala Va - #l Ser Thr Ser Ser Glu          450              - #   455              - #   460                          - - Tyr Met Gly Gly Ser Ala Ala Ile Gly Pro Il - #e Thr Pro Ala Thr Thr      465                 4 - #70                 4 - #75                 4 -      #80                                                                              - - Ser Ser Ile Thr Ala Ala Val Thr Ala Ser Se - #r Thr Thr Ser Ala        Val                                                                                             485  - #               490  - #               495             - - Pro Met Gly Asn Gly Val Gly Val Gly Val Gl - #y Val Gly Gly Asn Val                  500      - #           505      - #           510                  - - Ser Met Tyr Ala Asn Ala Gln Thr Ala Met Al - #a Leu Met Gly Val Ala              515          - #       520          - #       525                      - - Leu His Ser His Gln Glu Gln Leu Ile Gly Gl - #y Val Ala Val Lys Ser          530              - #   535              - #   540                          - - Glu His Ser Thr Thr Ala                                                  545                 5 - #50                                                    - -  - - (2) INFORMATION FOR SEQ ID NO:19:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 855 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: CDS                                                             (B) LOCATION: 1..853                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..855                                                          (D) OTHER INFORMATION: - #/note= "domain = glucocorticoid                          receptor - #ligand binding domain."                             - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:                              - - ACA AAG AAA AAA ATC AAA GGG ATT CAG CAA GC - #C ACT GCA GGA GTC TCA           48                                                                       Thr Lys Lys Lys Ile Lys Gly Ile Gln Gln Al - #a Thr Ala Gly Val Ser             1               5 - #                 10 - #                 15              - - CAA GAC ACT TCG GAA AAT CCT AAC AAA ACA AT - #A GTT CCT GCA GCA TTA           96                                                                       Gln Asp Thr Ser Glu Asn Pro Asn Lys Thr Il - #e Val Pro Ala Ala Leu                        20     - #             25     - #             30                  - - CCA CAG CTC ACC CCT ACC TTG GTG TCA CTG CT - #G GAG GTG ATT GAA CCC          144                                                                       Pro Gln Leu Thr Pro Thr Leu Val Ser Leu Le - #u Glu Val Ile Glu Pro                    35         - #         40         - #         45                      - - GAG GTG TTG TAT GCA GGA TAT GAT AGC TCT GT - #T CCA GAT TCA GCA TGG          192                                                                       Glu Val Leu Tyr Ala Gly Tyr Asp Ser Ser Va - #l Pro Asp Ser Ala Trp                50             - #     55             - #     60                          - - AGA ATT ATG ACC ACA CTC AAC ATG TTA GGT GG - #G CGT CAA GTG ATT GCA          240                                                                       Arg Ile Met Thr Thr Leu Asn Met Leu Gly Gl - #y Arg Gln Val Ile Ala            65                 - # 70                 - # 75                 - # 80       - - GCA GTG AAA TGG GCA AAG GCG ATA CTA GGC TT - #G AGA AAC TTA CAC CTC          288                                                                       Ala Val Lys Trp Ala Lys Ala Ile Leu Gly Le - #u Arg Asn Leu His Leu                            85 - #                 90 - #                 95              - - GAT GAC CAA ATG ACC CTG CTA CAG TAC TCA TG - #G ATG TTT CTC ATG GCA          336                                                                       Asp Asp Gln Met Thr Leu Leu Gln Tyr Ser Tr - #p Met Phe Leu Met Ala                       100      - #           105      - #           110                  - - TTT GCC TTG GGT TGG AGA TCA TAC AGA CAA TC - #A AGC GGA AAC CTG CTC          384                                                                       Phe Ala Leu Gly Trp Arg Ser Tyr Arg Gln Se - #r Ser Gly Asn Leu Leu                   115          - #       120          - #       125                      - - TGC TTT GCT CCT GAT CTG ATT ATT AAT GAG CA - #G AGA ATG TCT CTA CCC          432                                                                       Cys Phe Ala Pro Asp Leu Ile Ile Asn Glu Gl - #n Arg Met Ser Leu Pro               130              - #   135              - #   140                          - - TGC ATG TAT GAC CAA TGT AAA CAC ATG CTG TT - #T GTC TCC TCT GAA TTA          480                                                                       Cys Met Tyr Asp Gln Cys Lys His Met Leu Ph - #e Val Ser Ser Glu Leu           145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - CAA AGA TTG CAG GTA TCC TAT GAA GAG TAT CT - #C TGT ATG AAA ACC        TTA      528                                                                    Gln Arg Leu Gln Val Ser Tyr Glu Glu Tyr Le - #u Cys Met Lys Thr Leu                          165  - #               170  - #               175              - - CTG CTT CTC TCC TCA GTT GCT AAG GAA GGT CT - #G AAG AGC CAA GAG TTA          576                                                                       Leu Leu Leu Ser Ser Val Ala Lys Glu Gly Le - #u Lys Ser Gln Glu Leu                       180      - #           185      - #           190                  - - TTT GAT GAG ATT CGA ATG ACT TAT ATC AAA GA - #G CTA GGA AAA GCC ATC          624                                                                       Phe Asp Glu Ile Arg Met Thr Tyr Ile Lys Gl - #u Leu Gly Lys Ala Ile                   195          - #       200          - #       205                      - - GTC AAA AGG GAA GGG AAC TCC AGT CAG AAC TG - #G CAA CGG TTT TAC CAA          672                                                                       Val Lys Arg Glu Gly Asn Ser Ser Gln Asn Tr - #p Gln Arg Phe Tyr Gln               210              - #   215              - #   220                          - - CTG ACA AAG CTT CTG GAC TCC ATG CAT GAG GT - #G GTT GAG AAT CTC CTT          720                                                                       Leu Thr Lys Leu Leu Asp Ser Met His Glu Va - #l Val Glu Asn Leu Leu           225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - ACC TAC TGC TTC CAG ACA TTT TTG GAT AAG AC - #C ATG AGT ATT GAA        TTC      768                                                                    Thr Tyr Cys Phe Gln Thr Phe Leu Asp Lys Th - #r Met Ser Ile Glu Phe                          245  - #               250  - #               255              - - CCA GAG ATG TTA GCT GAA ATC ATC ACT AAT CA - #G ATA CCA AAA TAT TCA          816                                                                       Pro Glu Met Leu Ala Glu Ile Ile Thr Asn Gl - #n Ile Pro Lys Tyr Ser                       260      - #           265      - #           270                  - - AAT GGA AAT ATC AAA AAG CTT CTG TTT CAT CA - #A AAA T GA                 - #    855                                                                    Asn Gly Asn Ile Lys Lys Leu Leu Phe His Gl - #n Lys                                   275          - #       280                                             - -  - - (2) INFORMATION FOR SEQ ID NO:20:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 284 amino - #acids                                                (B) TYPE: amino acid                                                          (D) TOPOLOGY: linear                                                 - -     (ii) MOLECULE TYPE: protein                                           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:                              - - Thr Lys Lys Lys Ile Lys Gly Ile Gln Gln Al - #a Thr Ala Gly Val Ser        1               5 - #                 10 - #                 15              - - Gln Asp Thr Ser Glu Asn Pro Asn Lys Thr Il - #e Val Pro Ala Ala Leu                   20     - #             25     - #             30                  - - Pro Gln Leu Thr Pro Thr Leu Val Ser Leu Le - #u Glu Val Ile Glu Pro               35         - #         40         - #         45                      - - Glu Val Leu Tyr Ala Gly Tyr Asp Ser Ser Va - #l Pro Asp Ser Ala Trp           50             - #     55             - #     60                          - - Arg Ile Met Thr Thr Leu Asn Met Leu Gly Gl - #y Arg Gln Val Ile Ala       65                 - # 70                 - # 75                 - # 80       - - Ala Val Lys Trp Ala Lys Ala Ile Leu Gly Le - #u Arg Asn Leu His Leu                       85 - #                 90 - #                 95              - - Asp Asp Gln Met Thr Leu Leu Gln Tyr Ser Tr - #p Met Phe Leu Met Ala                  100      - #           105      - #           110                  - - Phe Ala Leu Gly Trp Arg Ser Tyr Arg Gln Se - #r Ser Gly Asn Leu Leu              115          - #       120          - #       125                      - - Cys Phe Ala Pro Asp Leu Ile Ile Asn Glu Gl - #n Arg Met Ser Leu Pro          130              - #   135              - #   140                          - - Cys Met Tyr Asp Gln Cys Lys His Met Leu Ph - #e Val Ser Ser Glu Leu      145                 1 - #50                 1 - #55                 1 -      #60                                                                              - - Gln Arg Leu Gln Val Ser Tyr Glu Glu Tyr Le - #u Cys Met Lys Thr        Leu                                                                                             165  - #               170  - #               175             - - Leu Leu Leu Ser Ser Val Ala Lys Glu Gly Le - #u Lys Ser Gln Glu Leu                  180      - #           185      - #           190                  - - Phe Asp Glu Ile Arg Met Thr Tyr Ile Lys Gl - #u Leu Gly Lys Ala Ile              195          - #       200          - #       205                      - - Val Lys Arg Glu Gly Asn Ser Ser Gln Asn Tr - #p Gln Arg Phe Tyr Gln          210              - #   215              - #   220                          - - Leu Thr Lys Leu Leu Asp Ser Met His Glu Va - #l Val Glu Asn Leu Leu      225                 2 - #30                 2 - #35                 2 -      #40                                                                              - - Thr Tyr Cys Phe Gln Thr Phe Leu Asp Lys Th - #r Met Ser Ile Glu        Phe                                                                                             245  - #               250  - #               255             - - Pro Glu Met Leu Ala Glu Ile Ile Thr Asn Gl - #n Ile Pro Lys Tyr Ser                  260      - #           265      - #           270                  - - Asn Gly Asn Ile Lys Lys Leu Leu Phe His Gl - #n Lys                              275          - #       280                                             - -  - - (2) INFORMATION FOR SEQ ID NO:21:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 50 base - #pairs                                                  (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..50                                                           (D) OTHER INFORMATION: - #/note= "element = copper inducible                       regulatory - #element (ACE1 binding site)."                     - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:                              - - AGCTTAGCGA TGCGTCTTTT CCGCTGAACC GTTCCAGCAA AAAAGACTAG  - #                  50                                                                         - -  - - (2) INFORMATION FOR SEQ ID NO:22:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 19 base - #pairs                                                  (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..19                                                           (D) OTHER INFORMATION: - #/note= "element = tet operator."           - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:                              - - ACTCTATCAG TGATAGAGT             - #                  - #                      - # 19                                                                   - -  - - (2) INFORMATION FOR SEQ ID NO:23:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 29 base - #pairs                                                  (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..29                                                           (D) OTHER INFORMATION: - #/note= "element = ecdysone response                      element."                                                       - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:                              - - GATCCGACAA GGGTTCAATG CACTTGTCA         - #                  - #                29                                                                      - -  - - (2) INFORMATION FOR SEQ ID NO:24:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 371 base - #pairs                                                 (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: double                                                      (D) TOPOLOGY: linear                                                 - -     (ix) FEATURE:                                                                  (A) NAME/KEY: misc.sub.-- - #feature                                          (B) LOCATION: 1..371                                                          (D) OTHER INFORMATION: - #/note= "element = heat shock                             inducible - #regulatory element (HSP81-1 promoter)."            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:                              - - GTGGAGTCTC GAAACGAAAA GAACTTTCTG GAATTCGTTT GCTCACAAAG CT -             #AAAAACGG     60                                                                 - - TTGATTTCAT CGAAATACGG CGTCGTTTTC AAAGAACAAT CCAGAAATCA CT -            #GGTTTTCC    120                                                                 - - TTTATTTCAA AAGAAGAGAC TAGAACTTTA TTTCTCCTCT ATAAAATCAC TT -            #TGTTTTTC    180                                                                 - - CCTCTCTTCT TCATAAATCA ACAAAACAAT CACAAATCTC TCGAAACGCT CT -            #CGAAGTTC    240                                                                 - - CAAATTTTCT CTTAGCATTC TCTTTCGTTT CTCGTTTGCG TTGAATCAAA GT -            #TCGTTGCG    300                                                                 - - ATGGCGGATG TTCAGATGGC TGATGCAGAG ACTTTTGCTT TCCAAGCTGA GA -            #TTAACCAG    360                                                                 - - CTTCTTAGCT T               - #                  - #                      - #      371                                                                  - -  - - (2) INFORMATION FOR SEQ ID NO:25:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 29 base - #pairs                                                  (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                 - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:                              - - GGATCCGGAT CAAAAATGGG AAGGGGTAG         - #                  - #                29                                                                      - -  - - (2) INFORMATION FOR SEQ ID NO:26:                                    - -      (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 30 base - #pairs                                                  (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                 - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:                              - - GGATCCGCTG CGGCGAAGCA GCCAAGGTTG         - #                  - #               30                                                                    __________________________________________________________________________

I claim:
 1. A substantially purified nucleic acid molecule encoding anAP1 gene product having an amino acid sequence selected from the groupconsisting of SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO:
 8. 2. Asubstantially purified nucleic acid molecule having a nucleic acidsequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO:5 and SEQ ID NO:
 7. 3. A substantially purified nucleotide sequencehaving at least ten contiguous nucleotides of SEQ ID NO:7, provided thatsaid nucleotide sequence does not encode a portion of a MADS domain. 4.A vector, comprising a nucleic acid molecule encoding an AP1 geneproduct selected from the group consisting of:the nucleic acid moleculeof claim 1 and the nucleic acid molecule of claim
 2. 5. A method ofproducing an AP1 gene product, comprising expressing a nucleic acidmolecule selected from the group consisting of:the nucleic acid moleculeof claim 1 and the nucleic acid molecule of claim
 2. 6. An expressionvector, comprising a nucleic acid molecule encoding an AP1 gene producthaving an amino acid sequence selected from the group consisting of SEQID NO: 4, SEQ ID NO: 6 and SEQ ID NO:
 8. 7. The expression vector ofclaim 6, wherein said expression vector is a plant expression vector. 8.A plant expression vector, comprising a nucleic acid molecule encodingan AP1 gene product having at least about 70 percent amino acid identitywith the amino acid sequence of SEQ ID NO: 2 in the region from aminoacid 1 to amino acid 163 or with the amino acid sequence of SEQ ID NO: 8in the region from amino acid 1 to amino acid
 163. 9. The plantexpression vector of claim 7, wherein said heterologous regulatoryelement is a constitutive regulatory element.
 10. The plant expressionvector of claim 9, wherein said constitutive regulatory element is acauliflower mosaic virus 35S promoter.
 11. The plant expression vectorof claim 7, wherein said heterologous regulatory element is an inducibleregulatory element.
 12. A kit for converting shoot meristem to floralmeristem in an angiosperm, comprising the plant expression vector ofclaim
 7. 13. A kit for promoting early reproductive development in aseed plant, comprising the plant expression vector of claim
 7. 14. Thenucleotide sequence of claim 3, which has at least 14 contiguousnucleotides of SEQ ID NO:7.
 15. The nucleotide sequence of claim 3,which has at least 25 contiguous nucleotides of SEQ ID NO:7.
 16. Thesubstantially purified nucleic acid molecule of claim 1, wherein saidAP1 gene product has the amino acid sequence SEQ ID NO:
 4. 17. Thesubstantially purified nucleic acid molecule of claim 1, wherein saidAP1 gene product has the amino acid sequence SEQ ID NO:
 6. 18. Thesubstantially purified nucleic acid molecule of claim 1, wherein saidAP1 gene product has the amino acid sequence SEQ ID NO:
 8. 19. Theexpression vector of claim 6, wherein said AP1 gene product has theamino acid sequence SEQ ID NO:
 4. 20. The expression vector of claim 6,wherein said AP1 gene product has the amino acid sequence SEQ ID NO: 6.21. The expression vector of claim 6, wherein said AP1 gene product hasthe amino acid sequence SEQ ID NO: 8.